<?xml version="1.0" encoding="ISO-8859-1" ?>
<rss version="2.0" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">

<channel>
<title cf:type="text">American Conference Institute</title>
<link>http://www.americanconference.com/</link>
<description cf:type="text">Business Information In A Global Context</description>
<copyright>C5 Group Inc.</copyright>
<category>Education/Conferences</category>
<image>
<url>http://www.americanconference.com/images/rss/aci.png</url>
<title>American Conference Institute</title>
<link>http://www.americanconference.com/</link>
</image>


<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Public and Corporate Procurement in Russia</title>
<link>http://www.americanconference.com/2013/562/public-and-corporate-procurement-in-russia/</link>
<pubDate>Tue 21 May 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Moscow | &lt;P align=right&gt;&lt;A name=RUS&gt;&lt;/A&gt;&lt;A href=&quot;http://sare.cicomm.com/admin/js/event-manager/index.php#ENG&quot;&gt;ENG&lt;/A&gt; | &lt;A href=&quot;http://sare.cicomm.com/admin/js/event-manager/index.php#RUS&quot;&gt;RUS&lt;/A&gt; &lt;/P&gt;
&lt;P align=center&gt;&lt;STRONG&gt;??????????? «??????????????? ? ????????????? ??????? ? ??????»&lt;BR&gt;21-22 ???, ??????, ??????&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;??????? ??????? ? ?????? ???????? ????? ???????????? ?????????. ???????????? ? ??????????? ??????????? ???????&amp;nbsp; (???) ? ????? ??????? ???????, ????? ? ????? ??? ?????? ? ?????? ??????. ??????????????? ???? ?????????? ??? ? ???? 2014 ???. &lt;BR&gt;??????????? ????? ?? ?? 18 ???? 2011 ?. N 223-?? &quot;? ???????? ???????, ?????, ????? ?????????? ?????? ??????????? ???&quot; ??????? ? ???? 1 ?????? 2012 ????. ????? ?????????? ? ???? ?????? ? ???, ??????? ??????? ? ?????? ????? ????????? ????????. ????? ???????????? ??????????????? ????????????? ??????? ????? ???????, ? ??? ????? ??????????????? ? ????????????, ????????????? ?????????? ????????, ?????????? ??????????, ????? ? ???????? ?????????? ???????????. ??? ??????? ?????????? ????? ???????? ?????????? ??????????????? ???????, ??????? ???????????? ???????? ? ??????????????? ????, ????????? ??????? ?????????? ??????. ????? ? ??? ??????? ??????????? ??????????? ????? ?? 21 ???? 2005 ???? N 94-?? &quot;? ?????????? ??????? ?? ???????? ???????, ?????????? ?????, ???????? ????? ??? ??????????????? ? ????????????? ????&quot;. ?????????? ???? ???????????? ???????????????? ????????????? ?????????? ???????????? ? ?????? ?????????? ???????? ???????, ? ?? ???????????? ??????? ? ???????????? ? ???????? ?? ????? ??????? ????? ???????? ? ???????? ???????????? ? ??????????? ??????.&lt;/P&gt;
&lt;P&gt;??????????? &lt;STRONG&gt;«??????????????? ? ????????????? ??????? ? ??????»&lt;/STRONG&gt; ?????? ?????????? ??? ??????? ???????? ??????? ? ???????? ????? ???????????? ? ????????. ??????????? ??????? ?? ????? ?????? ?????????????? ??????? ??????????????? ??????, ??????????????? ????????, ???????????? ?????????, ???????? ???????, ? ????? ?????????? ? ??????????? ?? ????????? ?????????, ?????? ??????????, ???????, ????????????? ? ???? ???????? ?????????? ???????? ??? ??????????? ?????????? ???????? ????????????, ??????? ???????? ?????????? ???????, ?????? ?????? ? ????? ???????? ?????????? ?????????? ???????????? ? ??????. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;????????? ??????????? ????????????. ??? ????????? ?????????, ??????????, ??????????? ? ????&amp;nbsp;????&amp;nbsp; &lt;/STRONG&gt;&lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;&lt;STRONG&gt;a.keable@C5-Online.com&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;.&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;?? ?????????????? ??????????? ? ???????????? ????????? ?? ???????????, ??????????, ??????????? ? &lt;BR&gt;&lt;STRONG&gt;????????? ???????????&lt;/STRONG&gt; &lt;BR&gt;????? ?????????&lt;BR&gt;email:&amp;nbsp;&amp;nbsp;&lt;A href=&quot;mailto:e.maksimova@C5-Online.com&quot;&gt;e.maksimova@C5-Online.com&lt;/A&gt;&lt;BR&gt;???: +44 (0)20 7878 6916&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;?? ???????? ??????????:&lt;BR&gt;&lt;/STRONG&gt;???? ????&lt;BR&gt;email: &lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;a.keable@C5-Online.com&lt;/A&gt;&lt;BR&gt;???: +44(0)20 78786931&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;?? ???????? ???????????:&lt;BR&gt;&lt;/STRONG&gt;?????????? ?????????? &lt;BR&gt;email: &lt;A href=&quot;mailto:v.penlington@C5-Online.com&quot;&gt;v.penlington@C&lt;U&gt;&lt;FONT color=#0000ff&gt;5-Online.com&lt;/A&gt; &lt;/FONT&gt;&lt;/U&gt;&lt;BR&gt;???:&amp;nbsp; +44(0)20 78786871&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P align=center&gt;&lt;A name=ENG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P align=center&gt;&lt;STRONG&gt;The Conference &quot;Public and Corporate Procurement in Russia&quot;&lt;BR&gt;21-22 May, Moscow, Russia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=center&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The procurement system in Russia is going through a major overhaul. The draft of brand new Law on Federal Contract System (FCS) in regard to goods, works and services purchase has been already adopted in the first reading. The preliminary date of its coming into force is year 2014.&lt;/P&gt;
&lt;P&gt;The Federal law of RF dated 18 July 2011 N 223-FZ &quot;Purchase of goods, works and services by certain types of legal entities&quot; came into force since 1 January 2012. Upon FCS coming into force the existing purchasing system in Russia will be completely changed. The draft stipulates regulation of complete purchasing cycle, including forecasting and planning, purchasing procedures implementation, contracts performance, audit and control under results. FCS aims to provide with the new quality of government order management, increase public control and antidumping measures, broaden biddings methods. FCS law will replace existing Federal Law dated 21 July 2005 N 94-?? &quot;On Procurement of Goods, Works and Services for State and Municipal Needs&quot;. Application of the current law regulating the purchase activity in Russia continues arising questions, thus non-compliance with laws and non-availability to switch to the new system may cause huge commercial and legal risks.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Public and Corporate Procurement in Russia&lt;/STRONG&gt; will become the platform for meeting of key players and dialog between government and business. The Conference will gather altogether representatives of government authorities and corporations, natural monopolies, business, as well as purchasers and contractors from different industries, members of associations, lawyers, consultants and other main parties involved into joint discussion of forthcoming developments, contemporary problems solution, experience exchange in the issues arising from procurement activities in Russia.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The conference program is now available. To make sure you receive the brochure please contact Anna Keable &lt;/STRONG&gt;&lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;&lt;STRONG&gt;a.keable@C5-Online.com&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;.&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;For additional information and speaking opportunities please contact:&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Conference producer:&lt;BR&gt;&lt;/STRONG&gt;Elena Maksimova&lt;BR&gt;email:&amp;nbsp;&lt;A href=&quot;mailto:e.maksimova@C5-Online.com&quot;&gt;&lt;STRONG&gt;e.maksimova@C5-Online.com&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt; &amp;nbsp;&lt;BR&gt;&lt;/STRONG&gt;tel: &lt;STRONG&gt;+44 (0)20 7878 6916&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;For marketing opportunities:&lt;BR&gt;&lt;/STRONG&gt;Anna Keable&lt;BR&gt;email:&lt;U&gt;&lt;FONT color=#0000ff&gt; &lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;a.keable@C5-Online.com&lt;/A&gt;&lt;/FONT&gt;&lt;/U&gt;&amp;nbsp;&lt;BR&gt;tel: +44(0)20 78786931&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;For sponsorship opportunities:&lt;BR&gt;&lt;/STRONG&gt;Vladislava Penlington&lt;BR&gt;email: &lt;A href=&quot;mailto:v.penlington@C5-Online.com&quot;&gt;v.penlington@C&lt;U&gt;&lt;FONT color=#0000ff&gt;5-Online.com&lt;/A&gt;&lt;BR&gt;&lt;/FONT&gt;&lt;/U&gt;tel:&amp;nbsp; +44(0)20 78786871&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Russia and CIS</category>
<category>Legal</category>
<category>Regulatory Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/562/public-and-corporate-procurement-in-russia/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">BIG FOUR</title>
<link>http://www.americanconference.com/2013/821/big-four/</link>
<pubDate>Tue 21 May 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | At this annual conference, pricing experts will lay out the fundamentals
 of &quot;Big Four&quot; pricing and pharmacy benefits programs in a logical, 
easy-to-understand format and will provide intensive training in the 
essential pricing concepts and methodologies related to &lt;b&gt;VA, DoD, PHS&lt;/b&gt;, and Coast Guard programs.&lt;br&gt;&lt;br&gt;The
 U.S. government spends billions of dollars per year on the purchase of 
drugs making it one of the largest purchasers of pharmaceuticals in the 
U.S. Sales to the government typically account for a large portion of a 
company's total revenue, and a company cannot remain competitive in 
today's market without selling to the government. As pharmaceutical 
manufacturers' revenue and profits are so closely tied to government 
contracts and pricing, it is essential to have a thorough understanding 
of the Veterans Health Care Act, Federal Supply Schedule Contracting, 
Federal Ceiling Price, and pharmacy benefits programs.&lt;br&gt;&lt;br&gt;While 
having the government as a client is lucrative, it can be costly, time 
consuming and confusing. Understanding the basics and key terms of &quot;Big 
Four&quot; pricing is necessary to ensure that companies do not enter into 
price contracts that obligate them to comply with impossible terms. 
Selling to the VA, DoD, PHS and Coast Guard also requires constant price
 calculations and price reporting. These calculations are often 
perplexing and result in price anomalies that can leave even the most 
seasoned contracting practitioner baffled. On top of complying with the 
&quot;Big Four's&quot; numerous rules and regulations, companies must also 
evaluate how their &quot;Big Four&quot; prices affect their overall pricing. &lt;br&gt;&lt;br&gt;Designed
 to give novices and experienced practitioners alike a complete 
understanding of core pricing competencies, ACI has assembled a faculty 
of the &lt;b&gt;government authorities&lt;/b&gt; on &quot;Big Four&quot; pricing and pharmacy benefits programs along with &lt;b&gt;expert pricing practitioners&lt;/b&gt;.
 This distinguished faculty will make sense of complicated terminology 
and pricing calculations and teach you how to navigate the complexities 
of working with the &quot;Big Four&quot; agencies.&lt;br&gt;&lt;br&gt;As our delegates would agree, you cannot afford to miss this event.&amp;nbsp; &lt;br&gt;&lt;b&gt;&lt;i&gt;&lt;br&gt;&quot;The
 ?Big Four' conference provided me with a great source of concepts and 
examples to follow and understand. I believe the boot camp is a fabulous
 tool for people who are new to government contracting and pricing.&quot;&lt;/i&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;Towanda Little, Associate Manager of Government Pricing, Eisai Inc, Prior Delegate&lt;br&gt;For
 those attendees seeking a primer on &quot;Big Four&quot; pricing, the 
pre-conference workshop, &quot;Big Four Pricing 101,&quot; is a great opportunity 
to learn the fundamentals of federal pricing and will prepare you for 
the more advanced discussions that will take place during the main 
conference. The post-conference workshop, &quot;Advanced Training in DoD and 
TRICARE Contracting, Formulary, and Operational Issues,&quot; will provide 
the information and strategies you need to make interactions with the 
DoD and TMA more efficient and less burdensome.&lt;br&gt;&lt;br&gt;&lt;b&gt;Register now by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering online at &lt;a href=&quot;http://www.americanconference.com/bigfourpharma&quot;&gt;www.americanconference.com/bigfourpharma&lt;/a&gt;&amp;nbsp; &lt;br&gt;&lt;/b&gt;&lt;br&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/821/big-four/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">8th Advanced Forum on Global Customs Compliance</title>
<link>http://www.americanconference.com/2013/567/8th-advanced-forum-on-global-customs-compliance/</link>
<pubDate>Wed 22 May 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Brussels | &lt;P align=center&gt;&lt;STRONG&gt;Minimise Importation Duties, Accelerate Customs Clearance and Optimise your Trade Compliance Operations&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;The challenge of staying compliant with global customs regulations is putting a lot of pressure on multinationals with global supply chains and numerous third parties, as a single error when dealing with thousands of international transactions could lead to border delays, significant fines and other cost-related issues. Customs professionals are finding it difficult to follow not only quickly-changing customs regulations such as the new GSP rules of origin; but also to deal with a whole array of confusing inconsistencies in the application of existing customs regulations and standards at local, EU or international level. Despite this, customs authorities are widening the scope of their customs monitoring to ensure that no stones are left unturned. It is imperative that you get up to speed on the asymmetric requirements in different jurisdictions; and your organisation implements effective and secure customs compliance systems to avoid being caught out in the event of an investigation or customs audit. &lt;/P&gt;
&lt;P&gt;With a global and difficult economic recovery underway, companies are importing and exporting more and more in emerging markets to boost growth and market share. Companies seeking to import into Russia &amp;amp; CIS, China, the Middle East, Brazil and Turkey must overcome complex customs requirements and non-tariff barriers to ensure that they do not suffer any penalties, import delays and expend additional costs on external legal fees. &lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;C5's Advanced Forum on Global Customs Compliance&lt;/STRONG&gt; event is now the largest and most valued conference of its kind in Brussels, and will again, at the 8th Advanced Forum bring together leading compliance executives, lawyers and government officials dedicated to global customs compliance to take you through all the key regulatory updates in the area of global customs and share best practices as to how to cost-effectively implement global customs compliance systems. &lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The brochure of the conference is now available. To make sure you get your copy, please contact Anna Keable, Marketing Manager&amp;nbsp;on &lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;a.keable@C5-Online.com&lt;/A&gt;.&lt;/STRONG&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Legal</category>
<category>Regulatory Compliance</category>
<category>International Trade</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/567/8th-advanced-forum-on-global-customs-compliance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Health Care Privacy and Security Forum</title>
<link>http://www.americanconference.com/2013/830/health-care-privacy-and-security-forum/</link>
<pubDate>Wed 22 May 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;P&gt;&lt;STRONG&gt;Prepare Now For New HIPAA Privacy and Security Responsibilities in the Age of HITECH.&lt;/STRONG&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;On January 17, 2013, HHS's&amp;nbsp;Office of Civil Rights (OCR) released the long- awaited &lt;STRONG&gt;Final Omnibus HIPAA Privacy Rule (the Final Rule)&lt;/STRONG&gt; pursuant to the HITECH Act and answered many long pondered questions for HIPAA covered-entities and a now expanded-circle of business associates concerning privacy and security of protected health care information; breach notification; and enforcement. As HHS Secretary Kathleen Sebelius stated, &quot;the new rule will help protect patient privacy and safeguard patients' health information in an ever expanding digital age.&quot;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The Final Rule goes into effect this March and has A&amp;nbsp;Mandate of Full Compliance by Late September. Yout Must Act Quickly to Meet These Deadlines and Have the Tools and the &quot;Know-How&quot; to Address the Legal and Business Challenges&amp;nbsp;in this Next&amp;nbsp;Layer of&amp;nbsp;the Health Care Privacy and Security Matrix.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Attend ACI's Health Care Privacy and Security Forum and Get the Critical Information thatYou Need to Meet Your HIPAA and HITECH Privacy and Security Challenges Head-On.&lt;/STRONG&gt;&lt;BR&gt;&lt;BR&gt;ACI has designed the third iteration of its Health Care Privacy and Security Forum to help you navigate the legal and business complexities associated with HIPAA; HITECH; state privacy and security laws and regulations; and the ever evolving legal and regulatory privacy and security landscape. Our faculty of privacy and security experts which includes government representatives will walk you through the legal and business challenges associated with the new regulations; &lt;STRONG&gt;HIT infrastructure and EHRs; HIEs; business associates; breach; encryption; enforcement; private law suits; secondary data usage; &lt;/STRONG&gt;and&lt;STRONG&gt; international protocols.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Benefit from Special Training and Strategy Sessions that Will Address the Essentials of HIPAA and HITECH and Critical Privacy and Security Compliance Audit Competencies.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;To enhance and complete your conference experience, we are pleased to offer the following additional sessions:&lt;BR&gt;&lt;BR&gt;? &lt;B&gt;HIPAA and HITECH Boot Camp: Intensive Training in Privacy and Security Essentials for Health Care Professionals&lt;/B&gt; which will provide you with the legal and regulatory backdrop for the more in-depth HIPAA and HITECH controversies discussed in the main conference; and&lt;BR&gt;&lt;BR&gt;? &lt;B&gt;The Working Group on Auditing, Updating and Perfecting Your Existing HIPAA / HITECH Privacy and Security Compliance Program&lt;/B&gt; which will help you prepare for HITECH-mandated HHS compliance audits applicable to both HIPAA covered-entities and business associates; and implement best practices to ensure that your current compliance program is in-check with current law and regulations.&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Reserve Your Place Now at this Critical HIPAA and HITECH Event.&lt;BR&gt;&lt;/STRONG&gt;&lt;BR&gt;Register now by calling &lt;STRONG&gt;1-888-224-2480&lt;/STRONG&gt;, faxing your registration form to &lt;STRONG&gt;1-877-927-1563&lt;/STRONG&gt; or logging on to &lt;STRONG&gt;www.AmericanConference.com/HIPAA-HITECH.&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<category>Ethics Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/830/health-care-privacy-and-security-forum/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Aviation Claims &amp; Litigation</title>
<link>http://www.americanconference.com/2013/801/aviation-claims--litigation/</link>
<pubDate>Wed 29 May 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;p&gt;&lt;strong&gt;The  aviation industry's premier claims and litigation event returns for its 5th  year, this time on the famed Magnificent Mile in Chicago, led by an expert  in-house/client faculty, FAA, DOT and other government officials, top law firms  and renowned federal judges.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The  aviation industry is facing unique challenges, including large scale products  liability claims, malfunctions and crashes in and out of the United States,  complex procedural issues and the potential for criminal liability. These all  have a significant impact on a company's bottom line, and with changing  regulations, enforcement priorities, investigative practices and a motivated  plaintiffs' bar, it is critical that counsel are prepared to manage claims and  are armed with the best defense strategies for their corporate clients. &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;ACI's  5th National Forum on Defending and Managing AVIATION CLAIMS &amp;amp; LITIGATION &lt;/strong&gt;is designed to offer even the most  seasoned aviation attorneys valuable insights on solving these challenges and  provide unparalleled networking opportunities with representatives from  companies including: &lt;em&gt;Bell Helicopter Textron, XL Insurance Company, Trans  States Holding, Catlin Canada, Allianz Global Corporate and Specialty, United  States Aircraft Insurance Group, Textron, Inc., Garmin International, Catlin  Group Ltd., British Airways, and many more?&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;This  is the only event in the industry that brings together federal judges,  regulatory and enforcement officials, leading outside litigators and key  in-house counsel and claims officers. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;By  attending you will: &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Hear an  in depth analysis from brokers, carriers, underwriters and adjusters on risk  management strategies, claims and coverage, valuation, and recent trends  affecting aviation insurance &lt;/li&gt;
  &lt;li&gt;Gain  valuable business development tips from in-house counsel who will provide  insight into case evaluation, managing the costs of litigation and working with  outside counsel &lt;/li&gt;
  &lt;li&gt;Improve  your litigation strategy by hearing directly from 6 federal judges on how they  interpret evidence and arguments specifically in the aviation context &lt;/li&gt;
  &lt;li&gt;Get the  latest updates on aviation investigation and enforcement trends from FAA and  DOT officials &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Plus,  complete your 2-day experience by getting 2 hours of Ethics CLE at the  workshop:&lt;/p&gt;
&lt;p&gt;Ensuring  Confidentiality in the Litigation of Aviation Claims&lt;/p&gt;
&lt;p&gt;Register now by calling &lt;strong&gt;888-224-2480 &lt;/strong&gt;or faxing your registration form to &lt;strong&gt;877-927-1563&lt;/strong&gt;. &lt;/p&gt;

</description>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<category>Transportation</category>
<category>Ethics Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/801/aviation-claims--litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Wage &amp; Hour Claims and Class Actions</title>
<link>http://www.americanconference.com/2013/804/wage--hour-claims-and-class-actions/</link>
<pubDate>Thu 30 May 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;The wage and hour landscape continues to evolve at a blistering pace, with the potential for damaging claims at an all-time high. That is why it is essential that defense counsel be fully prepared for the coming tidal wave of claims and class actions. Come join your colleagues and clients at the nation's premier wage and hour defense forum and hone the skills and strategies needed to keep pace with this rapidly changing area of law, defend against new and innovative claims, and prepare for emerging regulations and evolving enforcement priorities&lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;American Conference Institute's&lt;/i&gt; &lt;b&gt;18th National Forum on Wage &amp;amp; Hour Claims and Class Actions&lt;/b&gt; will provide you with an unparalleled opportunity to convene with expert in-house counsel from &lt;i&gt;Walmart, Coca-Cola, Bank of America, Microsoft, Home Depot, U.S. Bank, Dow Jones &amp;amp; Co., American Airlines, Darden Restaurants, Covidien, Cisco Systems, Wells Fargo, Marsh &amp;amp; McLennan, RBS, Kaplan, IBM, The Hartford, DIRECTV, Family Dollar Stores, TIAA-CREF, Reed Elsevier, and AXA Equitable&lt;/i&gt;, as well as renowned federal and state judges, top government officials, and leading outside defense counsel from around the nation, who will provide you with expert advice, insider strategies, and comprehensive updates on:&lt;br&gt;&lt;ul&gt;&lt;li&gt;Assessing the impact of &lt;i&gt;Wal-Mart v. Dukes &lt;/i&gt;and its progeny on FLSA collective actions, Rule 23 class actions, and hybrid cases&lt;/li&gt;&lt;li&gt;Obtaining decertification of a class at different stages of the litigation process&lt;/li&gt;&lt;li&gt;Overcoming the complexities of managing and defending against multidistrict litigation&lt;/li&gt;&lt;li&gt;Managing and defending against the latest claims from the plaintiffs' bar&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;br&gt;Register now by calling &lt;b&gt;1-888-224-2480&lt;/b&gt; or by faxing your&lt;br&gt;&lt;/div&gt;&lt;div align=&quot;center&quot;&gt;registration form to&lt;b&gt; 1-877-927-1563&lt;/b&gt;. You can also register online&lt;br&gt;at &lt;a href=&quot;http://www.AmericanConference.com/WageAndHour&quot;&gt;&lt;b&gt;AmericanConference.com/WageAndHour&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Employment &amp; Benefits</category>
<category>Litigation</category>
<category>Ethics Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/804/wage--hour-claims-and-class-actions/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Employee Benefit Plans</title>
<link>http://www.americanconference.com/2013/842/employee-benefit-plans/</link>
<pubDate>Thu 30 May 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | Employee benefit plans and the laws that govern them are inherently complex and constantly evolving. The preeminent issue on the tip of everyone's tongue is healthcare reform, or PPACA (Patient Protection and Affordable Care Act). While 2014 is the watershed year for the Act, employers need to begin their compliance efforts now.&lt;br&gt;&lt;br&gt;With guidance issuances and regulatory developments coming in following the November 2012 election,&lt;b&gt; ACI's 2nd National Advanced Compliance and Benchmarking Forum on Minimizing Legal Risks in the Design, Implementation &amp;amp; Administration of EMPLOYEE BENEFIT PLANS&lt;/b&gt; will make sense of it all and equip you with the essential information and practical guidance you need.&lt;br&gt;&lt;br&gt;Add to this the complex landscape of corporate scandals, major bankruptcies, and a volatile stock market, all resulting in billions of dollars in retirement plan losses, and it has never been more vital for in-house professionals and outside counsel for plan fiduciaries, sponsors, administrators, advisors and insurers to &lt;i&gt;avoid poor or inconsistent drafting, design, implementation, and administration of employee benefit plans.&lt;/i&gt;&lt;br&gt;&lt;br&gt;However, having good, accurate and consistent employee plan documents is vastly easier said than done. In keeping the language in employee benefi t plans &quot;up to snuff,&quot; counsel for companies, plan fiduciaries, sponsors, administrators, advisors and insurers face a distinct uphill battle, including: &lt;i&gt;Incomplete/missing/inconsistent documents; Document provisions not aligning with actual plan administration; Document &quot;slippage&quot; ? issues that arise when a plan's operating procedures and/or its administrative documents &quot;drift&quot; from the offi cial plan document; Improper delegation of decision-making authority? Just to name a few&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;As a result of this uphill battle&lt;/b&gt;, there is simply no room for error when it comes to minimizing the increased litigation risk in this high stakes arena. Companies regularly fi nd themselves facing millions of dollars in potential liability and recent cases have even involved claims of billions of dollars. &lt;b&gt;In response, this conference also serves as the prevention counterpart to our renowned ERISA Litigation conference&lt;/b&gt;, focusing on the &lt;u&gt;&lt;b&gt;front end preventive aspects&lt;/b&gt;&lt;/u&gt; of employee benefi ts law: Through a faculty of distinguished in-house counsel and leading outside counsel, this conference will provide even the most seasoned employee benefit lawyers with clarity and certainty with respect &lt;i&gt;to today's key risk minimization issues.&lt;/i&gt;</description>
<category>Employment &amp; Benefits</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/842/employee-benefit-plans/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Summit on Advertising Privacy Compliance: Mobile Apps, Smart Phones &amp; the World Wide Web</title>
<link>http://www.americanconference.com/2013/844/summit-on-advertising-privacy-compliance-mobile-apps-smart-phones--the-world-wide-web/</link>
<pubDate>Tue 4 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;In an Era Where Advertising is Moving Increasingly Toward the Digital Sphere, Ensure Your Company Remains Competitive and Compliant &lt;br&gt;
  Washington is Watching  You ? Are You Watching Your Consumers?&lt;/strong&gt;&lt;br&gt;
  &lt;br&gt;
  Behavioral targeting has become an area of great concern not only for the States, but the federal government as well.  The FTC and Congress have made it clear that new legislation is on the horizon.  As behavioral advertising becomes more pervasive, consumers are increasingly concerned that their privacy is being compromised.  Learn how to legally comply with privacy laws, while developing highly targeted marketing.  At &lt;strong&gt;American Conference Institute's Summit on Advertising Privacy Compliance: Mobile Apps, Smart Phones &amp;amp; the World Wide Web, you will have the opportunity to hear directly from the government, including the FTC and California, Texas and Virginia Attorney General's Offices. &lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;As Advertising Becomes More Global, Effectively Navigate Across Jurisdictional Variances &lt;/strong&gt;&lt;br&gt;
  &lt;br&gt;
Global advertising campaigns provide an immense opportunity for companies to reach a broader audience, but also bring greater risks with language barriers, cultural differences and differing privacy requirements.  In order to protect your investment, ensure that you fully understand the Safe Harbor requirements and understand the complexities of being a good global player in each of the respective companies that you do business. &lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Network With the Top U.S. Advertisers and the Attorneys Who Counsel Them&lt;/strong&gt;&lt;br&gt;
  &lt;br&gt;
  Networking breakfasts, lunches, and a cocktail reception provide multiple opportunities throughout the conference to interact with other attendees.  By attending this conference, you will have the opportunity to meet the movers and shakers in the advertising industry.  Our speaker faculty is comprised of more than 20 in-house counsel, giving you a tremendous opportunity to benchmark your practices.  Featured companies at this conference include: &lt;strong&gt;AIG, Avon, Best Buy, Foursquare, Google, Hewlett Packard, JPMorgan, Motorola, Nike, and many more!&lt;/strong&gt;&lt;br&gt;
  &lt;br&gt;
  &lt;strong&gt;Pre-Conference Drafting Day Enables You to Drill Down into the Nuances of Disclosures and Privacy Policies &lt;/strong&gt;&lt;br&gt;
  &lt;br&gt;
As an advertiser, you have the constant eyes of the FTC, FCC, and state governments monitoring your advertising privacy initiatives.  Because there are so many different components involved, creating a privacy infrastructure can be an overwhelming process.  The &lt;strong&gt;Advertisers' Working Group Session:  Drafting a Privacy Policy from the Ground Up &lt;/strong&gt;will enable attendees to drill down into the specific language that should be used when drafting an advertising privacy policy. &lt;/p&gt;
&lt;p&gt;The &lt;strong&gt;Disclosure Review:  Drafting a Universal Playbook for Mobile Disclosures &lt;/strong&gt;will offer you a unique opportunity to sit down and share best practices for developing mobile disclosures and will serve as a document exchange among practitioners. &lt;/p&gt;
&lt;p&gt;Register now to ensure your place at this industry-leading event.  Call &lt;strong&gt;1-888-224-2480&lt;/strong&gt;, fax your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt;, or register online at &lt;strong&gt;www.americanconference.com/advertisingprivacy. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;I look forward to seeing you in New York in June!&lt;/p&gt;
&lt;p&gt;Sincerely,&lt;br&gt;
    &lt;br&gt;
  Stacey B. Evans, J.D.&lt;br&gt;
  Senior Conference Director&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;

</description>
<category>Advertising &amp; Marketing</category>
<category>Regulatory &amp; Compliance</category>
<category>Telecoms &amp; Technology</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/844/summit-on-advertising-privacy-compliance-mobile-apps-smart-phones--the-world-wide-web/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">U.S. Economic Sanctions Enforcement &amp; Compliance</title>
<link>http://www.americanconference.com/2013/769/us-economic-sanctions-enforcement--compliance/</link>
<pubDate>Wed 5 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | U.S. sanctions against &lt;b&gt;Iran, Burma/Myanmar, Syria&lt;/b&gt; and other regimes continue to evolve, and with that, financial institutions and exporters across the globe face unprecedented U.S. enforcement risks. Recent big ticket, multi-million dollar settlements have served as a stark reminder of the extra-territoriality of OFAC sanctions, and the heavy price tag for violations. Whether you or your clients represent U.S. or foreign entities, OFAC, the U.S. Department of Justice and other agencies have made it clear that enforcement is worldwide and vigorous.&lt;br&gt;&lt;br&gt;Now in its sixth successful year, &lt;i&gt;&lt;b&gt;American Conference Institute's&lt;/b&gt;&lt;/i&gt; &lt;b&gt;Advanced Forum on Economic Sanctions Compliance &amp;amp; Enforcement&lt;/b&gt; is widely regarded as &lt;i&gt;the &lt;b&gt;only true benchmarking and networking forum focusing on highly complex issues affecting global financial, insurance and export transactions&lt;/b&gt;&lt;/i&gt;. The 2013 agenda has been updated to reflect all key, evolving OFAC, DoJ and SEC developments that are keeping you up at night.&lt;br&gt;&lt;br&gt;Each year, professionals from a broad range of organizations attend this event to ensure that they are fully updated on the myriad of best practices for implementing new, evolving sanctions restrictions, and strengthening their screening and compliance programs accordingly.&lt;br&gt;&lt;br&gt;The highly sophisticated 2013 agenda is &lt;u&gt;&lt;b&gt;fully updated&lt;/b&gt;&lt;/u&gt;, featuring a &lt;u&gt;&lt;b&gt;new expert speaker line-up&lt;/b&gt;&lt;/u&gt; of senior government officials, industry professionals and private practice experts. &lt;br&gt;&lt;br&gt;Based on the past success of this event, seats are expected to sell out. Register now by calling &lt;b&gt;1-888-224-2480&lt;/b&gt;; faxing your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt;; or registering online at &lt;a href=&quot;http://www.AmericanConference.com/OFAC&quot;&gt;&lt;b&gt;AmericanConference.com/OFAC&lt;/b&gt;&lt;/a&gt;.&lt;br&gt;&lt;br&gt;Save your seat at a &lt;b&gt;special early bird rate that will expire soon&lt;/b&gt;. Based on the past success of this event, &lt;b&gt;seats are expected to sell out&lt;/b&gt;. Register now by calling &lt;b&gt;1-888-224-2480&lt;/b&gt; or online.&lt;br&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/769/us-economic-sanctions-enforcement--compliance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Automotive Product Liability Litigation</title>
<link>http://www.americanconference.com/2013/805/automotive-product-liability-litigation/</link>
<pubDate>Thu 6 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;b&gt;Now in its 6th year, ACI's lauded Automotive Product Liability Litigation conference is the highest level national event on the market.&lt;/b&gt; It's the only one that combines federal and state judicial insights and networking and business development opportunities with dozens of in-house counsel from manufacturers and suppliers, all while allowing you to keep pace with the hot jurisdictions, case law, new and emerging defendants, and advancements in technology.&lt;br&gt;&lt;br&gt;&lt;i&gt;Vehicle safety assist technology, class actions and class certification, consumer fraud and disclosure/accuracy claims, seat back litigation, regulatory initiatives, jury consultants, distracted driving, social media, rising costs of litigation?&lt;b&gt;THE NEW PARADIGM IS HERE&lt;/b&gt;&lt;/i&gt;.&lt;br&gt;&lt;br&gt;In response, American Conference Institute is proud to bring you its 6th installment of the essential summit that shapes the future of products liability strategies for leading litigators and in-house counsel in the automotive industry: &lt;b&gt;Defending and Managing AUTOMOTIVE PRODUCT LIABILITY LITIGATION&lt;/b&gt;.&lt;br&gt;&lt;br&gt;Through a faculty of distinguished in-house counsel from &lt;b&gt;Bridgestone, Isuzu, Markel, Honda, Kawasaki, Chrysler, Hyundai, General Motors, Deere &amp;amp; Company, U-Haul, Kia, Toyota, Caterpillar, Yokohama Tire and many others&lt;/b&gt;, leading outside counsel, as well renowned federal and state jurists, &lt;i&gt;this conference will provide even the most seasoned automotive lawyers with clarity and certainty with respect to today's key issues.&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;i&gt;&lt;b&gt;BE A PART OF THIS ESSENTIAL SUMMIT THAT SHAPES THE FUTURE OF PRODUCTS LIABILITY STRATEGIES IN THE YEAR AHEAD FOR LEADING LITIGATORS AND IN-HOUSE COUNSEL IN THE AUTOMOTIVE INDUSTRY&lt;br&gt;&lt;/b&gt;&lt;/i&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;PLUS, BE SURE TO REGISTER FOR THE MASTER CLASS ON June 7:&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;E&lt;/b&gt;&lt;b&gt;nsuring Confidentiality in the Litigation of Automotive Product Liability Cases:&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;EARN 2 HOURS OF CLE ETHICS CREDITS&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;br&gt;Register now by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your registration form&lt;br&gt;&lt;/div&gt;&lt;div align=&quot;center&quot;&gt;to &lt;b&gt;877-927-1563&lt;/b&gt; or registering online at&lt;br&gt;&lt;a href=&quot;http://www.AmericanConference.com/Automotive&quot;&gt;&lt;b&gt;AmericanConference.com/Automotive&lt;br&gt;&lt;/b&gt;&lt;/a&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Litigation</category>
<category>Ethics Credits</category>
<category>Transportation</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/805/automotive-product-liability-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Energy Trading Compliance and Regulatory Enforcement</title>
<link>http://www.americanconference.com/2013/846/energy-trading-compliance-and-regulatory-enforcement/</link>
<pubDate>Thu 6 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Houston | &lt;p&gt;&lt;strong&gt;Led by CFTC and FERC, industry leading companies, and outside attorneys who are tuned into the recent changes, this is the only energy trading compliance conference that looks ahead and offers measurable strategies and tactics to ensure that compliance programs fit seamlessly into the new regulatory landscape.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;As the Dodd Frank regulations have materialized, the FERC and the CFTC continue to sort out their jurisdictional reach, and the industry finds itself faced with CFTC's new rules and final product definitions, companies have been left struggling with questions on how to comply with regulations in a post-Dodd Frank world. Increased enforcement efforts coupled with congressionally-sanctioned penalties makes regulatory compliance more important than ever. &lt;/p&gt;
&lt;p&gt;Now in its 7th installment, and back in Houston for the first time in years, &lt;strong&gt;ACI's Energy Trading Compliance &amp;amp; Regulatory Enforcement&lt;/strong&gt; is the industry's premier event that directly addresses the most pressing compliance issues and regulatory initiatives that companies and their outside counsel need to be aware of. This program is designed to offer insights into pending rules and enforcement programs by the energy regulatory bodies, and explains the impact of increased federal scrutiny on the energy trading practice. It features a distinguished faculty of leaders from &lt;strong&gt;&lt;u&gt;FERC and CFTC&lt;/u&gt;, as well as Hess Corporation, PJM Interconnection, Con Edison, Mercuria Energy Trading, Enbridge Energy Company, E.ON Energy Trading SE, DB Energy Trading LLC, National Energy Marketers Association, The Energy Authority, CenterPoint Energy, Inc., Xcel Energy, Tri-County Electric Cooperative, Inc., Bank of America Merrill Lynch, JP Morgan Chase, and Exelon.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Attend this conference to hear the leaders in the industry share their insights into the current state of the energy trading space, as well as proven strategies for preparing a compliance program that will be responsive to all of the newly enacted, and often difficult to grasp, regulatory changes. As the industry continues to be faced with drastic changes, you cannot afford to miss this important event to ensure your compliance program is ready.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Plus be sure to also register for the:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt; &lt;u&gt;Pre-Conference Primer&lt;/u&gt;: Fundamentals of Energy Trading Compliance&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;&lt;u&gt; Post-Conference Master Class&lt;/u&gt;: Maximizing the Effectiveness of Surveillance Programs to Meet Cross-Agency Requirements, Minimize Risk, &amp;amp; Reduce Sentencing&lt;/strong&gt;&lt;/li&gt;
&lt;/ul&gt;

</description>
<category>Energy &amp; Resources</category>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/846/energy-trading-compliance-and-regulatory-enforcement/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Biosimilars</title>
<link>http://www.americanconference.com/2013/823/biosimilars/</link>
<pubDate>Thu 6 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;b&gt;Attend the one event where the
industry leaders driving the business of biosimilars unite to set the standards
which will shape an evolving legal and regulatory landscape &lt;/b&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-top:12.0pt;margin-right:0in;margin-bottom:
12.0pt;margin-left:0in&quot;&gt;With the election over and PPACA firmly established as
law, the rush to the biosimilar market has begun in earnest.&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;At ACI's fourth annual Biosimilars
conference, the key figures who are shaping the evolving biosimilar
landscape--- leading policy makers, in-house representatives from branded and
generic biotechnology and pharmaceutical companies, and top-tier litigators and
patent prosecutors--- will convene to formulate solutions to the challenging
questions left standing in the wake of the historic legislation:&lt;/p&gt;

&lt;ul type=&quot;disc&quot;&gt;&lt;li class=&quot;MsoNormal&quot; style=&quot;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     mso-list:l0 level1 lfo1;tab-stops:list .5in&quot;&gt;Complying with the FDA
     standards on the abbreviated biosimilars pathway requirements&lt;/li&gt;&lt;li class=&quot;MsoNormal&quot; style=&quot;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     mso-list:l0 level1 lfo1;tab-stops:list .5in&quot;&gt;Meeting the heightened
     standard of interchangeability and outlining the parameters of similarity
     in the contextof large complex biological compounds&lt;/li&gt;&lt;li class=&quot;MsoNormal&quot; style=&quot;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     mso-list:l0 level1 lfo1;tab-stops:list .5in&quot;&gt;Analyzing the complex patent
     resolution mechanisms outlined in the statute and proactively preparing
     for the intricate exchange process &lt;/li&gt;&lt;li class=&quot;MsoNormal&quot; style=&quot;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     mso-list:l0 level1 lfo1;tab-stops:list .5in&quot;&gt;Ascertaining the volume and
     level of safety data that will be required to prove patient safety and
     efficacy to facilitate approval&amp;nbsp; &lt;/li&gt;&lt;li class=&quot;MsoNormal&quot; style=&quot;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     mso-list:l0 level1 lfo1;tab-stops:list .5in&quot;&gt;Determining the financial
     viability of biosimilars and exploring alternative pathways to approval
     including biobetters &lt;/li&gt;&lt;li class=&quot;MsoNormal&quot; style=&quot;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     mso-list:l0 level1 lfo1;tab-stops:list .5in&quot;&gt;The debate over naming and
     the new bills introduced restricting the ability of pharmacists to
     substitute generic versions of biological drugs for brand name products&lt;/li&gt;&lt;li class=&quot;MsoNormal&quot; style=&quot;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     mso-list:l0 level1 lfo1;tab-stops:list .5in&quot;&gt;Investigating the impact of
     citizen's petitions on the biosimilars market&lt;/li&gt;&lt;/ul&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-top:12.0pt;margin-right:0in;margin-bottom:
12.0pt;margin-left:0in&quot;&gt;&lt;b&gt;The major players are preparing for the
inevitable--- the litigation and the attacks on biosimilar IP that are sure to
come&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-top:12.0pt;margin-right:0in;margin-bottom:
12.0pt;margin-left:0in&quot;&gt;With a now estimated $140 billion in potential
biologics sales at stake annually and a wave of patent expirations starting in
2014, there will be a hard-fought battle to protect and increase market
share.&amp;nbsp; Whether you are on the branded or generic side, you cannot afford
to miss this opportunity to benchmark your tactics and strategies against the
industry leaders who will be the first to traverse the pathway.&amp;nbsp; Devise an
immediate action plan for your biosimilar prosecution and litigation strategies
in light of the barriers to entry, research and development costs, and
regulatory hurdles, which are balanced against an enormous potential for
increased profit margins.&amp;nbsp; &lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-top:12.0pt;margin-right:0in;margin-bottom:
12.0pt;margin-left:0in&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;Hear What Prior
Attendees are Saying about this Annual Leading Event:&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNoSpacing&quot; style=&quot;margin-left:.5in;text-indent:-.25in;mso-list:l1 level1 lfo2&quot;&gt;&lt;span style=&quot;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings&quot;&gt;&lt;span style=&quot;mso-list:Ignore&quot;&gt;-&lt;span style=&quot;font:7.0pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&quot;One of the best CLEs I've been to in 10 years&quot; &lt;/p&gt;

&lt;p class=&quot;MsoNoSpacing&quot; style=&quot;margin-left:.5in;text-indent:-.25in;mso-list:l1 level1 lfo2&quot;&gt;&lt;span style=&quot;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings&quot;&gt;&lt;span style=&quot;mso-list:Ignore&quot;&gt;-&lt;span style=&quot;font:7.0pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&quot;Excellent program ? informative and
thought-provoking.&quot; &lt;/p&gt;

&lt;p class=&quot;MsoNoSpacing&quot; style=&quot;margin-left:.5in;text-indent:-.25in;mso-list:l1 level1 lfo2&quot;&gt;&lt;span style=&quot;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings&quot;&gt;&lt;span style=&quot;mso-list:Ignore&quot;&gt;-&lt;span style=&quot;font:7.0pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&quot;I thought all the speakers did an excellent job
in terms of content and delivery.&quot;&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNoSpacing&quot; style=&quot;margin-left:.5in;text-indent:-.25in;mso-list:l1 level1 lfo2&quot;&gt;&lt;span style=&quot;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings&quot;&gt;&lt;span style=&quot;mso-list:Ignore&quot;&gt;-&lt;span style=&quot;font:7.0pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&quot;Excellent seminar.&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;A lot of learning, new points of view talked
about and dealt with.&quot;&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin&quot;&gt;Full conference details are on the way shortly.&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;If you are interested in speaking at this
event, contact Nicole Cutrufello-Turner at n.cutrufello@americanconference.com.&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;For information on sponsoring or exhibiting
at this event, contact Esther Fleischhacker at &lt;/span&gt;&lt;a href=&quot;mailto:e.fleischhacker@americanconference.com&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:
Calibri;mso-fareast-theme-font:minor-latin&quot;&gt;e.fleischhacker@americanconference.com&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin&quot;&gt;.&lt;/span&gt;&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot;&gt;Based on past success, &lt;b&gt;spaces will fill up quickly&lt;/b&gt;.
Register now by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your registration form to &lt;b&gt;877-927-1563
&lt;/b&gt;or registering online at &lt;a href=&quot;http://www.americanconference.com/biosimilars&quot;&gt;www.americanconference.com/biosimilars&lt;/a&gt;.
&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;&amp;nbsp;&lt;/p&gt;

&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;Hyperlink&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;}
&lt;/style&gt;
&lt;![endif]--&gt;</description>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/823/biosimilars/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Import Compliance &amp; Enforcement</title>
<link>http://www.americanconference.com/2013/835/import-compliance--enforcement/</link>
<pubDate>Tue 11 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;}
&lt;/style&gt;
&lt;![endif]--&gt;&lt;b&gt;Join senior government officials, highly respected companies and leading practitioners at what is regarded as the premier import compliance benchmarking event of the year.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Each year, import compliance and legal professionals attend &lt;b&gt;American Conference Institute's Advanced Forum on Import Compliance &amp;amp; Enforcement&lt;/b&gt; to meet and learn from leading trade compliance executives and attorneys, and ask questions directly to senior government officials. &lt;br&gt;&lt;br&gt;Now in its 8th successful year, the &lt;b&gt;fully updated&lt;/b&gt; and &lt;b&gt;highly practical agenda&lt;/b&gt; has evolved further to include even more discussion of highly complex U.S. import compliance challenges, along with more content on how to satisfy Canadian and Mexican customs authorities.&lt;br&gt;&lt;br&gt;Highly complex issues such as valuation, assists, transfer pricing and proving origin under key FTAs continue to challenge even the most seasoned import compliance professionals. At the same time, Centers of Excellence, ISA program changes, new C-TPAT risk assessment and foreign re-validation requirements, and recent CBP penalty trends will surely impact importers' global compliance programs going forward. &lt;b&gt;Unlike other conferences&lt;/b&gt;, this unique event is designed to provide attendees with a comprehensive benchmarking experience, where participants can&lt;br&gt;exchange best practices and lessons learned for 2013 and beyond.&lt;br&gt;&lt;br&gt;&lt;b&gt;Benefit from new sessions for 2013, including:&lt;/b&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;An in-depth session on &lt;b&gt;Centers of Excellence:&lt;/b&gt; Hear from two CBP offi cials and CEE participants about their recent experiences&lt;/li&gt;&lt;li&gt;Two highly focused sessions on valuation and transfer pricing:&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; - &lt;b&gt;The Finer Points of Allocating, Valuating and Declaring Assists: &lt;/b&gt;Critical&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Pitfalls to Avoid amid Heightened Penalty Risks&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; - &lt;b&gt;Reconciling IRS and CBP Positions&lt;/b&gt; on Valuation and Transfer Pricing&lt;/li&gt;&lt;li&gt;&lt;b&gt;ISA Member Case Studies&lt;/b&gt; ? Learn from new and longstanding members about their recent experiences, and how to meet ISA requirements&lt;/li&gt;&lt;li&gt;Enhanced focus on &lt;b&gt;C-TPAT and Foreign Re-Validations:&lt;/b&gt; Ask your questions to CBP and industry experts on how to satisfy expectations for C-TPAT risk assessments, and how the new EU Mutual Recognition Agreement affects importer validation requirements&lt;/li&gt;&lt;li&gt;SPECIAL FOCUS ON FTAs:&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; - &lt;b&gt;Q &amp;amp; A with CBP and Canada Border Services Agency&lt;/b&gt; on NAFTA Verification audits and enforcement&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&lt;b&gt; NAFTA, CAFTA AND U.S.-KOREA FTA SUCCESS STORIES:&lt;/b&gt; Gain practical know-how for minimizing duties, fees, taxes and red tape&lt;/li&gt;&lt;li&gt;Learn the finer points of developing a &lt;b&gt;global strategy for customs classification and tariff engineering&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;u&gt;&lt;b&gt;New, Intensive Pre-Conference Working Groups ? June 10, 2013:&lt;/b&gt;&lt;/u&gt;&lt;b&gt; &lt;br&gt;&lt;br&gt;A GLOBAL TRADE COMPLIANCE PROGRAM BENCHMARKING&lt;/b&gt; ?&lt;br&gt;How to Strengthen Your Global Trade Compliance Program to Enhance Competitiveness and Profi tability: Updating Your Business Case to Senior Management, and Approach to Data Integrity, Metrics, Quality and Costs&lt;br&gt;&lt;br&gt;&lt;b&gt;B CANADIAN CUSTOMS COMPLIANCE DO'S AND DON'TS&lt;/b&gt; ?&lt;br&gt;What Every Global Trade Compliance Professional Should Know about Customs Regulations in Canada: A Deep Dive into Core Requirements to Integrate into Your Global Trade Compliance Program&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;Book your seat now and benefi t from an early bird rate for a limited time. To register, call &lt;b&gt;1-888-224-2480&lt;/b&gt;; fax your registration form to&lt;b&gt; 1-877-927-1563&lt;/b&gt;; or register online at&lt;b&gt; &lt;a href=&quot;http://www.AmericanConference.com/Import&quot;&gt;AmericanConference.com/Import&lt;/a&gt;&lt;/b&gt;.&lt;br&gt;&lt;br&gt;</description>
<category>Regulatory &amp; Compliance</category>
<category>Aerospace and Defense</category>
<category>International Trade</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/835/import-compliance--enforcement/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">International &amp; Cross-Border Payments</title>
<link>http://www.americanconference.com/2013/847/international--cross-border-payments/</link>
<pubDate>Thu 13 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;p&gt;&lt;strong&gt;&lt;em&gt;Be a  part of the premier event on international and cross-border&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;payments  and obtain the critical insights and strategic knowledge needed&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt; to  overcome the legal, compliance, technical, and business hurdles that&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt; prevent  others from achieving success in the global payments market.&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;As the  world becomes increasingly connected, &lt;strong&gt;the global marketplace is quickly  becoming the only marketplace that matters &lt;/strong&gt;? and this is eminently visible  in the payments market.&lt;strong&gt;&amp;nbsp; &lt;/strong&gt;In order  to continue growing, financial institutions, payment processors, remitters,  card&lt;strong&gt; &lt;/strong&gt;networks, program managers, telecoms, and new and emerging payment  companies will&lt;strong&gt; &lt;/strong&gt;have to begin operating on a global basis, if they are  not already doing so.&amp;nbsp; However, &lt;strong&gt;with the  increased opportunities for new markets and vast growth potential comes a range  of legal, compliance, technical, and operational challenges&lt;/strong&gt;.&lt;strong&gt;&amp;nbsp; &lt;/strong&gt;Only  those companies that can&lt;strong&gt; &lt;/strong&gt;successfully overcome these challenges will be  able to thrive in the new payments landscape.&lt;strong&gt;&amp;nbsp; &lt;/strong&gt;And given the rapid pace of technological  advancement, combined with ever-changing and&lt;strong&gt; &lt;/strong&gt;often conflicting  country-and region-specific regulatory frameworks, &lt;strong&gt;companies that do not wish  to become obsolete must act now in order to be able to successfully compete in  the new global payments market.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Building on the  incredible success of our East Coast event and in response to demand from the  market, &lt;em&gt;American Conference Institute&lt;/em&gt; has developed the &lt;strong&gt;2nd  Advanced Forum on International &amp;amp; Cross-Border Payments&lt;/strong&gt;, now on the  West Coast!&amp;nbsp; Our unparalleled faculty of  international payments professionals, including in-house counsel and  compliance experts, senior executives from leading companies in the  global payments market, high-level regulatory and enforcement officials,  and top payments counsel from around the world, will provide attendees  with the insights and tools necessary to overcome the legal, compliance,  technical,and business challenges and achieve success in the evolving  global market.&lt;/p&gt;
&lt;p&gt;Register  now by calling &lt;strong&gt;888-224-2480 &lt;/strong&gt;or faxing your registration form  to &lt;strong&gt;877-927-1563&lt;/strong&gt;.&lt;strong&gt;&amp;nbsp; &lt;/strong&gt;You can also register  online at &lt;strong&gt;&lt;a href=&quot;http://www.AmericanConference.com/InternationalPayments&quot;&gt;www.AmericanConference.com/InternationalPayments&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://www.AmericanConference.com/InternationalPayments&quot;&gt;&lt;br&gt;&lt;/a&gt;&lt;br&gt;&lt;/p&gt;</description>
<category>Financial Services</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/847/international--cross-border-payments/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Anti-Corruption West Africa</title>
<link>http://www.americanconference.com/2013/554/anti-corruption-west-africa/</link>
<pubDate>Tue 18 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Lagos | &lt;P align=center&gt;&lt;STRONG&gt;C5's Second Forum on Anti-Corruption ? West Africa&lt;BR&gt;&lt;BR&gt;&lt;EM&gt;18-19 June, 2013&lt;BR&gt;&lt;/EM&gt;&lt;/STRONG&gt;&lt;BR&gt;&lt;EM&gt;&lt;STRONG&gt;Four Points by Sheraton, Lagos, Nigeria&lt;/STRONG&gt;&lt;BR&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Unparalleled networking and benchmarking opportunities with both an international and local faculty of senior-level executives and information you can't get anywhere else make this event the region's premier anti-corruption compliance forum. &lt;BR&gt;&lt;BR&gt;Last year your peers from a wide variety of industry sectors including&lt;STRONG&gt; Oil &amp;amp; Gas, Life Sciences, Finance, Consumer Goods, Energy, &lt;/STRONG&gt;and &lt;STRONG&gt;Telecoms &lt;/STRONG&gt;attended the &lt;EM&gt;Forum on Anti-Corruption ? West Africa&lt;/EM&gt;. Here is what they had to say about it: &lt;BR&gt;&lt;BR&gt;&lt;EM&gt;&quot;It was a very inclusive and interactive conference where opinions and experiences from most continents were candidly and constructively shared; combating corruption is not &quot;us against them&quot; but we are all in it together. This was an inspiring meeting with all the participants being involved, engaged, and prepared to speak up! It is worth to be repeated&quot; &lt;STRONG&gt;Chief Compliance Counsel EMEA, Tyco International (The Netherlands)&lt;/STRONG&gt;&lt;/EM&gt;&lt;BR&gt;&lt;EM&gt;&quot;Excellent presentation material and dialogue-very interactive with a genuine representation of the challenges faced within the region and sound guidance and real world examples on how to mitigate the risks associated with doing business in West Africa&quot; &lt;STRONG&gt;Africa Region Logistics Manager, FMC Technologies Inc.(USA)&lt;/STRONG&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&quot;I would certainly recommend this forum to my colleagues. The information came from a very wide spectrum of perspectives and the references and links were sufficiently numerous. I have a wider toolkit for attending&quot; &lt;STRONG&gt;Legal Counsel ? Compliance, British American Tobacco Nigeria&lt;/STRONG&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&quot;I sincerely think it is a great initiative for business in West Africa. It was useful for me to attend and to learn from others. I would recommend it to my colleagues&quot; &lt;STRONG&gt;Compliance &amp;amp; Ethics Manager, Diageo Guinness Cameroon &lt;/STRONG&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Join us for the &lt;STRONG&gt;Second Forum on Anti-Corruption in Lagos&lt;/STRONG&gt; and take part in the region's only event that addresses your company's local bribery risks and provides a detailed look at the anti-bribery landscape in countries including the South Africa, Nigeria, Ghana, Equatorial Guinea, Democratic Republic of Congo, Cameroon, Ivory Coast and other jurisdictions crucial to your operations in West Africa. The updated 2013 programme will once again feature a stellar international faculty that will provide practical insights and interactive discussions on third party due diligence, preventing joint venture pitfalls, conducting internal investigations, implementing robust financial controls, meeting local contents requirements while complying with regulations and other critical anti-bribery compliance issues. &lt;BR&gt;________________________________________&lt;BR&gt;&lt;BR&gt;For speaking opportunities and any programmatic questions please contact &lt;STRONG&gt;Yvette Lingom&lt;/STRONG&gt; at &lt;A href=&quot;mailto:y.lingom@c5-online.com&quot;&gt;&lt;STRONG&gt;&lt;EM&gt;y.lingom@c5-online.com&lt;/EM&gt;&lt;/STRONG&gt;&lt;/A&gt;&lt;EM&gt;.&lt;/EM&gt;&amp;nbsp; &lt;BR&gt;&lt;BR&gt;If you are interested in learning more about sponsorship for this event, please contact &lt;STRONG&gt;Ed Malkoun&lt;/STRONG&gt;, Group Leader at &lt;A href=&quot;mailto:E.Malkoun@c5-online.com&quot;&gt;&lt;STRONG&gt;&lt;EM&gt;E.Malkoun@c5-online.com&lt;/EM&gt;&lt;/STRONG&gt;&lt;/A&gt; or at 44 207 878 6973.&lt;BR&gt;&lt;BR&gt;For more information on media partnerships please contact &lt;STRONG&gt;Karina Kusova&lt;/STRONG&gt;&lt;A href=&quot;mailto:k.kusova@c5-online.com&quot;&gt;&lt;EM&gt;k.kusova@c5-online.com&lt;/EM&gt;&lt;/A&gt; &lt;/P&gt;</description>
<category>Regulatory Compliance</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/554/anti-corruption-west-africa/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">China Summit on Anti-Corruption</title>
<link>http://www.americanconference.com/2013/996/china-summit-on-anti-corruption/</link>
<pubDate>Tue 18 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Shanghai | &lt;P&gt;&lt;STRONG&gt;Unparalleled networking and benchmarking opportunities at China's premier anti-corruption compliance forum. &lt;/STRONG&gt;&lt;STRONG&gt;An international faculty of senior-level executives who will provide you with information you can't get anywhere else. No other conference delivers this much value. &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Heightened anti-corruption enforcement will affect more companies in Asia than ever before. Are your compliance program and internal controls sophisticated enough to withstand the impact of government investigations? Do you know what the latest cases reveal about new risk areas and compliance standards?&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Every June, in-house counsel, ethics and compliance executives, forensic accountants, finance and internal audit executives as well as corporate attorneys from China and around the globe attend ACI/C5's China Summit on Anti-Corruption. Reserve your place today for what is regarded as the Anti-Corruption event of the year in China. Now in its 6th successful year, &lt;STRONG&gt;ACI/C5's Anti-Corruption&lt;/STRONG&gt; conference will once again provide latest anti-corruption enforcement initiatives in China and practical solutions for multinational companies' specific China operational challenges.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Focus on Recent FCPA, UK Bribery Act, China Commercial Bribery and World Bank Prosecuted Cases &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Recent published cases highlight increasing risks for multinational companies doing business in China. Many more pending investigations reportedly also involve compliance issues in China. This summit will feature senior lawyers who were involved in anti-corruption investigations and will provide the audience with practical strategies to minimize risks of being investigated.&lt;BR&gt;&lt;BR&gt;Book your place today before the conference is sold out. &lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Regulatory &amp; Compliance</category>
<category>Legal</category>
<category>Regulatory Compliance</category>
<category>Ethics Credits</category>
<category>Aerospace and Defense</category>
<category>China &amp; Singapore</category>
<category>Anti-Corruption &amp; Fraud</category>
<category>Anti-Corruption / FCPA</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/996/china-summit-on-anti-corruption/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Rx Drug Pricing Boot Camp - West Coast Edition</title>
<link>http://www.americanconference.com/2013/825/rx-drug-pricing-boot-camp---west-coast-edition/</link>
<pubDate>Wed 19 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;P&gt;&lt;STRONG&gt;Master calculations and grasp complexities inherent to government payor programs&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The ninth iteration of &lt;STRONG&gt;ACI's National Rx Drug Pricing Boot Camp&lt;/STRONG&gt; promises to supply crucial information on effective and efficient management of government pricing programs to drug manufacturers, PBMs, plans, and pharmacies. Marrying a primer on the basics of pricing for government payor programs and a comprehensive, in-depth, training program, this conference ensures that pricing groups and other related departments are well-versed in critical concepts and methodologies. Further, you will be apprised of trends, best practices, and imminent changes in government payor programs and pricing areas. This course will enhance your understanding of complicated pricing calculations and will bring you up to speed on the latest in government pharmaceutical pricing.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Gain best practices to comply with new regulations&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;At press time, CMS has yet to issue its new regulations governing the calculation AMP. It is anticipated that at the time of this event the CMS rule will be finalized and the industry will be facing the challenge of complying with and responding to these new rules. This conference will bring you up-to-the-minute information on recently enacted rules, regulations, and CMS guidance, detailing how your company can incorporate changes resulting from the implementation of health care reform into your pricing and compliance practices. Our faculty of pricing experts will help maximize your company's participation in government payor programs by eliminating the confusion and uncertainty created by health care reform.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Network with and learn from your fellow pricing and reimbursement professionals&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;In addition to intensive training in core pricing concepts, the &lt;STRONG&gt;11th National Rx Drug Pricing Boot Camp&lt;/STRONG&gt; is also an excellent forum for drug pricing professionals to network with their peers. This event typically has about 80% of its attendees come from drug manufacturers, PBMs, plans and pharmacies, making it an excellent place to hear experts from other companies on how they overcome pricing challenges. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Maximize the value of attendance with pre- and post-conference workshops featuring background information and in-depth analysis of pricing issues&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The Pre-Conference Workshop A: &lt;STRONG&gt;Government Payor Pricing 101: Primer for Professionals New to Pharmaceutical Pricing &lt;/STRONG&gt;has been designed specifically for those attendees who need a basic introduction to the complex subject of government drug pricing. This workshop will set the stage for the main conference and help attendees fl ow seamlessly into the conversations over the following days.&lt;/LI&gt;
&lt;LI&gt;The Post-Conference Workshop B: &lt;STRONG&gt;The Master Class on Federal Government Contracts and Pricing: FSS, VA, DoD, and More&lt;/STRONG&gt; will build on the pricing fundamentals covered during the main conference and delve into the core pricing competencies for the &quot;Big Four&quot; government agencies. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Past iterations of the Boot Camp sold out; register now to ensure your place at this unique and important event. Call &lt;STRONG&gt;1-888-224-2480&lt;/STRONG&gt;, fax your registration form to &lt;STRONG&gt;1-877-927-1563&lt;/STRONG&gt;, or &lt;A&gt;online&lt;/A&gt;.&lt;/P&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/825/rx-drug-pricing-boot-camp---west-coast-edition/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">FCPA Boot Camp</title>
<link>http://www.americanconference.com/2013/836/fcpa-boot-camp/</link>
<pubDate>Wed 19 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;P&gt;&lt;STRONG&gt;FCPA enforcement is here to stay. Attend ACI's Chicago FCPA Boot Camp and hear from expert legal counsel, accountants and compliance officers from companies across industries as they provide you with proven FCPA compliance practices to confront the global enforcement challenges that lie ahead.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Designed to provide you with global FCPA compliance strategies and internal controls you can implement at your company or with your clients, attendees of this highly-rated &lt;STRONG&gt;Chicago FCPA Boot Camp&lt;/STRONG&gt; will walk away with practical FCPA compliance solutions to meet their company's operational challenges regardless of the industry or sector. This even features an unprecedented speaker faculty led by the practitioners in the field, senior legal counsel and compliance officers from companies with sophisticated anti-corruption programs.&lt;BR&gt;&lt;BR&gt;Network and benchmark with your peers as you are guided through a dive deep exploration into:&lt;BR&gt;&lt;BR&gt;?&amp;nbsp;SEC and DOJ Joint Guidance: hear directly from the government on how the recent Guidance will impact your global FCPA compliance efforts&lt;BR&gt;?&amp;nbsp;Third Party Due Diligence: Strategies for evaluating and vetting brokers, suppliers, and agents&lt;BR&gt;?&amp;nbsp;Employee Engagement: How to keep employees invested in your anti-corruption compliance program&lt;BR&gt;?&amp;nbsp;Internal Controls ? What your books and records should look like and how to ensure they meet SEC expectations&lt;BR&gt;?&amp;nbsp;CASE STUDY: Inside and Effective FCPA Internal Investigation&lt;BR&gt;&lt;BR&gt;And much more!&lt;BR&gt;&lt;BR&gt;Don't miss this opportunity to share and gain best practices from your colleagues while learning what steps your company can take to ensure its compliance program meets government standards. Hear first-hand from companies with innovative FCPA compliance programs and lawyers who are on the front lines as they teach you how to navigate the nuances of FCPA compliance.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Register by calling 888-224-2480; faxing your registration to 877-927-1563; or register online at &lt;/STRONG&gt;&lt;STRONG&gt;&lt;A href=&quot;http://www.americanconference.com/FCPAChicago&quot;&gt;www.americanconference.com/FCPAChicago&lt;/A&gt;&lt;/STRONG&gt;&lt;STRONG&gt;.&lt;BR&gt;&lt;/STRONG&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>CPE Credits</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/836/fcpa-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">3rd Latin America Summit on Anti-Corruption</title>
<link>http://www.americanconference.com/2013/993/3rd-latin-america-summit-on-anti-corruption/</link>
<pubDate>Mon 24 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">São Paulo | Anti-Bribery Investigations and Prosecutions are Increasing in Latin America and Around the Globe. Can your Anti- Corruption Compliance Program Sustain the Heat of a Government Investigation? Learn What it Takes to Ensure Your Operations are Compliant with the FCPA, UKBA, and relevant laws in the Latin American Region.&lt;br&gt;&lt;br&gt;The Latin American market is growing tremendously, particularly in Brazil. More growth means more opportunity, but also more risk of corruption. With a score of 43 on Transparency International's Corruption Perception Index, the Brazil market brings serious corruption challenges. Heightened anti-corruption enforcement will affect more companies doing business in Latin America than ever before. Now is the time to demonstrate to employees and the enforcement agencies that anti-corruption is an important corporate objective that is taken seriously in Latin America.&lt;br&gt;&lt;br&gt;The highly-rated 3rd Latin America Summit on Anti-Corruption will bring together leading anti-corruption industry experts and counsel in Latin America for unparalleled networking and benchmarking opportunities. This event will cover important topics, including:&lt;br&gt;&lt;ul&gt;&lt;li&gt;Third Party Risks: Applying the right level of due diligence when vetting and selecting local agents, brokers, intermediaries and distributors in Latin America&lt;/li&gt;&lt;li&gt;Bill of Law 6.826: What to make of Brazil's pending &quot;Clean Company Act&quot;&lt;/li&gt;&lt;li&gt;Creating a Culture of Communication and Compliance in Latin America: How to communicate with employees throughout the company and keep them engaged&lt;/li&gt;&lt;li&gt;&amp;nbsp;&quot;Clean Games&quot;: Preventing pitfalls when bidding for contracts associated with the World Cup 2014 and the Olympics 2016&lt;/li&gt;&lt;li&gt;Conducting an Effective Anti-Corruption Risk Assessment in Latin America&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;u&gt;Also benefit from&lt;/u&gt;:&lt;br&gt;&lt;ul&gt;&lt;li&gt;Special session with the &lt;b&gt;Controller General's Office ? Brazil&lt;/b&gt;&lt;/li&gt;&lt;li&gt;Case Study on how to scope an Internal Investigation from start to finish and determine your action plan&lt;/li&gt;&lt;li&gt;Interactive Q&amp;amp;A Session: How to Prevent Gift, Entertainment, and Hospitality Trip Wires&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;u&gt;Enhance Your Experience with New Working Groups&lt;/u&gt;:&lt;br&gt;&lt;br&gt;&lt;b&gt;A. SEC and DOJ Joint FCPA Guidance on the Hallmarks of Effective Compliance Programs&lt;/b&gt;: How to Make Sure to Your Latin American Operations Are Meeting U.S. Anti-Corruption Standards.&lt;br&gt;&lt;br&gt;&lt;b&gt;B&lt;/b&gt;. &lt;b&gt;A Practical Guide Into Anti-Corruption TRAINING&lt;/b&gt;: How to Create a Robust, Culturally-Sensitive and Practical Anti-Corruption Training Curriculum for Employees and Third Parties and Successfully Conduct Training.&lt;br&gt;&lt;/p&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/993/3rd-latin-america-summit-on-anti-corruption/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Employment Practices Liability Insurance</title>
<link>http://www.americanconference.com/2013/849/employment-practices-liability-insurance/</link>
<pubDate>Mon 24 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;P&gt;&lt;STRONG&gt;Be a part of the nation's leading EPLI forum, this time on the West Coast!&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Our January EPLI conference was the largest in a decade! Don't miss this opportunity to attend our encore event. Speakers from all over the nation will come together to ensure that you are prepared to manage and defend against the increasing number of claims being filed, positioned to take advantage of new opportunities in the EPLI market, equipped to minimize exposure to risk, armed to tackle the rising costs of litigation, and primed for aggressive new NLRB and EEOC initiatives and enforcement plans.&lt;/P&gt;
&lt;P&gt;It is more important than ever that claims professionals, underwriters, risk managers, in-house counsel, brokers and outside counsel thoroughly understand the EPLI market, claims trends, how to minimize exposure to risk, and the most effective ways to reduce the costs of defending against and settling EPL claims. Retaliation, discrimination and other types of employment cases are crowding court dockets across the country, and with new sources of claims emerging, the influx of cases is on the rise. Failure to stay ahead of the curve could lead to catastrophic losses including multi-million dollar verdicts and settlement amounts.&lt;/P&gt;
&lt;P&gt;That is why you cannot afford to miss American Conference Institute's 19th National Employment Practices Liability Insurance conference.&amp;nbsp; For the past eighteen years, this conference has been attracting leaders from both the insurance and employment law communities.&amp;nbsp; This west coast installment has been revamped and updated to include enhanced industry perspectives, and account for new developments, strategies and industry trends.&amp;nbsp; Hear cutting-edge discussions from our exceptional faculty including: &lt;EM&gt;&lt;STRONG&gt;Aon, Bliss &amp;amp; Glennon,&amp;nbsp; Boehringer Ingelheim Pharmaceuticals, Inc., Canam Steel Corporation, Chubb, Cisco Systems, Inc., CNA U.S. Specialty Lines, E.L.M., Euclid Specialty Managers, Freedom Specialty Insurance , Markel, Marsh, Monitor Liability Managers , Philadelphia Insurance Companies, Socius, Solae LLC, Travelers, Wells Fargo Insurance Services, Willis FINEX, U.S. Risk Brokers&lt;/STRONG&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;PLUS,&lt;/STRONG&gt; add value to your attendance by also registering for the Pre-Conference Primer:&lt;/P&gt;
&lt;P&gt;Fundamentals of the EPLI Market: A Boot Camp for Underwriters, Claims Counsel, Brokers, and Corporate and Private Practice Employment Attorneys&lt;/P&gt;
&lt;P&gt;You do not want to miss this unparalleled opportunity to network with industry leaders while obtaining the information that you need to achieve success in the evolving &lt;STRONG&gt;EPLI&lt;/STRONG&gt; marketplace.&amp;nbsp;This must-attend event will fill up quickly, so register now by calling &lt;STRONG&gt;1-888-224-2480&lt;/STRONG&gt;, faxing your registration form to &lt;STRONG&gt;1-877-927-1563&lt;/STRONG&gt;, or registering online at &lt;STRONG&gt;&lt;A href=&quot;http://www.AmericanConference.com/EPLISNF&quot;&gt;www.AmericanConference.com/EPLISNF&lt;/A&gt;&lt;/STRONG&gt;&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Employment &amp; Benefits</category>
<category>Insurance &amp; Reinsurance</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/849/employment-practices-liability-insurance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Aircraft Finance &amp; Leasing</title>
<link>http://www.americanconference.com/2013/841/aircraft-finance--leasing/</link>
<pubDate>Mon 24 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;P&gt;
&lt;TABLE style=&quot;BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-COLLAPSE: collapse; BORDER-TOP: medium none; BORDER-RIGHT: medium none; mso-border-top-alt: solid #4BACC6 1.0pt; mso-border-top-themecolor: accent5; mso-border-bottom-alt: solid #4BACC6 1.0pt; mso-border-bottom-themecolor: accent5; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt&quot; class=MsoTableLightShadingAccent5 border=1 cellSpacing=0 cellPadding=0&gt;
&lt;TBODY&gt;
&lt;TR style=&quot;mso-yfti-irow: -1; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes&quot;&gt;
&lt;TD style=&quot;BORDER-BOTTOM: #4bacc6 1pt solid; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BORDER-TOP: #4bacc6 1pt solid; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0in; mso-border-top-themecolor: accent5; mso-border-bottom-themecolor: accent5&quot; vAlign=top width=638&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; COLOR: #31849b; FONT-SIZE: 9pt; mso-themecolor: accent5; mso-themeshade: 191&quot;&gt;Here's just some of the companies already booked on to attend:&lt;?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;TABLE style=&quot;BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-COLLAPSE: collapse; BORDER-TOP: medium none; BORDER-RIGHT: medium none; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-border-alt: solid #78C0D4 1.0pt; mso-border-themecolor: accent5; mso-border-themetint: 191&quot; class=MsoTableMediumGrid1Accent5 border=1 cellSpacing=0 cellPadding=0&gt;
&lt;TBODY&gt;
&lt;TR style=&quot;mso-yfti-irow: -1; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes&quot;&gt;
&lt;TD style=&quot;BORDER-BOTTOM: #78c0d4 1pt solid; BORDER-LEFT: #78c0d4 1pt solid; PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 155.75pt; PADDING-RIGHT: 5.4pt; BACKGROUND: #d2eaf1; BORDER-TOP: #78c0d4 1pt solid; BORDER-RIGHT: #78c0d4 1pt solid; PADDING-TOP: 0in; mso-border-themecolor: accent5; mso-border-themetint: 191; mso-background-themecolor: accent5; mso-background-themetint: 63&quot; vAlign=top width=208&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Ex-Im Bank&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Citigroup&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;JetBlue Airways Corporation&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Goldman Sachs&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Airbus&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Banc of America Leasing&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;GECAS&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: #78c0d4 1pt solid; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 155.75pt; PADDING-RIGHT: 5.4pt; BACKGROUND: #d2eaf1; BORDER-TOP: #78c0d4 1pt solid; BORDER-RIGHT: #78c0d4 1pt solid; PADDING-TOP: 0in; mso-border-themecolor: accent5; mso-border-themetint: 191; mso-background-themecolor: accent5; mso-background-themetint: 63; mso-border-left-alt: solid #78C0D4 1.0pt; mso-border-left-themecolor: accent5; mso-border-left-themetint: 191&quot; vAlign=top width=208&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;BNP Paribas&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;J.P. Morgan&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Wells Fargo Bank Northwest&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Standard &amp;amp; Poor's&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Bombardier&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Morgan Stanley&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Canyon Partners&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: #78c0d4 1pt solid; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 155.75pt; PADDING-RIGHT: 5.4pt; BACKGROUND: #d2eaf1; BORDER-TOP: #78c0d4 1pt solid; BORDER-RIGHT: #78c0d4 1pt solid; PADDING-TOP: 0in; mso-border-themecolor: accent5; mso-border-themetint: 191; mso-background-themecolor: accent5; mso-background-themetint: 63; mso-border-left-alt: solid #78C0D4 1.0pt; mso-border-left-themecolor: accent5; mso-border-left-themetint: 191&quot; vAlign=top width=208&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;GA Telesis&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;KV Aviation UK Limited&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Deutsche Bank&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Credit Agricole Corporate &amp;amp; Investment Bank&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 1&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;Gulfstream Aerospace Corporation&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-yfti-cnfc: 5&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Tahoma','sans-serif'; COLOR: #31849b; FONT-SIZE: 9pt; mso-themecolor: accent5; mso-themeshade: 191&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;ATTENTION AIRCRAFT FINANCE &amp;amp; LEASING PROFESSIONAL&lt;/STRONG&gt;: lessors, airlines, manufacturers, private equity firms, banks, and law firms must be fully up-to-date on the latest deals, capital markets trends, the impact of private equity and export credit agencies, new market entrants, emerging regulations, and more, in order to maintain an edge over their competitors.&lt;/P&gt;
&lt;P&gt;That is why you cannot afford to miss &lt;STRONG&gt;American Conference Institute's 2nd National Forum on Aircraft Finance &amp;amp; Leasing.&lt;/STRONG&gt; In addition to unparalleled networking opportunities, this conference will provide attendees with the latest insights and expert advice from our exceptional faculty on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Accessing the capital markets and obtaining new sources of financing&lt;/LI&gt;
&lt;LI&gt;How long export credit agencies will be able to fill the financing void left by the capital markets&lt;/LI&gt;
&lt;LI&gt;Remaining competitive in the face of new and emerging market entrants&lt;/LI&gt;
&lt;LI&gt;Identifying and exploring new opportunities for growth, including emerging markets&lt;/LI&gt;
&lt;LI&gt;Evaluating new EETC financing structures and the challenges involved with unwinding them&lt;/LI&gt;
&lt;LI&gt;Ensuring that you are protected through the use of appropriate lease indemnity and liability provisions&lt;/LI&gt;
&lt;LI&gt;Obtaining accurate aircraft valuations in an uncertain market&lt;/LI&gt;
&lt;LI&gt;Renegotiating financing deals in light of current economic realities&lt;/LI&gt;
&lt;LI&gt;Overcoming the challenges of buying and selling used aircraft in the current market&lt;/LI&gt;
&lt;LI&gt;The latest industry dynamics and trends in the business jet market&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Be a part of the nation's premier Aircraft Finance &amp;amp; Leasing forum and ensure that you are positioned to: capitalize on new sources of financing, take advantage of opportunities in emerging markets, maximize your investment returns, and overcome legislative and regulatory hurdles facing the market.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;You do not want to miss this incredible opportunity to network with other industry leaders, while obtaining the critical insights that you need to achieve success in the evolving aircraft fi nance marketplace. This must-attend event will fi ll up quickly, so register now by calling &lt;STRONG&gt;888-224-2480&lt;/STRONG&gt;, faxing your registration form to &lt;STRONG&gt;877-927-1563&lt;/STRONG&gt;, or registering online at &lt;STRONG&gt;www.AmericanConference.com/AircraftFin&lt;/STRONG&gt;&lt;/P&gt;</description>
<category>Financial Services</category>
<category>Regulatory &amp; Compliance</category>
<category>Aerospace and Defense</category>
<category>Manufacturing &amp; Industrial</category>
<category>Transportation</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/841/aircraft-finance--leasing/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">ITAR Compliance &amp; Export Control Reform</title>
<link>http://www.americanconference.com/2013/783/itar-compliance--export-control-reform/</link>
<pubDate>Mon 24 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;style type=&quot;text/css&quot;&gt;
.booking {
	-moz-box-shadow:inset 0px 1px 0px 0px #bbdaf7;
	-webkit-box-shadow:inset 0px 1px 0px 0px #bbdaf7;
	box-shadow:inset 0px 1px 0px 0px #bbdaf7;
	background:-webkit-gradient( linear, left top, left bottom, color-stop(0.05, #79bbff), color-stop(1, #378de5) );
	background:-moz-linear-gradient( center top, #79bbff 5%, #378de5 100% );
	filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#79bbff', endColorstr='#378de5');
	background-color:#79bbff;
	-moz-border-radius:6px;
	-webkit-border-radius:6px;
	border-radius:6px;
	border:1px solid #84bbf3;
	display:inline-block;
	color:#ffffff;
	font-family:arial;
	font-size:15px;
	font-weight:bold;
	padding:6px 24px;
	text-decoration:none;
	text-shadow:1px 1px 0px #528ecc;
}.booking:hover {
	background:-webkit-gradient( linear, left top, left bottom, color-stop(0.05, #378de5), color-stop(1, #79bbff) );
	background:-moz-linear-gradient( center top, #378de5 5%, #79bbff 100% );
	filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#378de5', endColorstr='#79bbff');
	background-color:#378de5;
}.booking:active {
	position:relative;
	top:1px;
}
/* This imageless css button was generated by CSSButtonGenerator.com */
&lt;/style&gt;

&lt;div align=&quot;center&quot;&gt;
&lt;a href=&quot;http://www.americanconference.com/itarcompliance/hotel--venue&quot; class=&quot;booking&quot;&gt;Book Your &lt;br&gt;
Room Now&lt;/a&gt;&lt;/div&gt;

&lt;p&gt;&lt;strong&gt;Ensure Your ITAR Compliance Program is Strengthened and Revamped in Response to the Regulatory Overhaul&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Whether you are a first, second or third-tier exporter, export control reform&lt;/strong&gt; will affect ITAR licensing and classification requirements, and will mostly likely have a deep impact on your business operations. No matter how small or how big the effect, it is imperative that your trade compliance personnel manages the new regulatory framework, and adjust compliance practices accordingly. From changes in defi nitions, to the migration of items to Commerce Department jurisdiction, 2013 is determined to be a monumental year for exporters. Equally, many complex ITAR compliance requirements will remain, and it is critical to stay up to speed on the latest best practices for reducing heightened penalty risks.&lt;/p&gt;
&lt;p&gt;Now in its 8th year,&lt;strong&gt; ACI's Forum on ITAR Compliance &amp;amp; Export Control Reform &lt;/strong&gt;consistently delivers proven-effective strategies on practical ITAR compliance challenges facing industry. The technical nature of licensing reform and defi nitions such as &quot;specially designed&quot; make this an especially tricky area that requires signifi cant internal training and awareness. Participants will learn, benchmark and take away knowledge they can implement in their daily workflow, making your senior management extremely happy in this highly transitional regulatory environment!&lt;/p&gt;
&lt;p&gt; &lt;strong&gt;Key topics include:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; Complying with the transition timing requirements for licenses issued and agreements previously approved by DDTC&lt;/li&gt;
  &lt;li&gt; Drafting a Technology Security Plan (TSP) that includes &quot;procedures for screening employees for such substantives contacts&quot;&lt;/li&gt;
  &lt;li&gt; How to determine if you need prior DDTC approval for registration requirements, and  applying key exemptions from brokering rules&lt;/li&gt;
  &lt;li&gt; Working with your sales and product management teams to ensure they do not interpret &quot;reform&quot; as an excuse to treat the articles as no longer control&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&quot;ACI runs the most respected portfolio of international trade conferences in the country: &lt;/li&gt;
  &lt;li&gt;&quot;Another excellent program!&quot; ? Virgin Galactic &lt;/li&gt;
  &lt;li&gt;&quot;Nice conference. Good interaction between sessions, between speakers and attendees.&quot;  ? Lockheed Martin&lt;/li&gt;
  &lt;li&gt;&quot;Conference was more than expected ? excellent coverage of all ITAR issues&quot;  ? Mason Electric Co.&quot;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Why Choose ACI? &lt;/strong&gt;Unlike other conference providers, American Conference Institute  attorneys have conducted extensive research with the who's who of export controls and international trade Bar to craft a unique agenda that encompasses the most hot-button ITAR compliance challenges facing exporters today. Ensuring the agenda is timely and directly relevant to your organization's most pressing ITAR risks is our main goal. While reform will touch many industries and many businesses, other &quot;evergreen&quot; ITAR challenges will continue to be a top priority for in-house and outside counsel, keeping them up at night. To best serve your needs, our faculty has agreed to address your specific challenges ? submit your questions to &lt;strong&gt;ITAR@AmericanConference.com&lt;/strong&gt; before the Forum. &lt;/p&gt;


</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Aerospace and Defense</category>
<category>Transportation</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/783/itar-compliance--export-control-reform/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Shutdowns Turnarounds Superconference</title>
<link>http://www.americanconference.com/2013/906/shutdowns-turnarounds-superconference/</link>
<pubDate>Tue 25 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Houston | </description>
<category>Construction</category>
<category>Energy &amp; Resources</category>
<category>Transportation / Manufacturing &amp; Industrial / Logistics</category>
<category>Energy &amp; Resources</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/906/shutdowns-turnarounds-superconference/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Anti-Corruption London Edition</title>
<link>http://www.americanconference.com/2013/555/anti-corruption-london-edition/</link>
<pubDate>Tue 25 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">London | Unparalleled networking and benchmarking opportunities with both an international and UK-based faculty of senior-level executives and information you can't get anywhere else make this event the premier anti-corruption compliance forum in London. &lt;br&gt;&lt;br&gt;Last year your peers from a wide variety of industry sectors including &lt;b&gt;Oil &amp;amp; Gas, Life Sciences, Finance, Consumer Goods, Energy&lt;/b&gt;, and &lt;b&gt;Telecoms &lt;/b&gt;attended the Sixth Annual European Forum on Anti-Corruption in London. &lt;br&gt;&lt;br&gt;Join us for the &lt;b&gt;Seventh Annual Forum on Anti-Corruption in London &lt;/b&gt;and take part in the only event that addresses your company's evolving bribery risks and provides an update on the Serious Fraud Office's enforcement priorities including the prosecution of facilitation payments and hospitality, promotional or other business expenditures as well as the SFO's approach with respect to self-reporting under the new guidance. You will benefit from a detailed look into the anti-bribery landscape in other jurisdictions crucial to your global operations. The updated 2013 programme will once again feature a stellar international faculty that will provide practical insights and interactive discussions on third party due diligence, discussions on the implications of the introduction of deferred prosecution agreements, preventing joint venture pitfalls, conducting internal investigations, implementing robust financial controls, testing your internal procedures and compliance programmes to ensure they continue to be robust and in sync with global best practice. &lt;br&gt;________________________________________&lt;br&gt;&lt;br&gt;&lt;b&gt;The full programme for this event is now available.&lt;/b&gt;&amp;nbsp; &lt;br&gt;&lt;br&gt;To ensure you receive the brochure, please either download by clicking on the image to the right of your screen or please email &lt;br&gt;&lt;br&gt;Toby Hartley &lt;a href=&quot;mailto:T.Hartley@C5-Online.com&quot;&gt;T.Hartley@C5-Online.com&lt;/a&gt; requesting 'ACLABR' &lt;br&gt;&lt;br&gt;</description>
<category>Ethics Credits</category>
<category>Anti-Corruption / FCPA</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>International Trade</category>
<category>Legal</category>
<category>Regulatory Compliance</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/555/anti-corruption-london-edition/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Maximising Pharma Patents</title>
<link>http://www.americanconference.com/2013/580/maximising-pharma-patents/</link>
<pubDate>Tue 25 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">London | &lt;BR&gt;Strategies to maximise pharma patents will be significantly transformed. In February 2013 the European Commission will be publishing final draft rules on unitary patent and the unified patents court. Understanding the new legal regime and how these changes will affect pharma patent is essential for the pharma industry. 
&lt;P align=left&gt;The &lt;STRONG&gt;12th International Forum on Maximising Pharma Patents &lt;/STRONG&gt;will bring together eminent in-house counsel from the world's largest pharma and biotech companies and their expert advisors from a range of jurisdictions, including the US, Europe and Asia. A special keynote address will be given by leading judge on the unitary patent and the unified patents court.&lt;/P&gt;
&lt;P align=left&gt;The forum will include analysis of new procedural rules published by the European Commission on unitary patent and its impact on pharma patent management. Panel speakers will be leading judges, regulatory experts, and industry specialists speaking on how it will work in practice. &lt;/P&gt;
&lt;P align=left&gt;Judicial authorities will speak on SPC procedures, recent cases referred to the European Court of Justice on the scope of SPCs and the impact of the pending decisions for pharma patent extensions. Based on their first-hand experience, the distinguished panel will provide you with invaluable information and insights on pharma patent with a particular focus on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Understanding the challenges, risks, and opportunities of the proposed unitary patent. How the proposed unitary patent compares with the current European patent. Where and how you will be able to sue for infringement or challenge validity in Europe, in terms of what judges, what languages, and what type of procedure will be involved?&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Why will London be important for Pharma and biotech patents? What strategies should be considered during the transition to the new system?&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Scope of SPCs for combination products and the cases referred to the ECJ.&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Employing recent cases on SPCs in Europe and the US to file successful applications.&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Examining potential anti-competitive practices and recent patent settlement agreements.&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Guidance from the EU Commission on lifecycle extensions. &lt;/LI&gt;&lt;/UL&gt;
&lt;P align=center&gt;&lt;U&gt;Be where your industry will be on &lt;STRONG&gt;25th and 26th June 2013&lt;/STRONG&gt; and don't miss out on this unique opportunity to hear from and network with prominent judicial authorities, regulatory experts and industry specialists.&lt;/U&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;BR&gt;For speaking opportunities please contact:&lt;BR&gt;&lt;STRONG&gt;Tony Ram&lt;/STRONG&gt;, conference producer&lt;BR&gt;&lt;STRONG&gt;Tel:&lt;/STRONG&gt; +44(0)20 7878 6980&lt;BR&gt;&lt;STRONG&gt;Email:&lt;/STRONG&gt; &lt;A href=&quot;mailto:t.ram@c5-online.com&quot;&gt;t.ram@c5-online.com&lt;/A&gt; &lt;/P&gt;
&lt;P align=left&gt;For sponsorship opportunities please contact&amp;nbsp;:&lt;BR&gt;Daniel Capel&lt;BR&gt;&lt;STRONG&gt;Tel&amp;nbsp;:&lt;/STRONG&gt; +44(0)20 7878 6870&lt;BR&gt;&lt;STRONG&gt;Email&lt;/STRONG&gt;&amp;nbsp;: &lt;A href=&quot;mailto:d.capel@c5-online.com&quot;&gt;d.capel@c5-online.com&lt;/A&gt; &lt;/P&gt;
&lt;P align=left&gt;For media partnership opportunities&amp;nbsp;please contact:&lt;BR&gt;Karina Kusova&lt;BR&gt;&lt;STRONG&gt;Tel&amp;nbsp;:&lt;/STRONG&gt; +44(0)20 7878 6956&lt;BR&gt;&lt;STRONG&gt;Email&amp;nbsp;:&lt;/STRONG&gt; &lt;A href=&quot;mailto:k.kusova@c5-online.com&quot;&gt;k.kusova@c5-online.com&lt;/A&gt; &lt;/P&gt;</description>
<category>Legal</category>
<category>Pharmaceuticals and Biotech</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/580/maximising-pharma-patents/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">M&amp;A</title>
<link>http://www.americanconference.com/2013/576/ma/</link>
<pubDate>Tue 25 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Moscow | &lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;&lt;STRONG&gt;M&amp;amp;A&amp;nbsp;&lt;BR&gt;25 - 26 ???? 2013&lt;BR&gt;????????? ?????? ?????????????, ??????&lt;BR&gt;&lt;/STRONG&gt;&lt;BR&gt;???????????? ????????????? ????, ? ????? ???????? ? ?????? ? ???????????? ??????? ?????????? ?????? ?????? ???????? ????? ?? ???????? ???????????????? ??? ????????????. ???????? ????????? ?????????, ???????&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp; &lt;/SPAN&gt;????????? ?????? ???? ?????????????? ??? ?? ?????? ???????? 2013 ????, ???????? ???????????&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp; &lt;/SPAN&gt;? ???????? ?&amp;amp;? ?????????? ? ????????????? ???????????. ???????? ?? ????????????? ?????????, ?????? ?????? ???????? ???????? ????????????? ???????? ?????? M&amp;amp;A, ??? ???????? ??????? ?? ?? ??????. ???????? ?????????? ????????? ?????? ??????, ????????? ????????? ????????, ?????????? ??????? ?????????? ???&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp; &lt;/SPAN&gt;?????????? ???????? ???????????. &lt;!--?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /--&gt;&lt;?xml:namespace prefix = o /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;2-?? ??????????? ?????????? ???????? ?5 &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;«M&amp;amp;A»&lt;/B&gt; ??????? ?????????????? ?????????????? ???????, ???????, ? ????? ?????????? ? ????????????? ??????????, ???????? ?????????? ???????, ??????????? ??? ?????????, ????????????? ? ???????????????? ?????? ? ?????????? ???????????? ??????:&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 12pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-ansi-language: RU&quot; lang=RU&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;??? ??????? ?????????? ?????????????? ??????????? ? ?????? ???????? ???????????? ???????? ? ??? &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 12pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-ansi-language: RU&quot; lang=RU&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;??? ?????????? ??????? ?????????? ????????? ????? ?????????? ?????? ?&amp;amp;?; ????? ?? ?????????? ? ?????????? ??????? &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 12pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-ansi-language: RU&quot; lang=RU&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;??? ?????????? ???????? ? ?????? ????????????? ????????? ? ???????????, ??????? ?????????? ????? ?????????? ??????: ??????????? ???????? ?????????? ? ?????????? ??????????&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 12pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-ansi-language: RU&quot; lang=RU&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;??? ????????????????? ??? ?????????? ??????????? ????? ???????? ?????? &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;M&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;&amp;amp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;A&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;: ??? ?????? ???? ????????????? ???????? ???????? ???????????????, ? ??????? ?? ???? ???????? ?? ?????? ????????? ??????. ????????????? ???????????? ? ??????????&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp; &lt;/SPAN&gt;??????????? ??????&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 12pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-ansi-language: RU&quot; lang=RU&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;????????????? ??????????? ????? ??? ???????????????? ?????? ?&amp;amp;? ? ?????? ? ???????? ??????????? ????????????????&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-ansi-language: RU&quot; lang=RU&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;????? ??????? ????????? ??????? &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;Bribery&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=EN-GB&gt; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;Act&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt; ? &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;Foreign&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=EN-GB&gt; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;Corrupt&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=EN-GB&gt; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;Practices&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=EN-GB&gt; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot; lang=EN-GB&gt;Act&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt; ?? ??????? ???????? ? ?????? ? ?? ?? ????????? &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-ansi-language: RU&quot; lang=RU&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;????????? ??????????? ????????. ??? ????????? ?????????, ??????????, ??????????? ? ????&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;????&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot;&gt; &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;&lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;a&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;.&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;keable&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;@&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;C&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;5-&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;Online&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;.&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;com&lt;/SPAN&gt;&lt;/B&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;.&lt;BR&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;?? ?????????????? ??????????? ? ???????????? ????????? ?? ???????????, ??????????, ??????????? ? &lt;BR&gt;&lt;B&gt;????????? ???????????&lt;/B&gt; &lt;BR&gt;?????? ?????????? &lt;BR&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;email&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;: &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;&lt;A href=&quot;mailto:a.kud@c5-online.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;a&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;.&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;kud&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;@&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;c&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;5-&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;online&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;.&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;com&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;&lt;BR&gt;???: +44 20 7878 6878&lt;BR&gt;&lt;BR&gt;&lt;B&gt;?? ???????? ??????????:&lt;BR&gt;&lt;/B&gt;???? ????&lt;BR&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;email&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;: &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;&lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;a&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;.&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;keable&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;@&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;C&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;5-&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;Online&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue; mso-ansi-language: RU&quot; lang=RU&gt;.&lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;com&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;&lt;BR&gt;???: +44(0)20 78786931&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot; class=MsoNormal align=left&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;?? ???????? ???????????:&lt;BR&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN&gt;????? ??????????&lt;BR&gt;email: &lt;A href=&quot;mailto:v.penlington@c5-online.com&quot;&gt;v.penlington@c5-online.com&lt;/A&gt;&lt;BR&gt;???: &lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;+44 (0)20 7878 6978&lt;/SPAN&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;BR&gt;M&amp;amp;A&amp;nbsp;&lt;BR&gt;25 - 26 June 2013,&amp;nbsp;&lt;BR&gt;Hilton Leningradskaya Hotel, Moscow&lt;BR&gt;&lt;/STRONG&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;The prolonged economic recession, as well as the situation in Europe largely devalued assets of many companies making them particularly attractive for acquisition. According to experts, the global economy is anticipated to start its recovery already in the second half of 2013, creating the preconditions for a surge in M&amp;amp;A activity in the mid-term. Despite the positive trends, a key milestone in M&amp;amp;A is deriving synergies from M&amp;amp;A deals which is not an easy task. Given the unique specifics of each transaction there are many practical and legal issues that should be resolved in order to achieve the desired results. In fact M&amp;amp;A is still one of the main strategies for growth bringing a number of significant advantages and adding value to the core businesses of your company.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;&lt;STRONG&gt;C5's Second annual conference on &quot;M&amp;amp;A&quot;&lt;/STRONG&gt; will bring together representatives from the corporate sector, law firms, as well as Russian and international investors to address the issues that arise in the identification, due diligence and structuring of transactions, as well as sharing practical experience on how to:&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpFirst&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Palatino Linotype','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Palatino Linotype'; mso-bidi-font-family: 'Palatino Linotype'&quot; lang=EN-GB&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;?&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;Identify investment opportunities within and outside the core business of your company&lt;BR&gt;&lt;BR&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpMiddle&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Palatino Linotype','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Palatino Linotype'; mso-bidi-font-family: 'Palatino Linotype'&quot; lang=EN-GB&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;?&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;Capturing post-merger growth synergies: focus on integration and business functioning&lt;BR&gt;&lt;BR&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpMiddle&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Palatino Linotype','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Palatino Linotype'; mso-bidi-font-family: 'Palatino Linotype'&quot; lang=EN-GB&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;?&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;Monitor and evaluate the effectiveness of processes that occur after the completion of M&amp;amp;A transactions: developing synergy management &lt;BR&gt;&lt;BR&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpMiddle&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Palatino Linotype','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Palatino Linotype'; mso-bidi-font-family: 'Palatino Linotype'&quot; lang=EN-GB&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;?&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;Successfully negotiate the best deal in M&amp;amp;A post-closing legal claims: What actions to take if the acquired company has obligations that were not known at the time of completion of the M&amp;amp;A deal&lt;BR&gt;&lt;BR&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpMiddle&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Palatino Linotype','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Palatino Linotype'; mso-bidi-font-family: 'Palatino Linotype'&quot; lang=EN-GB&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;?&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;Implementation of British Law in structuring M&amp;amp;A's in Russia and the flexibility of Russian legislation&lt;BR&gt;&lt;BR&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpLast&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Palatino Linotype','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Palatino Linotype'; mso-bidi-font-family: 'Palatino Linotype'&quot; lang=EN-GB&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;?&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot; lang=EN-GB&gt;Assess the impact of Bribery Act and the Foreign Corrupt Practices Act on the acquisition of companies in Russia and abroad&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;STRONG&gt;The conference program is now available. To receive your copy of the brochure please contact Anna Keable, Marketing Manager at &lt;/STRONG&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;&lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;&lt;STRONG&gt;a.keable@C5-Online.com&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;STRONG&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P align=left&gt;For additional information please contact:&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Conference producer:&lt;BR&gt;&lt;/STRONG&gt;Andrej Kudrjavcev&lt;BR&gt;email: &lt;A href=&quot;mailto:a.kud@c5-online.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;a.kud@c5-online.com&lt;/SPAN&gt;&lt;/A&gt; &lt;BR&gt;tel:: +44 20 7878 6878&lt;BR&gt;&lt;BR&gt;&lt;B&gt;For marketing opportunities:&lt;BR&gt;&lt;/B&gt;Anna Keable&lt;BR&gt;email:&lt;U&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt; &lt;A href=&quot;mailto:a.keable@C5-Online.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;a.keable@C5-Online.com&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/U&gt;&amp;nbsp;&lt;BR&gt;tel: +44(0)20 78786931&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;For sponsorship opportunities:&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US&quot;&gt;&lt;BR&gt;Vlada Penlington&lt;BR&gt;email: &lt;A href=&quot;mailto:v.penlington@c5-online.com&quot;&gt;v.penlington@c5-online.com&lt;/A&gt;&lt;BR&gt;???: &lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: RU&quot; lang=RU&gt;+44 (0)20 7878 6978&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;/P&gt;</description>
<category>Russia and CIS</category>
<category>Legal</category>
<category>Financial Services</category>
<category>Private Equity and M&amp;A</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/576/ma/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">The Power of Prepaid</title>
<link>http://www.americanconference.com/2013/777/the-power-of-prepaid/</link>
<pubDate>Wed 26 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Financial Services</category>
<category>Regulatory &amp; Compliance</category>
<category>Telecoms &amp; Technology</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/777/the-power-of-prepaid/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Asbestos Claims &amp; Litigation</title>
<link>http://www.americanconference.com/2013/843/asbestos-claims--litigation/</link>
<pubDate>Wed 26 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;b&gt;ACI's 14th Asbestos Claims &amp;amp; Litigation returns in Chicago as the only event in the industry where outside counsel, in house counsel, renowned jurists, and medical experts can gain insight and trade strategy on the hottest jurisdictions, new and emerging theories of causation, and novel theories of liability.&lt;br&gt;&lt;/b&gt;&lt;br&gt;Excessive verdicts continue to hold steady across the nation and insurers are examining carefully how asbestos coverage impacts its claims management and handling. In addition, asbestos claims are on the rise as plaintiffs seek out friendly jurisdictions across the nation. Plaintiffs are now frequently targeting non traditional defendants including suppliers and retailers. Practitioners must stay on top of all the current theories, hire and retain the right medical experts, and prepare a sophisticated litigation strategy in the defense of asbestos claims. &lt;br&gt;&lt;br&gt;In this ever changing area, even the most seasoned practitioner needs to hone their skills and strategies to stay on pace and keep ahead of the curve. In response, &lt;b&gt;ACI's 14th Annual Forum on Asbestos Claims &amp;amp; Litigation&lt;/b&gt;, is the only event where law, science, and medicine intersect and provide practitioners with clarity and certainty with respect to the industry's most pressing issues.&lt;br&gt;&lt;br&gt;Register today to ensure your place by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your registration form to &lt;b&gt;877-927-1563&lt;/b&gt; or registering online at &lt;a href=&quot;http://www.AmericanConference.com/Asbestos&quot;&gt;AmericanConference.com/Asbestos&lt;br&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Insurance &amp; Reinsurance</category>
<category>Litigation</category>
<category>Environmental</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/843/asbestos-claims--litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Obstetric Malpractice</title>
<link>http://www.americanconference.com/2013/799/obstetric-malpractice/</link>
<pubDate>Wed 26 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Philadelphia | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;Be a part of the nation's premier obstetric malpractice conference and ensure that you keep abreast of the evolving standards of care, emerging theories of liability, and new defense strategies.&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;b&gt;Obstetric malpractice cases continue to result in massive verdicts&lt;/b&gt;, reaching amounts in excess of $100 million. &lt;b&gt;Claims are evolving&lt;/b&gt; in response to advances in medical technology, which can increase the potential for errors in the delivery room.&amp;nbsp; Further, &lt;b&gt;new standards of care&lt;/b&gt; &lt;b&gt;are emerging &lt;/b&gt;and with these new standards come&lt;b&gt; new malpractice claims&lt;/b&gt;. Given the state of obstetric malpractice, it is essential that all those along the obstetric malpractice continuum, including medical professionals, risk managers, insurance professionals, plaintiffs' attorneys, and defense counsel, be current on the latest claims and defense strategies and how they are impacting the practice.&lt;br&gt;&lt;br&gt;American Conference Institute's &lt;i&gt;&lt;u&gt;12th Annual Advanced Forum on Obstetric Malpractice Claims&lt;/u&gt;&lt;/i&gt; will bring together an &lt;b&gt;unparalleled faculty of medical experts, risk managers, insurance professionals, and leading plaintiffs' and defense attorneys&lt;/b&gt;, who will provide you with &lt;b&gt;the most up-to-date information on complex medical issues and litigation hurdles&lt;/b&gt;, including:&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Emerging standards of care, including the use of hypothermia&lt;/li&gt;&lt;li&gt;Perinatal asphyxia and neonatal brain injury&lt;/li&gt;&lt;li&gt;Shoulder dystocia&lt;/li&gt;&lt;li&gt;Claims arising from prenatal care&lt;/li&gt;&lt;li&gt;Fetal monitoring and surveillance&lt;/li&gt;&lt;li&gt;Placental pathology and neuroimaging and their impact on assessments of causation and timing&lt;/li&gt;&lt;li&gt;Intrauterine infections and genetic disorders&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;PLUS&lt;/b&gt;&lt;/u&gt;, add value to your attendance by also registering for the Post-Conference Litigation Master Class:&lt;br&gt;&lt;br&gt;&lt;b&gt;&lt;i&gt;Litigation and Trial Techniques for Every Stage of an Obstetric Malpractice Case &lt;/i&gt;&lt;/b&gt;&lt;br&gt;June 27, 2013 | 1:00 p.m. ? 4:00 p.m.&lt;br&gt;&lt;br&gt;&lt;br&gt;Register now by calling&lt;b&gt; 1-888-224-2480&lt;/b&gt; or by faxing your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt;.&amp;nbsp; You can also register online at &lt;a href=&quot;http://www.AmericanConference.com/ObMal&quot;&gt;AmericanConference.com/ObMal&lt;br&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Litigation</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/799/obstetric-malpractice/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">The Legal, Regulatory and Compliance Forum on Dietary Supplements</title>
<link>http://www.americanconference.com/2013/850/the-legal-regulatory-and-compliance-forum-on-dietary-supplements/</link>
<pubDate>Wed 26 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York City | &lt;P align=center&gt;&lt;STRONG&gt;Equip yourself with the tools and know-how that you need to navigate the dietary supplement industry's rapidly evolving legal, regulatory and political landscape.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Recent changes in Congress and at FDA have presented the dietary supplements industry with a whole new set of challenges.&amp;nbsp; The imminent departure of long ?time industry champion Senator Tom Harkin and the push for more stringent AER requirements in view of the caffeine/energy drink controversy in Congress, not to mention possible FDA rule making extending certain provisions of FSMA to dietary supplements have caused supplement manufacturers great concern.&amp;nbsp; However, signs of hope are on the horizon. FDA has agreed to revise a controversial draft guidance for New Dietary Ingredients -- a decision which industry groups have applauded and believe to signal the beginning of an open dialogue with the agency.&lt;/P&gt;
&lt;P&gt;To help you make sense of these developments and their potential impact on existing legal and regulatory structures affecting products intended to supplement the diet, &lt;STRONG&gt;American Conference Institute has developed The Legal, Regulatory and Compliance Forum on Dietary Supplements. &lt;/STRONG&gt;A distinguished faculty of over two dozen leading legal and regulatory Dietary Supplement experts --- including representatives from the &lt;STRONG&gt;FDA, FTC, NAD, CRN and NPA&lt;/STRONG&gt; --- will address the intricacies and implications of these new developments as well as existing challenges affecting such core dietary supplement functions as &lt;STRONG&gt;FDA and regulatory affairs; advertising and promotion; trademarks, trade names and line extensions; and studies.&lt;/STRONG&gt; They will provide you with the critical information that you now need to:&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;?&amp;nbsp;Master current NDI protocols and anticipate probable changes &lt;BR&gt;?&amp;nbsp;Examine the label as a means of advertising and promotion&lt;BR&gt;?&amp;nbsp;Explore borderline claims vis-à-vis the gray area between structure function and disease claims&lt;BR&gt;?&amp;nbsp;Analyze the use of social media in dietary supplement advertising&lt;BR&gt;?&amp;nbsp;Evaluate studies in support of allowed claims&lt;BR&gt;?&amp;nbsp;Overcome challenges with line extensions for monograph and NDA OTCs&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Learn to Prevent and Defend Enforcement Actions impacting Dietary Supplements by Mastering Critical AER, GMP and Recall Competencies.&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;This is the only legal and regulatory gathering specifically designed for the dietary supplement industry which will specifically address enforcement activity and preventative measures based on real world examples impacting products intended to supplement the diet.&amp;nbsp; Present and former FTC, NAD and FDA enforcers and industry experts will help you:&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;?&amp;nbsp;Understand the scope of FDA, DOJ and FTC enforcement as well as NAD actions impacting dietary supplements&lt;BR&gt;?&amp;nbsp;Explore the link between recent&amp;nbsp; GMP violations and enforcement activity in the dietary supplement space&lt;BR&gt;?&amp;nbsp;Establish internal AER review protocols and record keeping systems in accordance with inspection requirements &lt;BR&gt;?&amp;nbsp;Overcome challenges in forming effective recall execution strategies &lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;Benefit from Special Training and Strategy Sessions that will Address the Legal and Regulatory Essentials of Dietary Supplements and Complexities of Manufacturing Compliance.&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;To enhance and complete your conference and networking experience, attend one or both of the following strategy sessions:&lt;BR&gt;&lt;BR&gt;?&amp;nbsp;&lt;STRONG&gt;Pre- Conference Working Group: Dietary Supplements 101: Understanding the Essentials of Products &quot;Which [Are] Intended to Supplement the Diet&quot; &lt;/STRONG&gt;will provide an essential overview of the law and regulations governing&amp;nbsp; dietary supplements and set the stage for the complexities and challenges addressed during the main conference; and&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;&lt;STRONG&gt;GMP Master Class for Supplement Manufacturers:&amp;nbsp; In-Depth Legal and Business Strategies for Addressing Inspections, Enforcement Actions, and Compliance&lt;/STRONG&gt; will provide in-depth analysis of one of the most critical legal in regulatory competencies in the manufacturing of products intended to supplement the diet.&lt;/P&gt;
&lt;P&gt;Register today for the industry's premier and most comprehensive legal and regulatory forum on Dietary Supplements by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563, or logging on to &lt;A href=&quot;http://www.AmericanConference.com/dietarysupplements&quot;&gt;www.AmericanConference.com/dietarysupplements&lt;/A&gt;.&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Insurance &amp; Reinsurance</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<category>Food and Beverage</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/850/the-legal-regulatory-and-compliance-forum-on-dietary-supplements/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">US Defence Contracting and FAR Compliance in Europe</title>
<link>http://www.americanconference.com/2013/574/us-defence-contracting-and-far-compliance-in-europe/</link>
<pubDate>Wed 26 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">London | &lt;b&gt;The challenge of staying compliant with stringent US Government and Department of Defence (DoD) contracting requirements, namely the FAR and DFARS, is putting a lot of pressure on defence companies looking to deal with the biggest defence customer on the globe.&lt;/b&gt;&lt;br&gt;&lt;br&gt;As the regulations have only taken on an extra-territorial effect in recent years, European companies both big and small, are playing catch-up in terms of understanding the both complex and confusing regulations that play a significant role in determining how to secure and maintain your DoD contracts and avoid termination. From the FAR and DFARS a whole plethora of difficulties have arisen: from legal and commercial issues such as protecting European IP rights to ensuring the appropriate flow-down of FAR and DFARS requirements throughout the supply chain; to financial and pricing issues such as cost allowability and how to appropriately price contracts. Time and money are at stake: it is imperative that your company overcomes these challenges and gets to grips with US contracting culture fast, to avoid a difficult bidding landscape.&lt;br&gt;&lt;br&gt;In addition, with defence budgets in the US being tightened, the DCAA and DCMA are starting to turn their attention to European contracts to ensure that the DoD is only paying the best prices possible. With potential scrutiny resulting in debarment, withheld payments, fines and contract terminations, your company cannot afford to ignore FAR and DFARS requirements. &lt;br&gt;&lt;br&gt;Don't miss C5's forum on US Defence Contracting and DFARS Compliance in Europe ? the first of its kind on the continent, on how to address the most contentious US defence contracting and FAR/DFARS issues. Benefit from unparalleled networking and benchmarking with leading industry professionals and government officials, who will share best practices on understanding and managing the FAR and DFARS requirements.&lt;br&gt;&lt;br&gt;&lt;meta http-equiv=&quot;Content-Type&quot; content=&quot;text/html; charset=utf-8&quot;&gt;&lt;meta name=&quot;ProgId&quot; content=&quot;Word.Document&quot;&gt;&lt;meta name=&quot;Generator&quot; content=&quot;Microsoft Word 14&quot;&gt;&lt;meta name=&quot;Originator&quot; content=&quot;Microsoft Word 14&quot;&gt;&lt;link rel=&quot;File-List&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5COICE_297AEB47-F439-4D76-9C18-74B7AE7C09BD.0%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml&quot;&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;link rel=&quot;themeData&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5COICE_297AEB47-F439-4D76-9C18-74B7AE7C09BD.0%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx&quot;&gt;&lt;link rel=&quot;colorSchemeMapping&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5COICE_297AEB47-F439-4D76-9C18-74B7AE7C09BD.0%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml&quot;&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt;
&lt;!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073786111 1 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:&quot;&quot;;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
	mso-fareast-font-family:&quot;Times New Roman&quot;;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:10.0pt;
	line-height:115%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:1314530038;
	mso-list-type:hybrid;
	mso-list-template-ids:-1173161656 134807553 134807555 134807557 134807553 134807555 134807557 134807553 134807555 134807557;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:?;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:&quot;Courier New&quot;;}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:?;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:?;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:&quot;Courier New&quot;;}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:?;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:?;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:&quot;Courier New&quot;;}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:?;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
--&gt;
&lt;/style&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin-top:0cm;
	mso-para-margin-right:0cm;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-fareast-language:EN-US;}
&lt;/style&gt;
&lt;![endif]--&gt;&lt;meta http-equiv=&quot;Content-Type&quot; content=&quot;text/html; charset=utf-8&quot;&gt;&lt;meta name=&quot;ProgId&quot; content=&quot;Word.Document&quot;&gt;&lt;meta name=&quot;Generator&quot; content=&quot;Microsoft Word 14&quot;&gt;&lt;meta name=&quot;Originator&quot; content=&quot;Microsoft Word 14&quot;&gt;&lt;link rel=&quot;File-List&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5COICE_297AEB47-F439-4D76-9C18-74B7AE7C09BD.0%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml&quot;&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;link rel=&quot;themeData&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5COICE_297AEB47-F439-4D76-9C18-74B7AE7C09BD.0%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx&quot;&gt;&lt;link rel=&quot;colorSchemeMapping&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5COICE_297AEB47-F439-4D76-9C18-74B7AE7C09BD.0%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml&quot;&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt;
&lt;!--
 /* Font Definitions */
 @font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073786111 1 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:&quot;&quot;;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
	mso-fareast-font-family:&quot;Times New Roman&quot;;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:10.0pt;
	line-height:115%;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
--&gt;
&lt;/style&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin-top:0cm;
	mso-para-margin-right:0cm;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-fareast-language:EN-US;}
&lt;/style&gt;
&lt;![endif]--&gt;&lt;b&gt;The brochure for this conference is now available, click the image on
 the right of your screen to download your copy or contact Jessica Horner
 on &lt;/b&gt;&lt;meta http-equiv=&quot;Content-Type&quot; content=&quot;text/html; 
charset=utf-8&quot;&gt;&lt;meta name=&quot;ProgId&quot; content=&quot;Word.Document&quot;&gt;&lt;meta name=&quot;Generator&quot; content=&quot;Microsoft Word 14&quot;&gt;&lt;meta name=&quot;Originator&quot; content=&quot;Microsoft Word 14&quot;&gt;&lt;link rel=&quot;File-List&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml&quot;&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;link rel=&quot;themeData&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx&quot;&gt;&lt;link rel=&quot;colorSchemeMapping&quot; href=&quot;file:///C:%5CUsers%5CJ7D34%7E1.HOR%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml&quot;&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt;
&lt;!--
 /* Font Definitions */
 @font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073786111 1 0 415 0;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:&quot;&quot;;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:10.0pt;
	line-height:115%;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
--&gt;
&lt;/style&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin-top:0cm;
	mso-para-margin-right:0cm;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-fareast-language:EN-US;}
&lt;/style&gt;
&lt;![endif]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot;&gt;&lt;a href=&quot;mailto:j.horner@c5-online.com&quot;&gt;&lt;span style=&quot;font-size: 10pt; line-height: 115%; font-family: &amp;quot;Corbel&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot; lang=&quot;EN-GB&quot;&gt;j.horner@c5-online.com&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt; line-height: 115%; font-family: &amp;quot;Corbel&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;

&lt;a href=&quot;mailto:j.horner@c5-online.com&quot;&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;&lt;/span&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/strong&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;For speaking opportunities and further programme information, please contact
Emma Perry, Conference Producer on &lt;/span&gt;&lt;/strong&gt;&lt;a href=&quot;mailto:e.perry@c5-online.com&quot;&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;e.perry@c5-online.com&lt;/span&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;margin: 0cm 0cm 0.0001pt; text-align: justify;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;For sponsorship opportunities,
please contact Daniel Capel on&amp;nbsp; &lt;br&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;margin: 0cm 0cm 0.0001pt; text-align: justify;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href=&quot;mailto:d.capel@c5-online.com&quot;&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;d.capel@c5-online.com&lt;/span&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;margin: 0cm 0cm 0.0001pt; text-align: justify;&quot;&gt;&lt;br&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 11pt; font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;&quot;&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;

</description>
<category>Regulatory &amp; Compliance</category>
<category>Legal</category>
<category>Regulatory Compliance</category>
<category>International Trade</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/574/us-defence-contracting-and-far-compliance-in-europe/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Consumer Products Regulation &amp; Litigation</title>
<link>http://www.americanconference.com/2013/845/consumer-products-regulation--litigation/</link>
<pubDate>Wed 26 Jun 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;P&gt;ACI has developed Consumer Products Regulation and Litigation as a safety net for companies struggling to balance regulatory compliance and litigation risks.&amp;nbsp; This program weaves together judicial insights, regulatory perspectives, and the advice of industry leading counsel to give consumer products professionals the most up-to-date, expert tested advice possible on navigating this terse terrain now and in the future.&lt;BR&gt;&lt;BR&gt;There is no other conference available that not only addresses pressing changes in the industry impacting litigation, but also provides practical information to bolster your practice, cutting-edge information about emerging areas of concern, and an opportunity to hear insights from esteemed jurists from throughout the country.&lt;/P&gt;
&lt;P&gt;As the CPSC ratchets up its enforcement activities, any hint of product issues send companies over a tightrope of decision making where they have to balance the risks and expense of reporting, recalls, and possible civil penalties.&amp;nbsp; At the same time, manufacturers are the subject of increased exposure to reputational harms from the wildfire nature of internet reporting on product issues.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;As regulatory compliance concerns place increasing pressure on companies with no-injury class actions anticipated to follow suit, ACI has developed Consumer Products Regulation and Litigation as a safety net for this precarious position, weaving together judicial insights, regulatory perspective, and the advice of industry leading counsel to give consumer products professionals the most up-to-date, expert tested advice possible on navigating this terse terrain now and in the future.&amp;nbsp; This is the only event which will provide:&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;An immersive examination of the specific legal concerns affecting consumer products with the guidance of co-chairs Cheryl Falvey and Eric Rubel&amp;nbsp; &lt;/P&gt;
&lt;P&gt;?&amp;nbsp;Feedback on dealing with aggressive actions from the&amp;nbsp; counsel for In the Matter of Maxfield and Oberton Holdings, LLC&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;Strategies for managing reputational backlash from a brain trust of in-house counsel, outside counsel, and public relations professionals &lt;/P&gt;
&lt;P&gt;?&amp;nbsp;Proven practice tips on the regulatory nuances to exploit when performing a recall including how to gracefully negotiate when you do not agree with the CPSC&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;Trends and management tips with respect to class action litigation from jurists and industry leading litigators&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;A structured approach to understanding and meeting overlapping regulatory requirements&lt;BR&gt;&lt;BR&gt;Space limited. Ensure you attend this event by reserving your space now. Register by calling 1-888-224-2480. &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Litigation</category>
<category>Healthcare</category>
<category>Environmental</category>
<category>Food and Beverage</category>
<category>Manufacturing &amp; Industrial</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/845/consumer-products-regulation--litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Long Term Gas Supply Contracts</title>
<link>http://www.americanconference.com/2013/579/long-term-gas-supply-contracts/</link>
<pubDate>Tue 2 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Berlin | &lt;P&gt;With the increasing flexibility that LNG, spot markets and shale gas offer, the European gas industry in 2013 is witnessing a significant shift in the traditional order of power. &lt;/P&gt;
&lt;P&gt;The last 12 months have delivered a number of landmark arbitration decisions on long-term gas supply contracts, with significant awards adjusting price structures away from oil indexation and striking down take-or-pay provisions. &lt;/P&gt;
&lt;UL&gt;&lt;/UL&gt;
&lt;P&gt;These arbitrations have raised a number of critical issues and provided a new level of clarity for long-term contracts currently in dispute. &lt;/P&gt;
&lt;P&gt;Both sides of the market are looking for concrete answers to the myriad challenges they face in both re-negotiating their existing contracts and drafting future long term gas supply contracts. What has industry learned from these crucial developments and how can you apply the lessons learned to your contract negotiation and arbitration strategies right now?&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;C5's&lt;/EM&gt;&lt;/STRONG&gt;&lt;EM&gt; third annual&lt;/EM&gt;&lt;STRONG&gt; Congress on Long Term Gas Supply Contracts&lt;/STRONG&gt; is the only event focused exclusively on this industry critical issue. Now firmly established as a leading event in the gas industry calendar, this Congress attracts all key players from both the supplier and purchaser sides. It is an event that no-one involved in the negotiation or renegotiation of long term gas supply contracts simply can afford to miss. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Leading arbitrators, legal counsel and expert witnesses will provide comprehensive and practical advice on:&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Drafting robust long terms supply contracts that are reflective of current contract trends, arbitration awards, and the shifting market sentiment from oil to spot indexed pricing&lt;/LI&gt;
&lt;LI&gt;Successfully commercially negotiating pricing reviews on existing long term contracts&lt;/LI&gt;
&lt;LI&gt;Common legal issues encountered in arbitration and how to get them right&lt;/LI&gt;
&lt;LI&gt;The impact of new supply sources, suppliers, LNG and shale gas on pricing and contract negotiations going forward&lt;/LI&gt;&lt;/UL&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;BR&gt;For speaking opportunities please contact&lt;/STRONG&gt; &lt;BR&gt;&lt;STRONG&gt;Ben Sharples&lt;/STRONG&gt;, conference producer&lt;BR&gt;&lt;STRONG&gt;Tel:&lt;/STRONG&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; +44(0)20 7878 6914&lt;BR&gt;&lt;STRONG&gt;Email:&lt;/STRONG&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;A href=&quot;mailto:j.price@c5-online.com&quot; target=nw&gt;b.sharples@c5-online.com&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;For sponsorship opportunities please contact&amp;nbsp;:&lt;BR&gt;&lt;/STRONG&gt;Vlada Penlington&lt;BR&gt;&lt;STRONG&gt;Tel&amp;nbsp;:&lt;/STRONG&gt; +44(0)20 7878 6978&lt;BR&gt;&lt;STRONG&gt;Email&lt;/STRONG&gt;&amp;nbsp;: &lt;A href=&quot;mailto:v.penlington@c5-online.com&quot;&gt;v.penlington@c5-online.com&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;For media partnership opportunities&amp;nbsp;please contact:&lt;BR&gt;&lt;/STRONG&gt;Karina Kusova&lt;BR&gt;&lt;STRONG&gt;Tel&amp;nbsp;:&lt;/STRONG&gt; +44(0)20 7878 6956&lt;BR&gt;&lt;STRONG&gt;Email&amp;nbsp;:&lt;/STRONG&gt; &lt;A href=&quot;mailto:k.kusova@c5-online.com&quot;&gt;k.kusova@c5-online.com&lt;/A&gt; &lt;/P&gt;</description>
<category>Legal</category>
<category>Energy</category>
<category>Regulatory Compliance</category>
<category>International Trade</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/579/long-term-gas-supply-contracts/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Transfer Pricing West Africa</title>
<link>http://www.americanconference.com/2013/581/transfer-pricing-west-africa/</link>
<pubDate>Tue 9 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Lagos | &lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 9pt&quot;&gt;With West African countries experiencing strong economic growth, tax administrations are becoming increasingly aware of the importance of effective transfer pricing rules that ensure that multinationals report and pay tax on the correct proportion of profits they make in Africa.&lt;/SPAN&gt;&lt;BR&gt;&lt;BR&gt;Concerned with the need to curb revenue leakages in their economies West African countries such as Nigeria, Ghana and Cameroon have recently passed new transfer pricing laws to prevent mispricing and potential loss of tax revenue &lt;/P&gt;
&lt;P&gt;Tighter regulation created by the new laws will create an urgent need for companies to fully re-evaluate and re-adjust their inter-enterprise pricing arrangements.&amp;nbsp; &lt;BR&gt;&lt;BR&gt;Early reconsideration of existing models of transfer pricing and the establishment of effective tax planning processes that are compliant with the new rules will significantly reduce tax risks of companies and provide a significant competitive advantage.&lt;BR&gt;&lt;BR&gt;C5's practical conference on Transfer Pricing&amp;nbsp;will provide you with the guidelines and tools for successful tax planning so that you can ensure that your company is fully prepared for the new requirements.&lt;BR&gt;&lt;BR&gt;Leading West African and foreign tax experts, including tax managers from multinational companies, tax authorities, auditors and lawyers will share their valuable experiences and provide practical guidance for building new and effective business models and tips on how to adapt to the new laws.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;This two day conference will focus on some of the key challenges facing companies in the region including:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Preparing Your Company for The Practical Application of New Laws and Understanding its Impact on Your Tax Framework&lt;/LI&gt;
&lt;LI&gt;How to Overcome the Lack of Data for Comparable Transactions&lt;/LI&gt;
&lt;LI&gt;Challenges Associated with Defining Appropriate Transfer Pricing Methods for Your Business&lt;/LI&gt;
&lt;LI&gt;How to Prepare, Maintain and Update Appropriate Transfer Pricing Documentation&lt;/LI&gt;
&lt;LI&gt;Defence Strategies in Tax Audits: How to Ensure Compliance and Mitigate Risks&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;The event will be part of the global series of conferences on transfer pricing, organised by C5 in conjunction with the American Conference Institute and the Canadian Conference Institute.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Do not miss this truly unique opportunity to meet key market participants and get a comprehensive analysis of the new changes, which will help you to develop the best strategies for your company.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;The conference programme is still in development. To ensure you receive a copy of the brochure please contact Karina Kusova at &lt;/EM&gt;&lt;/STRONG&gt;&lt;A href=&quot;mailto:k.kusova@c5-online.com&quot;&gt;&lt;STRONG&gt;&lt;EM&gt;k.kusova@c5-online.com&lt;/EM&gt;&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;U&gt;For more information please contact:&lt;/U&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Speaking&amp;nbsp;opportunities&lt;/STRONG&gt;&lt;U&gt;&lt;BR&gt;&lt;/U&gt;Guy Lloyd&lt;BR&gt;Tel:&amp;nbsp;&amp;nbsp;+ 44 (0) 207 878 6915&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;BR&gt;&lt;A href=&quot;http://www.c5-online.com/2013/569/g.lloyd@C5-Online.com&quot;&gt;g.lloyd@C5-Online.com&lt;/A&gt;&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Marketing and media support enquiries:&lt;/STRONG&gt;&lt;BR&gt;Karina Kusova&lt;BR&gt;Tel:&amp;nbsp;&amp;nbsp;&amp;nbsp; +44 (0) 20 7878 6956&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;BR&gt;&lt;A href=&quot;mailto:marketing@c5-online.com&quot;&gt;marketing@c5-online.com&lt;/A&gt;&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Sponsorship opportunities:&lt;/STRONG&gt;&lt;BR&gt;Dan Capel&lt;BR&gt;Tel:&amp;nbsp;&amp;nbsp;+44 (0) 20 7878 6870&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;BR&gt;&lt;A href=&quot;http://www.c5-online.com/2013/569/d.capel@C5-online.com&quot;&gt;d.capel@C5-online.com&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Legal</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/581/transfer-pricing-west-africa/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Global Patenting Strategy and Practice</title>
<link>http://www.americanconference.com/2013/857/global-patenting-strategy-and-practice/</link>
<pubDate>Mon 15 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;P&gt;&lt;STRONG&gt;Your Marketplace is Global ? Ensure that Your Patent Protection is Too&lt;BR&gt;&lt;/STRONG&gt;&lt;BR&gt;As businesses increasingly look to global markets to increase their market share in a rapidly evolving and more-competitive-than-ever worldwide marketplace, it is imperative that companies racing to get their products on shelves around the globe ensure that proper IP protections are always in place first. However, despite harmonization efforts, the difficulty in developing an effective international patenting strategy is that patenting systems around the world have standards for patentability, inventive step, or opposition procedures that are not fully aligned. With so many available jurisdictions, each with their own concepts of what patents are and their own local rules and customs, it can be extremely difficult for even seasoned patent counsel to develop systems for advising clients on how to safely take products from national to international markets and ensure that their products will be protected in every market they enter.&lt;BR&gt;&lt;BR&gt;&lt;EM&gt;&lt;STRONG&gt;Receive the Expert Instruction Needed to Synthesize a Fully Informed Patenting Strategy to Maximize Global Market Share&lt;BR&gt;&lt;/STRONG&gt;&lt;/EM&gt;&lt;BR&gt;&lt;STRONG&gt;American Conference Institute's Advanced Summit on Global Patenting&lt;/STRONG&gt; &lt;STRONG&gt;Strategy &amp;amp; Practice&lt;/STRONG&gt; unites seasoned counsel with experience practicing in critical jurisdictions to share their wealth of knowledge and help you understand not only the mechanics of obtaining patents around the world, but also strategies for the most effective and efficient means of protecting IP in a global marketplace. Representing companies in an array of industry sectors, our expert faculty will address questions like:&lt;BR&gt;&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 
&lt;UL&gt;
&lt;LI&gt;How do you select the right local counsel depending on your needs?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;What jurisdictions provide effective patent protection for your products and which ones do not and what are&lt;BR&gt;the specific costs involved?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;How to reconcile the issues that arise when coordinating with inventors in numerous countries simultaneously?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;Which safeguards must multinational entities put into place when marketing and selling products protected&lt;BR&gt;by trade secrets?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;How do inventor compensation issues impact decisions to patent in one country or another?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;How do you draft claims broadly enough in different countries to cover all commercial embodiments&lt;BR&gt;and reasonably foreseeable competitive challenges?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;What written description requirements meet the standards required by multiple jurisdictions including the EU&lt;BR&gt;and Asian countries?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;When do outcomes from opposition proceedings in one jurisdiction impact the ability to protect a product in others?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;
&lt;LI&gt;Can evidence obtained in one country be used in litigation for other countries?&lt;BR&gt;And much more!&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;STRONG&gt;&lt;/UL&gt;Enhance your conference experience by attending the post conference workshops:&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;&lt;/U&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/LI&gt; 
&lt;UL&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;Mastering the Foreign Patent Law and Regulatory Requirements for Life Sciences Companies in a Global Context and the Post Conference Interactive Working Group Session&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;Negotiating the Obstacles and Challenges Associated with Patenting a Product in Numerous Jurisdictions&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;&lt;/UL&gt;This forum will enhance your understanding of patent practice in foreign jurisdictions and help you make more fully informed recommendations for your business and clients. Reserve your spot at this critically important conference&lt;BR&gt;by calling &lt;STRONG&gt;888-224-2480&lt;/STRONG&gt;, by fax at &lt;STRONG&gt;877-927-1563&lt;/STRONG&gt;, or online at &lt;A href=&quot;http://www.americanconference.com/PatentingStrategy&quot;&gt;www.americanconference.com/PatentingStrategy&lt;/A&gt;.&lt;BR&gt;&lt;BR&gt; 
&lt;P&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;
&lt;UL&gt;&lt;/UL&gt;
&lt;UL&gt;&lt;/UL&gt;
&lt;UL&gt;&lt;/UL&gt;
&lt;UL&gt;&lt;/UL&gt;</description>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Hatch-Waxman</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/857/global-patenting-strategy-and-practice/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Food &amp; Beverage Marketing &amp; Advertising</title>
<link>http://www.americanconference.com/2013/813/food--beverage-marketing--advertising/</link>
<pubDate>Tue 16 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | Over the past three years, ACI has been rapidly expanding its portfolio of events that cater specifically to the needs of in-house counsel and private practice attorneys representing the food and beverage industries. Back again for a third installment, ACI is pleased to announce the production for the &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;i&gt;3rd Advanced &lt;span style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span style=&quot;font-size:10.0pt;line-height:115%;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA&quot;&gt;Regulatory and
Compliance Summit on&lt;/span&gt;&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span style=&quot;font-size:10.0pt;line-height:115%;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA&quot;&gt; Food &amp;amp; Beverage Marketing and Advertising, &lt;/span&gt;&lt;/b&gt;&lt;/i&gt;which will take place this July 2013 in Washington, DC.&lt;br&gt;&lt;br&gt;Don't miss this opportunity to network and benchmark with a senior-level group of your peers from the leading food and beverage manufacturers, as you are engaged in a thoughtful, two-day discussion of current regulatory marketing and advertising issues specific to the food and beverage industry. &lt;br&gt;&lt;br&gt;Attendees of this industry-leading event will walk away with firsthand insights into how to approach &lt;b&gt;claim substantiation&lt;/b&gt;, impact of the recent POM decision, &lt;b&gt;structure marketing and advertising initiatives targeted to children&lt;/b&gt;, as well as product packaging and labeling so as to avoid getting caught in the regulatory crosshairs. &lt;br&gt;&lt;br&gt;In our continuous effort to improve the quality of our programs and offer you the best value, ACI is pleased to accept your topic and panel suggestions as well as speaker nominations for the 2013 program. Please contact Adam Denenberg at &lt;b&gt;&lt;a href=&quot;a.denenberg@americanconference.com&quot;&gt;a.denenberg@americanconference.com&lt;/a&gt;&lt;/b&gt; with any content related suggestions or for speaking opportunities.&lt;br&gt;&lt;br&gt;For more information on sponsorship opportunities, please contact Dan Schmidt, Business Development Executive at &lt;b&gt;&lt;a href=&quot;D.Schmidt@americanconference.com&quot;&gt;D.Schmidt@americanconference.com&lt;/a&gt;&lt;/b&gt;. &lt;br&gt;&lt;br&gt;For more information on media and association partnerships please contact Adam Denenberg at &lt;b&gt;&lt;a href=&quot;a.denenberg@americanconference.com&quot;&gt;a.denenberg@americanconference.com&lt;/a&gt;&lt;/b&gt;.&amp;nbsp;&amp;nbsp; &lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Advertising &amp; Marketing</category>
<category>Regulatory &amp; Compliance</category>
<category>Environmental</category>
<category>Food and Beverage</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/813/food--beverage-marketing--advertising/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Legal and Regulatory Summit on Generic Drugs</title>
<link>http://www.americanconference.com/2013/858/legal-and-regulatory-summit-on-generic-drugs/</link>
<pubDate>Wed 17 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York City | &lt;P&gt;Equip Yourself with the Tools and Know-How that You Need to Navigate the Generic Drug Industry's Rapidly Evolving Legal, Regulatory and Political Landscape&lt;/P&gt;
&lt;P&gt;Between the new requirements of the Generic Drug User Fee Act, the evolving risk of product liability exposure, and the barriers of REMS, the generic industry is facing formidable challenges on multiple fronts.&amp;nbsp; To help you make sense of these developments and their potential impact on the short and long terms goals of generic drug makers, the American Conference Institute has developed &lt;STRONG&gt;The Legal and Regulatory Summit on Generic Drugs &lt;/STRONG&gt;as a &quot;state of the union&quot; of the legal and regulatory ? as well as political and global -- changes affecting the generic pharmaceutical industry.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;This exclusive forum for generic pharmaceutical companies brings together a distinguished faculty of leading experts ? including representatives from top generic companies ? to address the intricacies and implications of these new developments as well as existing challenges affecting such core generic drug company functions as &lt;STRONG&gt;ANDA litigation, new product acquisition, IP, regulatory affairs and policy positions.&lt;/STRONG&gt;&amp;nbsp; They will provide you with the updated, critical insights you need to:&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;Forecast future opportunities relative to 180-day exclusivity&lt;BR&gt;?&amp;nbsp;Analyze GDUFA's impact on the cost of business&lt;BR&gt;?&amp;nbsp;Apply the IP underpinnings of the industry to regulatory and business considerations&lt;BR&gt;?&amp;nbsp;Craft a biosimilars strategy that will leverage existing resources&amp;nbsp; &lt;BR&gt;?&amp;nbsp;Separate hysteria from fact in assessing the anti-trust implications of reverse payment settlements&lt;/P&gt;
&lt;P&gt;Don't miss this opportunity to gain a critical understanding of the topics that collectively impact the future of the generic pharmaceutical industry.&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;To enhance and complete your conference experience, attend one or both of our two interactive half-day sessions designed to give you the edge in your generics practice:&lt;BR&gt;&lt;BR&gt;A: Pre-Conference Roundtable:&amp;nbsp; Addressing the Day to Day Legal, Regulatory, and Business Challenges of Generic Manufacturers, Facilitated by In-House Counsel&lt;BR&gt;&lt;/STRONG&gt;Prepare for the discussions of the main conference in this informal caucus deliberating the most pressing topics confronting in-house counsel in their daily practices.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;B: Business Development Master Class: In-House Counsel Perspectives on Selecting and Evaluating Outside Counsel)&lt;BR&gt;&lt;/STRONG&gt;Get the insider's assessment on what factors companies give precedence to when it comes to choosing, retaining, and assigning business to outside counsel.&lt;/P&gt;
&lt;P&gt;Register today for the industry's premier and most comprehensive legal and regulatory forum on Generic Drugs.&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Litigation</category>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Hatch-Waxman</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/858/legal-and-regulatory-summit-on-generic-drugs/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Anti-Corruption Compliance in High Risk Markets</title>
<link>http://www.americanconference.com/2013/827/anti-corruption-compliance-in-high-risk-markets/</link>
<pubDate>Mon 22 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;p&gt;&lt;strong&gt;Anti-Corruption Investigations and Prosecutions are Increasing Globally. Can Your Anti-Corruption Compliance Program Sustain the Heat of a Government Investigation? Learn What it Takes to Ensure Your Operations in High Risk Markets are Compliant with Relevant Anti-Corruption Laws.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;What constitutes a high risk partner in Brazil versus India? What does the investigative process look like in Thailand as opposed to Russia? How do you train employees to identify and report red flags in Uganda versus Indonesia? These questions and others require multinational corporations to rethink anti-corruption compliance and adopt a more local approach to effectively address corruption risks.&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;em&gt; Raise your global anti-corruption IQ - It is critical to have an effective and comprehensive anti-corruption compliance program in high risk markets that will demonstrate to your employees and government agencies that anti-corruption is an important corporate objective for your high risk markets and one that is taken seriously.&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;American Conference Institute's 4th Global Forum on Anti-Corruption in High Risk Markets&lt;/strong&gt; is designed to provide practical, country-specific guidance on monitoring third party anti-corruption compliance, conducting effective risk assessments, what pending legislation in BRIC countries could affect your global operations, understanding the complexities of data privacy protections, and keeping employees in high risk markets engaged in your anti-corruption compliance program.&lt;/p&gt;
&lt;p&gt;This unique event will provide a country-by-country compliance roadmap and first hand local insights from:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Barbara Becker, Legal and Compliance Manager, &lt;strong&gt;Adidas&lt;/strong&gt; (Argentina)&lt;/li&gt;
  &lt;li&gt;Yogesh Goel, Global Compliance Officer, Indian Subcontinent, &lt;strong&gt;SAP&lt;/strong&gt; (India)&lt;/li&gt;
  &lt;li&gt;Javier Zamora, Assistant General Counsel, &lt;strong&gt;NIKE, Inc.&lt;/strong&gt; (USA)&lt;/li&gt;
  &lt;li&gt;Anton Alferov, Regional Compliance Counsel,&lt;strong&gt; Halliburton&lt;/strong&gt; (Moscow)&lt;/li&gt;
  &lt;li&gt;Javier Lopez de Obeso, Institutional Internal Control Unit, Legal Area, &lt;strong&gt;Pemex&lt;/strong&gt; (Mexico)&lt;/li&gt;
  &lt;li&gt;Bobby Butler, Chief Compliance Officer, &lt;strong&gt;Universal Weather &amp;amp; Aviation, Inc.&lt;/strong&gt; (USA) &lt;/li&gt;
  &lt;li&gt;Beng Ti Tan, General Counsel, Risk and Compliance Officer, &lt;strong&gt;Bureau Veritas&lt;/strong&gt; (Hong Kong)&lt;/li&gt;
  &lt;li&gt;Bruno Ferraz de Camargo, Senior Legal Director, General Counsel, &lt;strong&gt;Philips&lt;/strong&gt; (Brazil)&lt;/li&gt;
  &lt;li&gt;Jeremy Gray, Chief Operating Officer / Chief Financial Officer, &lt;strong&gt;W.R. Grace&lt;/strong&gt; (Singapore)&lt;/li&gt;
  &lt;li&gt;Jay Martin, Vice President, Chief Compliance Officer,&lt;strong&gt; Baker Hughes&lt;/strong&gt; (USA)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Unlike like other training events, you will take away tools you can use in your daily work to ensure anti-corruption compliance. Benefit from country-focused panels on:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; &lt;strong&gt;CASE STUDY&lt;/strong&gt; ? Localizing Your Gift s and Entertainment Policy to Match Market Risks &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt; Focus on China &lt;/strong&gt;? Responding to the Anti-Corruption Crackdown in the PRC: Cultural Barriers, SOEs, and China as the Target of U.S. Regulators &lt;/li&gt;
  &lt;li&gt; &lt;strong&gt;Interactive Q&amp;amp;A Session&lt;/strong&gt; ? From a Culture of Corruption to a Culture of Compliance: Ensuring That Employees Are Engaged and Vested in Your Local Compliance Programs&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;&lt;u&gt;Enhance Your Experience with Pre-Forum Interactive Working Groups ? July 22, 2013&lt;/u&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A.&lt;/strong&gt;  &lt;strong&gt;A Practical Guide to Risk-Based Third Party Vetting: Conducting Effective Due Diligence in High Risks Markets&lt;/strong&gt; ? During this hands-on benchmarking session, attendees participate in a comprehensive review of key factors to consider, understand complex government relationships and connections when screening and vetting third parties. &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;B.&lt;/strong&gt; &lt;strong&gt;Minimizing Bribery Risks in Mexico: A Complete Review of the Legislative Landscape and How to Address Complex Anti-Corruption Risks in your Mexican Operations &lt;/strong&gt;- This practical and interactive session will explore the legislative landscape in Mexico, while also providing attendees with best practices for preventing corruption violations, dealing with facilitation payments and addressing bribery demands.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Register early to guarantee your place and take advantage of early bird discounts&lt;/strong&gt;&lt;/em&gt;. Call &lt;strong&gt;1-888-224-2480&lt;/strong&gt;; fax your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt;; or register online at &lt;strong&gt;www.AmericanConference.com/FCPARiskMarkets&lt;/strong&gt;&lt;/p&gt;

</description>
<category>Anti-Corruption / FCPA</category>
<category>Regulatory &amp; Compliance</category>
<category>Regulatory Compliance</category>
<category>Ethics Credits</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/827/anti-corruption-compliance-in-high-risk-markets/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Long Term Care Regulatory Boot Camp</title>
<link>http://www.americanconference.com/2013/851/long-term-care-regulatory-boot-camp/</link>
<pubDate>Mon 22 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;Get the ultimate roadmap to the complicated &lt;br&gt;landscape of Long Term Care regulatory law&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;/div&gt;From opening a long term care facility, to enduring an investigation, to appealing tags, to full scale litigation, there are a plethora of regulatory hurdles that must be overcome to avoid non-compliance. The regulatory landscape in this area is complex and it is essential for attorneys who do not have regulatory practices ? but who do deal with long term care compliance and litigation ? to have a familiarity with these concepts.&lt;br&gt;&lt;br&gt;&lt;b&gt;Litigation often follows regulatory violations and the two are inextricably linked. Ensure you have a firm grasp of relevant regulations to achieve the best outcomes for your cases.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Many litigators and in-house counsel ? despite their tenure litigating long term care cases ? are not well-versed in the regulatory hurdles found in this space. Whether you are an in-house or outside counsel litigator or in-house regulatory counsel, &lt;b&gt;Long Term Care Regulatory Boot Camp&lt;/b&gt; will provide you with the insights you need.&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Boost your regulatory IQ&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;/div&gt;ACI's &lt;b&gt;Long Term Care Regulatory Boot Camp&lt;/b&gt; has been designed to give litigators (both in-house and outside), as well regulatory counsel, a strong working knowledge of core long term care regulatory competencies.&lt;br&gt;&lt;br&gt;A distinguished faculty of regulatory experts will share their knowledge and give you critical insights on:&lt;br&gt;&lt;ul&gt;&lt;li&gt;Relevant regulations that govern all aspects of long term care facilities&lt;/li&gt;&lt;li&gt;The survey and certification process&lt;/li&gt;&lt;li&gt;All aspects of the appeals process, including DAB, IDR, and IIDR&lt;/li&gt;&lt;li&gt;Medicare/Medicaid fraud and other audits&lt;/li&gt;&lt;li&gt;Elder Abuse statutes&lt;/li&gt;&lt;li&gt;FCA, anti-kickback, and qui tam&lt;/li&gt;&lt;li&gt;Labor and employment issues&lt;/li&gt;&lt;li&gt;The impact of Health Care Reform on long term care facilities&lt;/li&gt;&lt;li&gt;Complying with requirements for admission, transfer and discharge of residents&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;b&gt;Attend the pre-conference regulatory primer or post-conference master class to get the background and the in-depth information you need to maximize your learning and networking experience at this event!&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Pre-conference Regulatory Primer A&lt;/b&gt;: Long Term Care Regulations 101 will address topics to set the stage for the main conference by helping you thoroughly comprehend the long term care regulatory structure and the essentials of the certification and survey process, including different options for appeals. Maximize the value of your attendance and get the background you need to participate in the conversations at Long Term Care Boot Camp.&lt;br&gt;&lt;br&gt;&lt;b&gt;Post-Conference Master Class B&lt;/b&gt;: Developing Litigation Strategies, Substantive Arguments, and Skills to Keep Surveys out of Evidence will provide you with the tools to make smart decisions when a civil lawsuit runs concurrent with a regulatory violation. Understand the interplay between survey findings and litigation at this in-depth post-conference session.&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Employment &amp; Benefits</category>
<category>Insurance &amp; Reinsurance</category>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/851/long-term-care-regulatory-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">DCAA Audit &amp; Compliance Boot Camp</title>
<link>http://www.americanconference.com/2013/784/dcaa-audit--compliance-boot-camp/</link>
<pubDate>Wed 24 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Diego | &lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; TEXT-AUTOSPACE: ; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&lt;/SPAN&gt;&lt;?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; TEXT-AUTOSPACE: ; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;STRONG&gt;GAIN CRITICAL BEST PRACTICES FOR MAXIMIZING ALLOWABILITY AND REDUCING PAYMENT WITHHOLDING RISKS IN THIS CHALLENGING DCAA AUDIT AND COMPLIANCE ENVIRONMENT!&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;Back in San Diego due to popular demand, &lt;STRONG&gt;American Conference Institute's&lt;/STRONG&gt; critically &lt;EM&gt;acclaimed DCAA Audit &amp;amp; Compliance Boot Camp&lt;/EM&gt; is the only comprehensive, in-depth and practical training of its kind. In an era of backlog and government spending cuts, &lt;STRONG&gt;&lt;U&gt;there has never been a more critical time&lt;/U&gt;&lt;/STRONG&gt; to ensure that you are up-to-speed on how to maximize allowability and reduce withholding risks.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;At this unique nuts and bolts course, participants will have the opportunity to delve into core cost or pricing and audit requirements, and learn from government and leading companies in a highly interactive setting. &lt;STRONG&gt;Unlike other training events&lt;/STRONG&gt;, this Boot Camp will include intensive case studies, roundtable discussions and hands-on exercises to solidify your knowledge of core requirements and best practices. Each session is specifically designed to provide you with practical tools that you can apply to your daily work. Speakers will engage in a step-by-step analysis and explanation of key concepts and requirements that are crucial to your organization's bottom line.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;The 2013 program has evolved in response to industry feedback and recent developments, with more in-depth sections on the most critical DCAA audit and compliance challenges affecting your business. &lt;STRONG&gt;Benefit from enhanced discussions on incurred cost audits, business systems demonstrations, contract terminations, subcontracting compliance and pricing requirements.&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;DCAA and DCMA have also offered their robust support of this event. There is &lt;STRONG&gt;&lt;U&gt;no replacement&lt;/U&gt;&lt;/STRONG&gt; for face-to-face discussion and Q &amp;amp; A with key agency decision-makers. Few events on the west coast offer you the opportunity to hear directly from:&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;Don Mullinax &lt;BR&gt;Regional Director, Western Region&lt;BR&gt;&lt;STRONG&gt;Defense Contract Audit Agency&lt;/STRONG&gt; &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;David Johnson Keith &lt;BR&gt;Deputy Regional Director, Western Region &lt;BR&gt;&lt;STRONG&gt;Defense Contract Audit Agency&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;A. Palmer&lt;BR&gt;CACO / DACO Team Supervisor&lt;BR&gt;&lt;STRONG&gt;Defense Contract Management Agency&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;BR&gt;You can also benchmark and network with industry leaders, who have track records of successfully navigating DCAA audits and meeting the agency's compliance expectations: Raytheon, United Launch Alliance, ViaSat, Boeing, Salient Federal Solutions and Orbital Sciences Corporation.&lt;BR&gt;&lt;BR&gt;Group Pricing is available. Send your entire team and register early as seats at this event are expected to fill to capacity. Registrations will be taken on a first come, first served basis. Call &lt;STRONG&gt;1-888-224-2480&lt;/STRONG&gt;; fax your registration form to 1-877-927-1563 or register online above.&lt;BR&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;/P&gt;</description>
<category>Financial Services</category>
<category>Regulatory &amp; Compliance</category>
<category>Aerospace and Defense</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/784/dcaa-audit--compliance-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Consumer Finance Class Actions &amp; Litigation</title>
<link>http://www.americanconference.com/2013/807/consumer-finance-class-actions--litigation/</link>
<pubDate>Mon 29 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;font size=&quot;2&quot;&gt;Consumer financial services companies are facing &lt;b&gt;unprecedented regulatory and enforcement scrutiny and mounting litigation&lt;/b&gt;, and there is no sign of change coming anytime soon.&amp;nbsp; That is why it is essential that in-house an outside counsel have a mastery of new class action trends, emerging theories of liability, the latest enforcement actions and regulatory initiatives, and the most effective defense and settlement strategies.&amp;nbsp; &lt;br&gt;&lt;br&gt;It is with this in mind that American Conference Institute has developed its 1&lt;b&gt;6th National Conference on Consumer Finance Class Actions &amp;amp; Litigation.&lt;/b&gt;&amp;nbsp; We have assembled an unparalleled faulty of federal and state regulatory and enforcement officials, senior in-house counsel, renowned federal and state judges, and leading outside defense counsel who will provide you with expert advice, critical insights, and comprehensive updates on:&lt;br&gt;&lt;br&gt;&lt;/font&gt;&lt;ul&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;The latest &lt;b&gt;enforcement actions and initiatives from the CFPB &lt;/b&gt;and other federal and state agencies, and their impact on the consumer finance industry&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;&lt;b&gt;Consumer finance class action litigation, arbitration, and settlement trends:&lt;/b&gt; new cases, emerging theories of liability, certification and arbitration developments, offers of full relief, innovations in settlement strategies, and more&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;&lt;b&gt;Mortgage and foreclosure litigation:&lt;/b&gt; defending against TILA claims and defeating foreclosure defenses and borrower stall tactics&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;New and emerging strategies for defending against claims and class actions relating to &lt;b&gt;TCPA, FDCPA, and FCRA&lt;/b&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;Managing and defending against class actions and claims arising from &lt;b&gt;student loans, auto lending, credit, debit, and prepaid cards, and bank add-on services and products&lt;/b&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;&lt;b&gt;Judicial perspectives&lt;/b&gt; on class certification, arbitration, settlement considerations, bankruptcy litigation, e-discovery, and more&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;&lt;b&gt;Analyzing debt collection litigation trends &lt;/b&gt;and using that information to prevent future lawsuits&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font size=&quot;2&quot;&gt;&lt;b&gt;Fair lending:&lt;/b&gt; managing and defending against claims of discriminatory lending and assessing the status of ?disparate impact' in lending litigation and enforcement, including in the areas of &lt;b&gt;student loans and auto financing&lt;/b&gt;&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;font size=&quot;2&quot;&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;PLUS, add value to your attendance by also registering for the exclusive post-conference Master Class on Trial Strategy:&lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;br&gt;A Focus on Trials: Aggressively Defending Consumer Finance Cases, Stemming the Tide of Litigation, and Empowering Lenders To Go Back Into the Courtroom&lt;br&gt;&lt;br&gt;&lt;b&gt;July 30, 2013 | 4:00 p.m.-6:00 p.m.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Register now by calling 1-888-224-2480 or by faxing your registration form to &lt;b&gt;1-877-927-1563. &lt;/b&gt;You can also register online at &lt;b&gt;&lt;a href=&quot;http://www.AmericanConference.com/CFCAChicago&quot;&gt;www.AmericanConference.com/CFCAChicago&amp;nbsp; &lt;/a&gt;&lt;/b&gt;&lt;br&gt;&lt;/font&gt;&lt;br&gt;</description>
<category>Financial Services</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/807/consumer-finance-class-actions--litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Life Insurance and AD&amp;D Claims and Litigation</title>
<link>http://www.americanconference.com/2013/852/life-insurance-and-add-claims-and-litigation/</link>
<pubDate>Mon 29 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;h3&gt;The preeminent Life Insurance and Accidental Death event is back for itssecond year. Join top defense and plaintiff lawyers and in-house counsel and claims professionals as they meet to devise practical solutions for today's most critical litigation issues.&lt;/h3&gt;
&lt;p&gt;The litigation landscape involving life insurance and annuity claims has exploded in recent months, including increased
class action claims targeting retained asset accounts and new and ramped up filing stemming from STOLI products in the
secondary market. To complicate matters further, Plaintiffs are mobilizing and challenging rescission of policies and quickly
resorting to bad faith claims when claims are denied. Unclaimed property audits have the industry on high alert, and
accidental death claims have become worrisome as the industry grapples with the definition of an accident. The potential
outcomes of these cases are extremely risky and the costs of the suits are astronomical (in addition to the expense and
resources needed to carefully inspect applications and investigate statements related to the insured's health and finances in an effort to flag statements of material misrepresentations).&lt;/p&gt;
&lt;p&gt;New and recent developments in case law, complex statutes, and NAIC promulgated rules are critical aspects of any
litigation strategy. In response, American Conference Institute presents its &lt;strong&gt;2nd Annual Advanced Forum on LIFE
INSURANCE and AD&amp;amp;D CLAIMS AND LITIGATION&lt;/strong&gt;. This forum is your &quot;one-stop&quot; venue where practitioners can
network with leading insurers from around the country, and learn from top plaintiff and defense attorneys, and renowned
judges, who will share their expertise on how to develop strategy and create a winning approach to all aspects of life
insurance, accidental death and annuity claims.&lt;/p&gt;
&lt;p&gt;Hone your skills and sharpen your life insurance and accidental death claims and litigation strategy by attending this
unique two-day event. It features leaders in the field from: &lt;em&gt;&lt;strong&gt;MetLife, Pacific Life Insurance Company, Aflac, The Guardian
Life Insurance Company of America, Transamerica Life Insurance Company, Crump Life Insurance Services, Assurant
Employee Benefits, Combined Insurance Company of America, Legal &amp;amp; General America, Inc.&lt;/strong&gt;&lt;/em&gt; and many others.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;u&gt;Plus, be sure to also attend the Innovative Master Class:&lt;/u&gt;&lt;/strong&gt;&lt;br&gt;
&lt;strong style=&quot;color:#093&quot;&gt;Litigating a Life Insurance, Accidental Death and Annuity Case from Start to Finish&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Register now by calling &lt;strong&gt;888-224-2480&lt;/strong&gt;, faxing your registration form to 877-927-1563 or registering online&lt;/p&gt;
</description>
<category>Insurance &amp; Reinsurance</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/852/life-insurance-and-add-claims-and-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Bad Faith Litigation</title>
<link>http://www.americanconference.com/2013/855/bad-faith-litigation/</link>
<pubDate>Tue 30 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;b&gt;The 25th installment of ACI's Bad Faith Litigation series returns to the west coast with a revamped faculty of leading in-house counsel and claims professionals, prestigious jurists from different jurisdictions, and premier outside counsel from across the nation.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Bad faith litigation shows no signs of slowing down as more claims are filed in hotbed jurisdictions like Washington, California, Florida, and other states. The claims are costly, huge verdicts are being handed down every day, and more states are passing statutory bad faith laws. It is now more important than ever for insurers and policyholders to stay current on all that is happening in the bad faith litigation arena. Practitioners must stay ahead of the curve and create the best strategies for resolving coverage disputes, responding to demand letters, negotiating settlement demands, and managing discovery disputes.&lt;br&gt;&lt;br&gt;In response, &lt;b&gt;American Conference Institute&lt;/b&gt; brings you its 25th installment (&lt;i&gt;back on the west coast&lt;/i&gt;) of its acclaimed&lt;b&gt; Bad Faith Litigation&lt;/b&gt; forum for all the critical updates on case law, proposed legislation and strategies. Get effective tips on how you can ensure the best result for your case and client. This installment will feature:&lt;br&gt;&lt;ul&gt;&lt;li&gt;&lt;i&gt;Insurers In-house roundtable&lt;/i&gt;: This specialized in-house panel will focus on 1) best practices in claims investigation and litigation decisions; 2) settling bad faith claims and working with outside counsel; 3) dealing with the insured; and much more&lt;/li&gt;&lt;li&gt;&lt;i&gt;Point/counterpoint panel session with policyholders and insurers and how they assert/defend bad faith claims and punitive damages&lt;/i&gt;: Adapt your strategies to the new wave of claims being asserted and hear what key actions (or inactions) could lead your client into litigation.&lt;/li&gt;&lt;li&gt;&lt;i&gt;Discussions with distinguished jurists&lt;/i&gt;: Get valuable insight on effective theories and evidentiary issues, from state and federal judges that have presided over bad faith suits.&lt;/li&gt;&lt;li&gt;&lt;i&gt;Narrowly tailored panel sessions&lt;/i&gt;: Our narrowly tailored, comprehensive panels will shed light on the most effective ways to recognize bad faith set-ups, properly investigate a claim, litigate questionable coverage, manage discovery, respond to punitive damage claims and much, much more.&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;Register now by calling &lt;b&gt;888-224-2480 &lt;/b&gt;or faxing your registration form to &lt;b&gt;877-927-1563&lt;/b&gt;. You can also register online at &lt;a href=&quot;http://www.AmericanConference.com/BadFaithSNF&quot;&gt;&lt;b&gt;AmericanConference.com/BadFaithSNF&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Litigation</category>
<category>Insurance &amp; Reinsurance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/855/bad-faith-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Mortgage Fraud</title>
<link>http://www.americanconference.com/2013/854/mortgage-fraud/</link>
<pubDate>Tue 30 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;p&gt;&lt;strong&gt;&lt;u&gt;ATTENTION MORTGAGE FRAUD PROFESSIONAL: &lt;/u&gt;&lt;/strong&gt;The dynamics have changed, with short sale, reverse mortgage, income and
distressed asset fraud all running rampant, and a shift in the housing market to a purchase and repurchase environment. Attorneys and counsel,
compliance and QA officers, investigators, underwriters, appraisers, loan processors, and servicers must modify their risk controls given the
new dynamics to avoid today's heightened federal and state prosecution and enforcement.&lt;/p&gt;
&lt;p&gt;That is why you cannot afford to miss &lt;strong&gt;American Conference Institute's 8th National Mortgage Fraud Summit&lt;/strong&gt;. In addition to unparalleled
networking opportunities, this conference will provide attendees with the latest insights and expert advice from our exceptional faculty including:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;The view from the federal government: Emerging schemes, regulatory oversight, &lt;strong&gt;civil and criminal fraud enforcement &amp;amp; prosecutions
(including False Claims and FIRREA, and suits against attorneys for defrauding lenders)&lt;/strong&gt;, and forecasting the next wave of investigations&lt;/li&gt;
&lt;li&gt;Increased&lt;strong&gt; state and local influence and priorities on the mortgage front&lt;/strong&gt;: How they're examining fraud and their positions on emerging
schemes, changing regulation, prosecutions, investigations, and working with law enforcement&lt;/li&gt;
&lt;li&gt;Industry response to federal and states panels: &lt;strong&gt;Internal controls and fraud prevention in mortgage servicing&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;The emergence of&lt;strong&gt; short sale fraud perpetrated by borrowers and third-parties&lt;/strong&gt;: How to modify your current risk controls in response&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Loan modification&lt;/strong&gt; by borrowers and third-parties: The latest fraudulent schemes and predatory behavior&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Foreclosure rescue scams&lt;/strong&gt;: Red flags and how to combat fraud and misrepresentation when the scammer gets hold of the borrower&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Mortgage repurchase demands&lt;/strong&gt;: Responding to the rise in SARs as older loans are investigated/re-investigated&lt;/li&gt;
&lt;li&gt;Conforming to &lt;strong&gt;anti-money laundering (AML) and SAR regulations&lt;/strong&gt; and meeting&lt;strong&gt; Bank Secrecy Act&lt;/strong&gt; demands&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Reverse mortgage fraud&lt;/strong&gt; prevention and risk management given new regulatory and enforcement scrutiny&lt;/li&gt;
&lt;li&gt;Integrity in the&lt;strong&gt; appraisal market&lt;/strong&gt;: Strategically preparing appraisals for fraud avoidance, implementing adequate controls, and ensuring that
appraisers are qualified&lt;/li&gt;
&lt;li&gt;Mitigating potential liability for &lt;strong&gt;defalcation and settlement agent fraud&lt;/strong&gt;: Due diligence, identity theft of settlement and title agents, forged
quit claim deeds, damages that may be covered by&lt;strong&gt; title insurance&lt;/strong&gt;, and beyond&lt;/li&gt;
&lt;li&gt;Case studies on &lt;strong&gt;loss recovery programs &lt;/strong&gt;that work: Why and when to pursue recovery and maximizing recovery once you do&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Plus be sure to also book for the Master Class:&lt;/strong&gt;&lt;br&gt;
Best Practices on Oversight of Third Parties to Avoid Being Held Accountable for the Acts of Providers&lt;/p&gt;
&lt;p&gt; This event will fill up quickly, so register now by calling&lt;strong&gt; 1-888-224-2480&lt;/strong&gt;, faxing your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt;, or registering online&lt;/p&gt;
</description>
<category>Financial Services</category>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/854/mortgage-fraud/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Employment Discrimination</title>
<link>http://www.americanconference.com/2013/848/employment-discrimination/</link>
<pubDate>Wed 31 Jul 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;The premier employment discrimination litigation conference returns for its fourth year, with more in-house counsel client presence, more government regulators and enforcers, and top federal and state jurists who are actively involved in these cases.&lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;br&gt;The volume of employment discrimination litigation remains on the rise in 2013 as the changes to employment legislation and employment rights &amp;amp; responsibilities continue to be both extensive and significant. In light of the presently growing compensation culture, the increased number of displaced employees in the current economy, the recent tendency for employees to be more aware of their rights than ever before, and increased policy targeting by the EEOC, it is obvious that employers and their counsel today cannot afford to be anything less than vigilant.&lt;br&gt;&lt;br&gt;In response, American Conference Institute is proud to introduce the &lt;i&gt;4th installment of the essential advanced forum that will shape the future of employment discrimination strategies for leading litigators and in-house counsel: Defending and Managing&lt;/i&gt; &lt;b&gt;EMPLOYMENT DISCRIMINATION LITIGATION&lt;/b&gt;. This conference will provide even the most seasoned litigators with clarity and certainty with respect to today's key issues.&lt;br&gt;&lt;br&gt;In addition to a faculty of renowned federal and state judges, the EEOC, DOL OFCCP, DOJ, and NLRB, the conference features an unparalleled client presence, including leaders in the field from: &lt;i&gt;American Airlines, Pfizer, Wells Fargo, Marsh &amp;amp; McLennan, Cooper Industries, American Capital, Bank of America, FedEx Corp., Caterpillar, Boehringer Ingelheim, ConvaTec, Trans States Holdings, Covidien, Capital Contractors, Wake Forest Institute, International Paper Co., PSEG Services, Novartis Pharmaceuticals, ACE, Masco Corp., Rent-A-Center, Daiichi Sankyo, Darden Restaurants, Home Depot, Canam Steel, Credit Suisse, Royal Bank of Scotland,&lt;br&gt;Reed Elsevier, Equifax, Dow Jones, Medtronic, Citi, Advance Auto Parts, CenterPoint Energy, Macy's Inc. and more&lt;/i&gt;.&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;Register now by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your registration form to &lt;b&gt;877-927-1563&lt;/b&gt; or &lt;a onclick=&quot;newWindow('https://transactions.c5groupinc.com/event_reg.php?conf=3455&amp;amp;site=2&amp;amp;lang=en&amp;amp;gap=4','reg_now','600','720',''); pageTracker._link(this.href); return false;&quot; href=&quot;javascript:void(null);&quot;&gt; online&lt;/a&gt;.&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Employment &amp; Benefits</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/848/employment-discrimination/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Digital Advertising Compliance: Sweepstakes, Social Media and Promotions</title>
<link>http://www.americanconference.com/2014/861/digital-advertising-compliance-sweepstakes-social-media-and-promotions/</link>
<pubDate>Mon 9 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;According to Brandwatch, each day, there are 3.2 billion interactions on Facebook, 500 million tweets posted, and 5 million images uploaded to Instagram.&lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Are you maximizing your company's digital advertising use?&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Facebook, Twitter, Instagram and Vine are all the rage in online media as billions of people worldwide take to these platforms to connect with friends and brands.  Today's marketers look to social media technologies as innovative and cost-effective ways to reach their targeted audiences while also achieving branding and marketing communication goals. However, these rapidly evolving technologies continue to present legal challenges for promotional lawyers. By attending &lt;strong&gt;American Conference Institute's (ACI) 2nd Annual Summit on Digital Advertising Compliance: Sweepstakes, Promotions &amp;amp; Social Media&lt;/strong&gt;, September 9    -11, 2013, you will have the opportunity to hear from leading executives who have successfully kept up with these changes to implement successful social media promotions.  &lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;FTC Chairwoman Ramirez Signifies a Focus on COPPA Enforcement&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;As smart phones become a more widely used method of interaction among children, there is an increasing concern for privacy protection. Congress and the FTC are tackling this concern in a very real and impactful way, and you must be prepared for forthcoming changes. Chairwoman Ramirez has stated that the FTC values the big stick it carries and wants to &quot;emphasize the importance of enforcement.&quot; Ensure that your social media promotions are COPPA compliant.&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Ensure Your Company is Abiding by the .com Disclosures&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Hear directly from advertising experts involved in the FTC's roundtable discussions on mobile app disclosures. It is more critical than ever that your company's disclosures are clear and conspicuous on all devices and platforms that consumers may use to view the ad. Learn how to follow the updated guidelines, given the spatial and technological limitations of various platforms and gadgets.&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Pre-Conference Workshops Give You a Headstart on Conference Learning&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;ACI&lt;/strong&gt; is proud to present two pre-conference workshops. &lt;strong&gt;Workshop A&lt;/strong&gt; will provide attendees a 50-State Game Plan to navigate the unique bonding and registration requirements of different states, giving participants an opportunity to drill down into the complexities of federal and state sweepstakes laws.   &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Workshop B&lt;/strong&gt; will provide an in-depth Rules Drafting session, giving the participants a hands-on approach to writing sweepstakes rules, directly from the attorneys responsible for writing this language.&lt;/p&gt;
&lt;p&gt;Attend this comprehensive two day event to get the most up to date guidance on developing compliant sweepstakes campaigns utilizing new media platforms. Both days of the program not applicable to your practice? No problem ? register for a one-day pass! This event features separately bookable components to best fit your time, budget, and practice constraints. Register now by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt;, faxing your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt;, or visiting us online at &lt;strong&gt;www.americanconference.com/digitaladvertising. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Join the ACI: Advertising Law group on LinkedIn for program updates.&lt;/p&gt;
&lt;p&gt;Kind Regards,&lt;br&gt;
Stacey B. Evans, &lt;br&gt;
J.D.  Senior Conference Director &lt;/p&gt;
&lt;br&gt;</description>
<category>Advertising &amp; Marketing</category>
<category>Litigation</category>
<category>Intellectual Property</category>
<category>Regulatory &amp; Compliance</category>
<category>Food and Beverage</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/861/digital-advertising-compliance-sweepstakes-social-media-and-promotions/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Alaska Oil and Gas Congress</title>
<link>http://www.americanconference.com/2014/910/alaska-oil-and-gas-congress/</link>
<pubDate>Mon 16 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Anchorage | </description>
<category>Aboriginal</category>
<category>Construction</category>
<category>Energy &amp; Resources</category>
<category>Transportation / Manufacturing &amp; Industrial / Logistics</category>
<category>Energy &amp; Resources</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/910/alaska-oil-and-gas-congress/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Anti-Corruption Southern Africa</title>
<link>http://www.americanconference.com/2014/570/anti-corruption-southern-africa/</link>
<pubDate>Tue 17 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Johannesburg | Unparalleled networking and benchmarking opportunities with both an international and local faculty of senior-level executives and information you can't get anywhere else make this event the region's premier anti-corruption compliance forum. &lt;br&gt;&lt;br&gt;Last year your peers from a wide variety of industry sectors including &lt;b&gt;Oil &amp;amp; Gas, Life Sciences, Finance, Consumer Goods, Energy, Mining&lt;/b&gt; and &lt;b&gt;Telecoms&lt;/b&gt; attended the Forum on Anti-Corruption - Southern Africa. Here is what they had to say about it: &lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;&quot;Exceptionally good and well-balanced into Legislation and practical application and practices&quot; &lt;/b&gt;&lt;/i&gt;&lt;br&gt;Operational Risk &amp;amp; Control Manager, &lt;b&gt;BP Southern Africa&lt;/b&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;i&gt;&lt;b&gt;&quot;Well organised and very topical. Brilliant that we had local US and UIC views and a great mix of delegates with a wide source of experience which made for engaging and spirited discussion&quot; &lt;/b&gt;&lt;/i&gt;&lt;br&gt;Senior Consultant, &lt;b&gt;Control Risks (South Africa)&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;&lt;i&gt;&quot;Definitely I will recommend it to my colleagues. It was practical with very individual examples in how to build a compliance environment in the business&quot;&lt;/i&gt;&lt;/b&gt; &lt;br&gt;Ethics and Compliance Officers, &lt;b&gt;Vodacom (South Africa)&lt;br&gt;&lt;br&gt;&lt;i&gt;&quot;Good effort in making the programme relevant for a practitioner, such as an in-house counsel&quot; &lt;br&gt;&lt;/i&gt;&lt;/b&gt;Regional Compliance Counsel for Africa and Middle East, &lt;b&gt;Nokia Siemens Networks (Kenya)&lt;br&gt;&lt;br&gt;&lt;i&gt;&quot;The conference was beneficial both in terms of information and skill development and I would recommend it to other workmates and enforcement officers&quot; &lt;/i&gt;&lt;br&gt;&lt;/b&gt;Director for Community Education, &lt;b&gt;Anti-Corruption Commission (Zambia)&lt;br&gt;&lt;br&gt;&lt;i&gt;&quot;Extremely informative from the perspective of legal background and application. Yes I would recommend it to others&quot; &lt;br&gt;&lt;/i&gt;&lt;/b&gt;Regional Anti-Bribery &amp;amp; Anti-Corruption Manager South Africa, &lt;b&gt;Barclays Bank Plc&lt;/b&gt;&lt;br&gt;&lt;br&gt;Join us for the &lt;b&gt;Third Forum on Anti-Corruption in Johannesburg&lt;/b&gt; and take part in the region's only event that addresses your company's local bribery risks and provides a detailed look at the anti-bribery landscape in countries including the South Africa, Malawi, Zimbabwe, Zambia, Namibia, Malawi and other jurisdictions crucial to your operations in Southern Africa. The updated 2013 programme will once again feature a stellar international faculty that will provide practical insights on third party due diligence, preventing joint venture pitfalls, conducting internal investigations, building a culture of compliance whilst adhering to varying local customs and local content requirements, implementing robust financial controls, complying with the BEE Act while preventing corruption and fraud in public procurement and other critical anti-bribery compliance issues. &lt;br&gt;_____________________________________________________________&lt;br&gt;The conference programme is currently under development but please check back soon for the program agenda and faculty list. For speaking opportunities and any programmatic questions please contact Yvette Lingom at &lt;a href=&quot;y.lingom@c5-online.com&quot;&gt;y.lingom@c5-online.com&lt;/a&gt;.&amp;nbsp; &lt;br&gt;&lt;br&gt;If you are interested in learning more about sponsorship for this event, please contact Ed Malkoun, Group Leader at &lt;a href=&quot;E.Malkoun@c5-online.com&quot;&gt;E.Malkoun@c5-online.com&lt;/a&gt; or at 44 207 878 6973.&lt;br&gt;&lt;br&gt;For more information on media partnerships please contact Toby Hartley at &lt;a href=&quot;K.Kusova@c5-online.com&quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;/span&gt;&lt;/font&gt;&lt;/a&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;a href=&quot;http://www.c5-online.com/2013/560/anti-corruption-australia/O.Ponomareva@C5-Online.com&quot;&gt;T.Hartley@C5-Online.com&lt;/a&gt;&lt;/font&gt; or at 44 207 878 6964&lt;br&gt;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Regulatory &amp; Compliance</category>
<category>Legal</category>
<category>Regulatory Compliance</category>
<category>Ethics Credits</category>
<category>Anti-Corruption &amp; Fraud</category>
<category>International Trade</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/570/anti-corruption-southern-africa/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">FDA Boot Camp</title>
<link>http://www.americanconference.com/2014/859/fda-boot-camp/</link>
<pubDate>Tue 17 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Boston | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;The approval process?pre-approval concerns?product labeling?
clinical trials?adverse events reports? patent concerns? exclusivity.
? all are critical aspects in the commercialization process for drugs,
biologics, and devices which are governed by FDA law and regulation. Recent court
cases, and high profile trials concerning FDA-regulated products have made it
clear that it is essential for attorneys who do not have regulatory practices ?
but who do deal with FDA-regulated products ? to have a familiarity with
these concepts. The changing business dynamics of the life sciences industry
have also made it critical for business executives, policy analysts and
securities experts who work in this field to have a clear understanding of the dynamics
of the FDA.&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot; align=&quot;center&quot;&gt;&lt;b&gt;Law-suits ? Business Development and Investment&lt;/b&gt;&lt;/p&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;

&lt;/b&gt;&lt;/div&gt;&lt;p class=&quot;MsoNormal&quot; align=&quot;center&quot;&gt;&lt;b&gt;Strategies ? Compliance Protocols ? Policy Matters ?&lt;/b&gt;&lt;/p&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;

&lt;/b&gt;&lt;/div&gt;&lt;p class=&quot;MsoNormal&quot; align=&quot;center&quot;&gt;&lt;b&gt;Pricing and Reimbursement Decisions ? Patent and Product&lt;/b&gt;&lt;/p&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;

&lt;/b&gt;&lt;/div&gt;&lt;p class=&quot;MsoNormal&quot; align=&quot;center&quot;&gt;&lt;b&gt;Life Cycle Management&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;&amp;nbsp;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;Litigation as well as numerous other legal, business, and
policy decisions concerning FDA-regulated products often hinge on what happened during the pre-approval, approval, or post-approval
periods.&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;Many products liability lawyers, patent counsel, business
and investment experts, medical and regulatory affairs professionals, and
those involved in pricing and reimbursement ? despite their tenure in
working with FDA regulated products ? are not well-versed in the essentials
of the approval process and the regulatory hurdles of the post-approval
period. Whether you are a products liability or patent litigator, in-house
counsel, in-house business development or federal affairs professional, FDA
Boot Camp will provide you the insights you need.&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot; align=&quot;center&quot;&gt;&lt;b&gt;Boost your FDA regulatory IQ Learn about the FDA approval process and the ins and outs of
post-approval challenges&lt;/b&gt;&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot;&gt;ACI's FDA Boot Camp has been designed to give products or
patent litigators, as well as patent prosecutors, industry in-house
counsel, and life sciences investment and securities experts, a strong working
knowledge of core FDA competencies.&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot;&gt;A distinguished faculty of top FDA regulatory experts ? a
&quot;Who's Who of the FDA Bar&quot; ? will share their knowledge and give you
critical insights on:

&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? The organization, jurisdiction, functions, and operations
of the FDA&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? The essentials of the approval process for drugs,
biologics, and devices, including:&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? NDAs ? OTC Approval&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? INDs ? 510(k) submissions&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? BLAs ? PMA process&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? Clinical trials for drugs and biologics and the clearance
process for devices&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? The classification of devices and the concept of
&quot;risk-based&quot; classification&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? The role of the Hatch-Waxman Act in the patenting of drugs
and biologics&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? Labeling in the drug and biologics approval process&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? cGMPs and other manufacturing concerns relative to
products liability&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? Proactive adverse events monitoring and signal detection&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;? Recalls, product withdrawals, and FDA oversight authority&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;&amp;nbsp;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;Attend the pre-conference workshop or post-conference master classes to get the background and/or the in-depth information you need to maximize your learning and networking experience at this event!&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot;&gt;Workshop A: Fundamentals of FDA Regulatory Law will address
topics to set the stage for the main conference by helping you
thoroughly comprehend the structure of the FDA and the essentials of the
pre-approval, approval, and post-approval process. Get the background you need to flow
seamlessly into the conversations at FDA Boot Camp.&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot;&gt;Master Class B: Hatch-Waxman and BPCIA: Overview of
Biosimilars and Life Cycle Planning for Drugs and Biologics will provide an
in-depth overview of biosimilars as well as analyses of bioequivalency and
exclusivities and their role in patent and product life cycle management.&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot;&gt;Master Class C: Post-Approval Marketing Guidance and
Preemption Protocols will address issues that arise post-approval,
including advertising, promotion, and off -label promotion and enforcement, as
well as preemption fundamentals. 

&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot;&gt;Attend this conference and learn to navigate your way
through the regulatory maze that plays such a crucial role to your cases and
practice areas. Seats at prior iterations of ACI's FDA Boot Camp sold out.
Don't delay ? register now by calling 1-888-224-2480, faxing your registration
form to 1-877-927-1563, or registering online at &lt;a href=&quot;http://www.AmericanConference.com/FDABootCampBoston&quot;&gt;&lt;span style=&quot;color:windowtext&quot;&gt;www.AmericanConference.com/FDABootCampBoston&lt;/span&gt;&lt;/a&gt;
&lt;/p&gt;

&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;}
&lt;/style&gt;
&lt;![endif]--&gt;</description>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/859/fda-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">8th EU Pharma Regulatory Law</title>
<link>http://www.americanconference.com/2014/589/8th-eu-pharma-regulatory-law/</link>
<pubDate>Wed 18 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">London | &lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 10pt&quot; class=MsoNormal align=center&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 10pt&quot; class=MsoNormal align=center&gt;&lt;FONT face=Calibri&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;I style=&quot;mso-bidi-font-style: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-SIZE: 12pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;/B&gt;&lt;SPAN style=&quot;mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P align=center&gt;&lt;SPAN style=&quot;mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;FONT size=3&gt;&lt;FONT face=Calibri&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 16pt; mso-fareast-language: EN-GB&quot;&gt;8&lt;SUP&gt;th&lt;/SUP&gt;&amp;nbsp;EU Pharma Regulatory Law&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 9pt; mso-fareast-language: EN-GB&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P align=center&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 10pt; BACKGROUND: white&quot; class=MsoNormal align=center&gt;&lt;B&gt;&lt;I&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;18th-19th September 2013&lt;BR&gt;&amp;nbsp;Crowne Plaza- The City Hotel, London, United Kingdom&lt;/SPAN&gt;&lt;/I&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 9pt; mso-fareast-language: EN-GB&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; BACKGROUND: white&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;2013 has presented a unique set of challenges to the pharmaceutical industry.&amp;nbsp;&amp;nbsp;Transparency is becoming ever more prevalent in all aspects of the regulatory process, regulatory bodies are sanctioning drug companies unlike ever before, competitors are using new strategies to gain possession of your best-kept secrets, the impact of technology continues to grow, and new legislation is coming into force which will alter the playing field for everyone.&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 9pt; mso-fareast-language: EN-GB&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; BACKGROUND: white&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;C5's&amp;nbsp;&amp;nbsp;EU Pharma Regulatory Law&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;conference taking place on the 18&lt;SUP&gt;th&lt;/SUP&gt;-19&lt;SUP&gt;th&lt;/SUP&gt;September 2013 in London,&amp;nbsp;&amp;nbsp;will focus on the practical solutions to the current challenges facing pharma companies, legal practitioners, and regulatory and compliance officers.&amp;nbsp;&amp;nbsp;You will hear the specific strategies used by industry experts in dealing with regulatory challenges in 2013, which will impact your company in 2014 and beyond.&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Gain insights from the legal opinions of key European and government regulators; hear cutting edge case studies from the lawyers involved; get up-to-date information on the critical issues that will enable your company to maximise profits by avoiding harsh sanctions.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0cm 0cm 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;By attending this event and hearing from the top experts in this field, you will acquire the best strategies to:&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 36pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 7pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Deal effectively with the transparency inherent in the forthcoming clinical trials data requirements, protecting your competitive commercial knowledge without running afoul of the new requirements.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 36pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 7pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Safeguard your confidential business information contained in the medical authorisation dossier from your competitors.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 36pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 7pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Avoid the harsh pharmacovigilance sanctions recently sought by the EMA under the financial penalties legislation.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 36pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 7pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Ensure that your competitive strategies, including use of the patent scheme will not subject your company to sanctions.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 36pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 7pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Guarantee compliance with all new revisions to regulatory law, including API legislation, the medical device recast, the revisions to the EFPIA advertising code, and recent cases on the CJEU and cases and inquiries on the EU member state level.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 36pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 7pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Utilise digital technologies to the benefit of your company, and ensure compliance with the specific concerns surrounding Health Technology Assessments, E-health, and social media.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 10pt 36pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; BACKGROUND: white; COLOR: black; FONT-SIZE: 7pt; mso-fareast-language: EN-GB&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;BACKGROUND: white; COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Surmount new reimbursement and pricing limitations that have severely impacted profitability.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt; BACKGROUND: white&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 12pt; mso-fareast-language: EN-GB&quot;&gt;Get the best return on your company's investment.&amp;nbsp;&amp;nbsp;Learn the best strategies to navigate through the current challenges in pharma regulation.&amp;nbsp;&amp;nbsp;Don't miss out on this unique opportunity.&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 9pt; mso-fareast-language: EN-GB&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; MARGIN: 0cm 0cm 10pt&quot; class=MsoNormal&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 10pt&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;FONT size=3 face=Calibri&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;BR&gt;The conference program is still in development. To ensure you receive your copy of the brochure please contact Karina Kusova at &lt;/EM&gt;&lt;/STRONG&gt;&lt;/FONT&gt;&lt;A href=&quot;mailto:k.kusova@c5-online.com&quot;&gt;&lt;FONT color=#0000ff size=3 face=Calibri&gt;&lt;STRONG&gt;&lt;EM&gt;k.kusova@c5-online.com&lt;/EM&gt;&lt;/STRONG&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;BR&gt;&lt;BR&gt;&lt;FONT size=3&gt;&lt;FONT face=Calibri&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 12pt 0cm 0pt; BACKGROUND: white&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; COLOR: black; FONT-SIZE: 11pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;&lt;BR&gt;For speaking opportunities please contact:&lt;BR&gt;&lt;SPAN&gt;&lt;STRONG&gt;Dominic Marino&lt;/STRONG&gt;&lt;/SPAN&gt;, Conference Producer&lt;BR&gt;&lt;SPAN&gt;&lt;STRONG&gt;Tel:&lt;/STRONG&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;EM&gt;+44(0)20 7878 6903&lt;/EM&gt;&lt;BR&gt;&lt;SPAN&gt;&lt;STRONG&gt;Email:&lt;/STRONG&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; FONT-SIZE: 11pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;&lt;A href=&quot;mailto:d.marino@c5-online.com&quot;&gt;&lt;SPAN style=&quot;mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;FONT color=#0000ff&gt;&lt;EM&gt;d.marino@c5-online.com&lt;/EM&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; COLOR: black; FONT-SIZE: 11pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 12pt 0cm; BACKGROUND: white&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; COLOR: black; FONT-SIZE: 11pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;For sponsorship opportunities please contact:&lt;BR&gt;Brian Reffell&lt;BR&gt;&lt;SPAN&gt;&lt;STRONG&gt;Tel&amp;nbsp;:&lt;/STRONG&gt;&lt;EM&gt;&amp;nbsp;&lt;/EM&gt;&lt;/SPAN&gt;&lt;EM&gt;+44(0)20 7878 6933&lt;/EM&gt;&lt;BR&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;&lt;STRONG&gt;Email&lt;/STRONG&gt;&lt;/SPAN&gt;&amp;nbsp;:&lt;SPAN class=apple-converted-space&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; FONT-SIZE: 11pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;&lt;A href=&quot;mailto:b.reffell@c5-online.com&quot;&gt;&lt;SPAN style=&quot;mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;FONT color=#0000ff&gt;&lt;EM&gt;b.reffell@c5-online.com&lt;/EM&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; COLOR: black; FONT-SIZE: 11pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 12pt 0cm; BACKGROUND: white&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; COLOR: black; FONT-SIZE: 11pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;For media partnership opportunities&amp;nbsp;please contact:&lt;BR&gt;Karina Kusova&lt;BR&gt;&lt;SPAN&gt;&lt;STRONG&gt;Tel&amp;nbsp;:&lt;/STRONG&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;EM&gt;+44(0)20 7878 6956&lt;/EM&gt;&lt;BR&gt;&lt;SPAN&gt;&lt;STRONG&gt;Email&amp;nbsp;:&lt;/STRONG&gt;&lt;EM&gt;&amp;nbsp;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Calibri','sans-serif'; FONT-SIZE: 11pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin&quot;&gt;&lt;A href=&quot;mailto:k.kusova@c5-online.com&quot;&gt;&lt;SPAN style=&quot;mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;FONT color=#0000ff&gt;&lt;EM&gt;k.kusova@c5-online.com&lt;/EM&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;BR&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Legal</category>
<category>Pharmaceuticals and Biotech</category>
<category>Regulatory Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/589/8th-eu-pharma-regulatory-law/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Emerging Payment Systems</title>
<link>http://www.americanconference.com/2014/860/emerging-payment-systems/</link>
<pubDate>Wed 18 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;BE A PART OF THE NATION'S PREMIER FORUM ON EMERGING PAYMENT SYSTEMS AND ENSURE THAT YOU ARE PREPARED FOR THE LEGAL, COMPLIANCE, TECHNICAL, AND BUSINESS ISSUES ARISING FROM NEW PRODUCTS AND TECHNOLOGIES&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;The payments industry is facing unprecedented growth, rapid technological advancements, and a flood of new entrants into the market.&amp;nbsp; Questions abound as to how all of the stakeholders will work together, which products will be welcomed by consumers and retailers, best practices for managing privacy and data security risks, and how federal and state regulatory frameworks will be applied to emerging payment systems.&amp;nbsp; &lt;b&gt;While many of these new payment products have the potential to become attractive revenue streams, they are also fraught with uncertainties relating to regulatory, compliance, security, and business issues&lt;/b&gt;.&lt;br&gt;&lt;br&gt;Building on the incredible success of our Emerging Payment Systems series of conferences, and in response to demand from the market, &lt;b&gt;American Conference Institute&lt;/b&gt; has developed the &lt;b&gt;6th National Forum on Balancing Innovation with Consumer Protections in Emerging Payment Systems&lt;/b&gt;. This conference will bring together an unparalleled faculty of in-house counsel and compliance professionals, senior executives from industry-leading companies, high-level regulatory and enforcement officials, and top outside counsel specializing in emerging payment systems who will provide you with the insights and tools necessary to navigate the legal, compliance, technical, and business hurdles arising from new payment products and technologies.&amp;nbsp; &lt;br&gt;&lt;b&gt;&lt;br&gt;&lt;u&gt;PLUS&lt;/u&gt;, ADD VALUE TO YOUR ATTENDANCE BY ALSO REGISTERING FOR THE PRE- AND POST-CONFERENCE MASTER CLASSES:&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;A&amp;nbsp;&lt;/b&gt;&amp;nbsp;&amp;nbsp; &lt;b&gt;PRE-CONFERENCE MASTER CLASS&lt;/b&gt; ? &lt;i&gt;Understanding the Technology Underlying Emerging Payment Systems: Practical, Legal, and Regulatory Considerations for Attorneys and Compliance Professionals &lt;/i&gt;&lt;br&gt;&amp;nbsp;&amp;nbsp;&lt;b&gt;&amp;nbsp; September 18, 2013 | 8:00 a.m. ? 10:00 a.m.&lt;br&gt;&lt;/b&gt;&lt;br&gt;&lt;b&gt;B&amp;nbsp;&amp;nbsp;&lt;/b&gt;&amp;nbsp;&lt;b&gt; POST-CONFERENCE MASTER CLASS&lt;/b&gt; ? &lt;i&gt;Credit, Debit, and Prepaid Cards: New Regulations and Reforms and Their Impact on ?Traditional' Payment Methods&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/i&gt;&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;September 19, 2013 | 1:40 p.m. ? 3:40 p.m.&lt;br&gt;&lt;/b&gt;&lt;br&gt;</description>
<category>Financial Services</category>
<category>Regulatory &amp; Compliance</category>
<category>Telecoms &amp; Technology</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/860/emerging-payment-systems/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">US Online Gaming Law 2013</title>
<link>http://www.americanconference.com/2014/582/us-online-gaming-law-2013/</link>
<pubDate>Thu 19 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Las Vegas | Finally. &lt;br&gt;&lt;br&gt;After years of talk and inactivity between the States and the Federal government on the regulation of online gaming, Nevada, New Jersey and Delaware have taken the bull by the horns, becoming the first States of many to legalise online gaming. With the doors to the world's largest gaming market finally opening, 2014 will be a year of incredible opportunity for gaming operators and industry service providers, bringing first access to an online market that is expected to reach $10 billion a year nationwide by 2017.&amp;nbsp;&amp;nbsp; &amp;nbsp;`&lt;br&gt;&lt;br&gt;Lucrative opportunities exist, however there remains a number of commercial and regulatory challenges to be met before your online strategies can become reality. The expansion of gaming opportunities within any jurisdiction is changing so rapidly that anyone involved in the launch of an online gaming service needs to remain on top of all these developments. &lt;br&gt;&lt;br&gt;Attracting over 100 attendees, C5's&amp;nbsp; annual US Online Gaming Law forum is now an established event in the online gaming calendar, and is the only one to focus specifically on online gaming regulation and regulatory compliance, written exclusively for those responsible for applying for and complying with online gaming licenses. &lt;br&gt;&amp;nbsp;&lt;br&gt;Key regulators, distinguished in-house counsel and business leaders from casinos, online operators, lotteries, tribes, tech companies and their expert legal advisers from across the country will help your company advance its key growth strategies by sharing their implementable insights and experiences on:&lt;span class=&quot;bold&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;ul&gt;&lt;li&gt;How the market leaders are capitalising right now on the 
opportunities presented by the regulation of online gaming regulations 
and what can you learn from their experience &lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Successfully navigating the state-by-state regulatory framework to plot your online market entry strategies&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;The regulatory, legal and commercial pitfalls that operators need to avoid as they enter the online space&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;How
 partnerships between gaming operators and suppliers are being used as a
 means of overcoming the barriers to entry for online gaming &lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Consolidating
 your social, mobile, online and land-based ventures to offer a 
streamlined and fully integrated experience to your player base&lt;br&gt;&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class=&quot;bold&quot;&gt;&lt;/span&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Regulatory &amp; Compliance</category>
<category>Regulatory Compliance</category>
<category>Legal</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/582/us-online-gaming-law-2013/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">3rd India Summit on Anti-Corruption</title>
<link>http://www.americanconference.com/2013/985/3rd-india-summit-on-anti-corruption/</link>
<pubDate>Mon 23 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New Delhi | &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Anti-Bribery Investigations and Prosecutions are Increasing in India and Around the Globe. &lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Can your Compliance Controls Sustain the Heat of a Government Investigation?&lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Learn What it Takes Ensure Your Operations in India are Compliant with the FCPA, UKBA, and Indian Anti-Corruption Laws.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Heightened anti-corruption enforcement will affect more companies in India than ever before. Recent corruption investigations and news headlines including Oracle, NewsCorp, and Wal-Mart illustrate that corruption continues to be a serious concern for companies doing business in India. Considering these cases and the public outcry against corruption in India, it is imperative that companies fine- tune an effective and comprehensive anti-corruption compliance program.  Now is the time to demonstrate to your employees and the enforcement agencies that anti-corruption is an important corporate objective that is taken seriously in India.&lt;/p&gt;
&lt;p&gt;Happening for the first time in New Delhi, this highly-rated &lt;strong&gt;3rd India Summit on Anti-Corruption&lt;/strong&gt; will bring together leading anti-corruption industry experts and counsel in India for unparalleled networking and benchmarking opportunities. The agenda was developed after extensive research with domestic companies and multinationals doing business in India, and includes the most relevant anti-corruption compliance developments. The event will cover important topics such as:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; Contrasting FCPA, UKBA, and Prevention of Corruption Act Requirements: A holistic approach to understanding the anti-corruption laws that impact doing business in India &lt;/li&gt;
  &lt;li&gt; Minimising Third Party Risks: Applying risk-based due diligence when vetting and selecting local agents, brokers, and distributors &lt;/li&gt;
  &lt;li&gt; What is a Bribe? Facilitation Payments, Speed Money, and Baksheesh ? How to develop a policy to identify and prevent these payments &lt;/li&gt;
  &lt;li&gt; Creating a Culture of Ethics and Compliance in India: How to keep employees engaged in and adhering to your anti-corruption program &lt;/li&gt;
  &lt;li&gt; Fundamentals of Anti-Corruption Risk-Assessment: How to determine your company's risk profile and design the right internal controls to detect corruption&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Also benefit from:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; Special sessions with &lt;strong&gt;The World Bank, Organization for Economic Cooperation and Development, Transparency International, &lt;/strong&gt;and&lt;strong&gt; I-Paid-A-Bribe&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt; Case Study: Joint Ventures and Consortia ? Due Diligence, Reps and Warranties&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;Interactive Benchmarking and Best Practices&lt;/em&gt;: How to ensure the success of your anti-corruption compliance programs in India&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Enhance Your Experience with New Working Groups. In these comprehensive and practical working sessions, you will benefit from enhanced Q&amp;amp;A, case studies, and the exchange of hands-on practices to help you build upon or fine-tune your anti-corruption compliance program.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A TRAIN THE ANTI-CORRUPTION TRAINER&lt;/strong&gt;: A Practical Guide on How to Design an Effective Training Curriculum for Employees and Third Parties and Successfully Conduct Training in India&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;B Developing a Compliant Gift, Travel and Hospitality Policy In India&lt;/strong&gt;: A Complete Guide on How to Balance Legal Needs with Local Standards of Entertainment&lt;/p&gt;
&lt;p&gt;Register early to guarantee your place and take advantage of early bird discounts. Call &lt;strong&gt;1-888-224-2480&lt;/strong&gt;; fax your registration form to 1-&lt;strong&gt;877-927-1563&lt;/strong&gt;; or register online at&lt;strong&gt; www.AmericanConference.com/AntiCorruptionIndia&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Regulatory &amp; Compliance</category>
<category>Regulatory Compliance</category>
<category>Ethics Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/985/3rd-india-summit-on-anti-corruption/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Cyber &amp; Data Risk Insurance</title>
<link>http://www.americanconference.com/2014/865/cyber--data-risk-insurance/</link>
<pubDate>Mon 30 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;ACI's 7th CYBER &amp;amp; DATA RISK INSURANCE CONFERENCE RETURNS TO NYC!&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;This is the annual late September tradition that provides the highest level insights on advancements in technology, products, pricing, coverage options, prevention strategies and more. It's also the only Cyber Risk event that brings you enforcement and regulatory initiatives straight from the federal and state agencies.&lt;br&gt;&lt;br&gt;Domestic and foreign cyber attacks and data breaches have routinely made the front pages of major newspapers. Hackers are gaining sensitive corporate data and control and access into and out of network systems. The problem has become so pervasive that the President has issued an Executive Order detailing plans for critical infrastructure to share information. Furthermore, the market itself has grown and expanded. Cyber liability policies are not limited to just big corporations. Smaller companies are realizing the importance of purchasing a stand alone cyber policy, adding endorsements to a GL, or adding cyber coverage to an existing coverage. With the growth of the market and the continued evolution of technology, it is critical that you are up to date in the ever growing area of cyber and data risk insurance.&lt;br&gt;&lt;br&gt;In response to new risks and exposures, &lt;b&gt;American Conference Institute&lt;/b&gt; has developed the 7th installment of its lauded &lt;b&gt;Cyber &amp;amp; Data Risk Insurance&lt;/b&gt; conference. A September tradition in NYC, join us to hear from a highly regarded faculty including the &lt;b&gt;FTC, DOJ, SEC, FDIC, various state AG offices, as well as the industry's leaders from around the country&lt;/b&gt;. Each year the event has grown in scope and size and this year the agenda is brimming &lt;b&gt;with cutting edge topics and new additions to the faculty. &lt;/b&gt;This is the &quot;go to&quot; event where you can learn about &lt;i&gt;&lt;b&gt;advancements in technology, products, pricing, coverage options, prevention strategies and more.&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;br&gt;Hear and network with the industry leaders about the right coverage options for your company and how you can protect data from financial and reputational loss. &lt;b&gt;Compare products, and learn about pricing policies and new exposures to risk in this ever growing industry.&lt;/b&gt; Whether you are an insurance agent, broker, risk adjuster, claims manager, and/or counsel you will walk away from the conference with invaluable information that you can use in your practice right away.&lt;br&gt;&lt;br&gt;Register now by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your registration form to &lt;b&gt;877-927-1563&lt;/b&gt; or registering online at &lt;b&gt;&lt;a href=&quot;http://www.AmericanConference.com/cyberrisk&quot;&gt;www.AmericanConference.com/cyberrisk&lt;/a&gt;&lt;/b&gt;&lt;br&gt;</description>
<category>Insurance &amp; Reinsurance</category>
<category>Telecoms &amp; Technology</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/865/cyber--data-risk-insurance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Wage &amp; Hour Claims And Class Actions</title>
<link>http://www.americanconference.com/2014/866/wage--hour-claims-and-class-actions/</link>
<pubDate>Mon 30 Sep 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;The wage and hour landscape continues to evolve at a blistering pace, with the potential for damaging claims at an all-time high. Given the complexity of state and federal laws regarding classification of workers and overtime pay, the increased number of displaced employees in the current economy, and the recent enhancement of DOL enforcement efforts, it is no wonder why wage and hour litigation is the fastest growing type of class action today.&amp;nbsp;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;That is why it is essential that employers and their counsel be fully prepared for the coming tidal wave of claims and class actions. Come join your colleagues and clients at the nation's premier wage and hour forum and hone the skills and strategies needed to&lt;i&gt; keep pace with this rapidly changing area of law, manage and defend against new and innovative claims, and prepare for emerging regulations and evolving enforcement priorities.&lt;/i&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;br&gt;&lt;div&gt;&lt;span style=&quot;font-size: 9pt; font-family: Tahoma, sans-serif; color: rgb(34, 30, 31);&quot;&gt;American Conference Institute's &lt;b&gt;19th National Forum on Wage
&amp;amp; Hour Claims and Class Actions &lt;/b&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 9pt; font-family: Tahoma, sans-serif; color: rgb(34, 30, 31);&quot;&gt;will also provide you with an
unparalleled opportunity to network expert in-house counsel from &lt;b&gt;&lt;i&gt;The Home
Depot, Providence Health &amp;amp; Services, Canam Steel Corporation, Florida Power
and Light, Citigroup, Capital Contractors, Kaplan, Best Buy, Pinnacle West
Capital, ConAgra Foods, Accor, DirecTV, Bank of America, Wells Fargo, Advance
Auto Parts, Real Mex Restaurants, Family Dollar Stores, Marsh &amp;amp; McLennan,
Medtronic, Microsoft, Cisco Systems, California Pizza Kitchen, Sears, and more.
&lt;/i&gt;&lt;/b&gt;In addition, renowned federal and state judges, top government
officials, and leading outside counsel from around the nation will provide you
with expert advice, strategies, and comprehensive updates on:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif;&quot;&gt;Assessing the impact of &lt;i&gt;Wal-Mart v. Dukes&lt;/i&gt; and its progeny on FLSA collective actions, Rule 23 class actions, and hybrid cases&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif;&quot;&gt;Certification/decertification of a class at different stages of the litigation process&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif;&quot;&gt;Overcoming the complexities of managing and defending against multidistrict litigation&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif;&quot;&gt;Managing and defending against the latest claims from the plaintiffs' bar&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif;&quot;&gt;Ensuring compliance with new federal and state wage-hour regulations and avoiding government agency targeting&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif;&quot;&gt;Preparing for comprehensive federal and state integrated audits&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif;&quot;&gt;Using settlement and mediation to resolve claims and avoid costly litigation&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div&gt;&lt;span style=&quot;font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px;&quot;&gt;Register now by calling&lt;b&gt; 1-888-224-2480&lt;/b&gt; or by faxing your registration form to 1-877-927-1563.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;You can also register online at &lt;a href=&quot;http://www.AmericanConference.com/WageAndHourSF&quot;&gt;www.AmericanConference.com/WageHourSNF&lt;/a&gt;&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;br&gt;&lt;span style=&quot;font-size: 9pt; line-height: 115%; font-family: Tahoma, sans-serif; background-position: initial initial; background-repeat: initial initial;&quot;&gt;For Sponsorship Opportunities, please contact&amp;nbsp;&lt;/span&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 9pt; line-height: 115%; font-family: Tahoma, sans-serif; font-weight: normal;&quot;&gt;Aaron R. Goldstein at&amp;nbsp;&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size: 9pt; line-height: 115%; font-family: Tahoma, sans-serif;&quot;&gt;212-352-3220 x5260 or&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;font-size:9.0pt;line-height:115%;font-family:&amp;quot;Tahoma&amp;quot;,&amp;quot;sans-serif&amp;quot;;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA&quot;&gt;&lt;a href=&quot;mailto:a.goldstein@americanconference.com&quot;&gt;a.goldstein@americanconference.com&lt;/a&gt;&lt;/span&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Employment &amp; Benefits</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/866/wage--hour-claims-and-class-actions/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">19th FCPA Boot Camp</title>
<link>http://www.americanconference.com/2013/867/19th-fcpa-boot-camp/</link>
<pubDate>Tue 1 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | Investigations are continuing to rise by FCPA regulatory authorities and it appears as if no industry is immune from enforcement, particularly in the technology sector. In addition, according to James Koukios, FCPA Assistant Chief, Department of Justice, the DOJ has &quot;a lot of cases in the hopper&quot; when discussing investigations in Latin America.&lt;br&gt;&lt;br&gt;Designed to provide a forum for addressing the continuing and emerging areas of focus for FCPA enforcement, American Conference Institute's 19th FCPA Boot Camp is a must-attend event for legal counsel, fraud examiners, investigative and compliance counsel/officers and FCPA attorneys. Attendees of this highly rated boot camp will walk away with a comprehensive understanding of the current enforcement environment, along with practical strategies for addressing high risk areas of exposure across their business operations.&lt;br&gt;&lt;br&gt;This program is currently in production ? for content and speaker inquiries, please contact Adam Denenberg at &lt;b&gt;&lt;a href=&quot;A.Denenberg@AmericanConference.com&quot;&gt;A.Denenberg@AmericanConference.com&lt;/a&gt;&lt;/b&gt; or 212-352-3220 ext. 5233.&amp;nbsp; &lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/867/19th-fcpa-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Paragraph IV Disputes Master Symposium</title>
<link>http://www.americanconference.com/2014/881/paragraph-iv-disputes-master-symposium/</link>
<pubDate>Wed 2 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;P&gt;For nearly a decade, you have trusted &lt;STRONG&gt;American Conference Institute (ACI)&lt;/STRONG&gt; to bring you the finest programs on &lt;STRONG&gt;Hatch-Waxman litigation&lt;/STRONG&gt;. With your input and support, our annual &lt;STRONG&gt;Paragraph IV Disputes conference&lt;/STRONG&gt; which is held each spring in &lt;STRONG&gt;New York City&lt;/STRONG&gt; has become the conference that not only sets the standards for &lt;STRONG&gt;Paragraph IV litigation&lt;/STRONG&gt;, but also serves as the annual meeting place for the &quot;who's who&quot; of pharmaceutical patent litigation. &lt;BR&gt;&lt;BR&gt;As our delegates have said about &lt;STRONG&gt;ACI's Paragraph IV Disputes:&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;&lt;EM&gt;&quot;First-rate content, analysis and presentations&quot;&lt;BR&gt;&quot;Always an informative, up-to-date, relevant and cogent conference&quot;&amp;nbsp;&lt;BR&gt;&quot;Excellent&quot;&lt;BR&gt;&quot;Comprehensive agenda and impressive speakers who are at the top of their profession.&quot;&lt;BR&gt;&lt;/EM&gt;&lt;BR&gt;It is now our goal to bring you a conference designed to take your Hatch-Waxman skills to the next level.&amp;nbsp; With the help and input of our Hatch-Waxman Advisory Board we have developed of Paragraph IV Disputes Master Symposium.&amp;nbsp; Come to this conference and meet with the leading legal minds in this area as you acquire the skills needed for the new era of extreme Hatch-Waxman litigation.&lt;BR&gt;&lt;BR&gt;Our faculty of respected and renowned counsel for brand name and generic pharmaceutical companies will provide insights the&lt;STRONG&gt; intricacies of pre-suit Considerations, law suit commencement, motion practice and final adjudication in Hatch-Waxman Litigation. &lt;/STRONG&gt;Sessions will address the key elements of Paragraph IV litigation in addition to some of the most pressing and recent controversies in this area, including:&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;The impact of patent reform on Hatch-Waxman litigation&lt;BR&gt;?&amp;nbsp;The boundaries of 271(e)(1) relative to infringing pre vs. post market activities&lt;BR&gt;?&amp;nbsp;New obviousness considerations in light of recent decisions and the AIA&lt;BR&gt;?&amp;nbsp;The potential effects of FDASIA and the GAIN Act on Paragraph IV Challenges&lt;BR&gt;?&amp;nbsp;Exclusivity concerns for brands as well as generics&lt;BR&gt;?&amp;nbsp;New rulings in divided infringement and inducement of infringement&lt;BR&gt;?&amp;nbsp;Damages theories relative to launching at risk&lt;BR&gt;?&amp;nbsp;The further evolution of the inequitable conduct ruling post-Therasense&lt;/P&gt;
&lt;P&gt;We are also pleased to offer you informative and hands-on workshops which will complete your conference and networking experience:&lt;BR&gt;&amp;nbsp;&lt;BR&gt;&lt;STRONG&gt;
&lt;UL&gt;
&lt;LI&gt;Workshop A:&lt;/STRONG&gt; Hatch-Waxman and BPCIA Master Class ? Perfecting Your IP and Regulatory IQ of Small and Large Molecules&lt;/LI&gt;&lt;/UL&gt;&lt;BR&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Workshop B:&lt;/STRONG&gt; Post-Grant Review and Inter Partes Review Boot Camp: Essential Considerations for Brand Names and Generics Regarding the Use of These PTO Procedures in Paragraph IV Scenarios 
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;Seating is limited; don't delay ? register now by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563, or registering online at &lt;A href=&quot;http://www.americanconference.com/PIVDisputesChicago&quot;&gt;www.americanconference.com/PIVDisputesChicago&lt;/A&gt;.&lt;BR&gt;&lt;BR&gt;Full conference details are on the way shortly. If you are interested in speaking at this event, contact &lt;STRONG&gt;Lisa Piccolo&lt;/STRONG&gt; at&amp;nbsp;&lt;A href=&quot;mailto:l.piccolo@americanconference.com&quot;&gt;l.piccolo@americanconference.com&lt;/A&gt;.&amp;nbsp;For information on sponsoring or exhibiting at this event, contact&lt;STRONG&gt; Esther Fleischhacker&lt;/STRONG&gt; at &lt;A href=&quot;mailto:ef@americanconference.com&quot;&gt;ef@americanconference.com&lt;/A&gt;.&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;
&lt;UL&gt;&lt;/UL&gt;</description>
<category>Regulatory &amp; Compliance</category>
<category>Litigation</category>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Hatch-Waxman</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/881/paragraph-iv-disputes-master-symposium/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Prepaid Card Compliance</title>
<link>http://www.americanconference.com/2014/873/prepaid-card-compliance/</link>
<pubDate>Thu 3 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0in 0in 0pt&quot; align=center&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot;&gt;ACI's 8th National &lt;U&gt;&lt;SPAN style=&quot;COLOR: #660000&quot;&gt;PREPAID CARD COMPLIANCE&lt;/SPAN&gt;&lt;/U&gt;&lt;SPAN style=&quot;COLOR: #660000&quot;&gt;&amp;nbsp; &lt;/SPAN&gt;&lt;SPAN style=&quot;COLOR: black&quot;&gt;-- Call for Speakers Now Open&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot;&gt;&lt;?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;The next installment of the &lt;I&gt;Prepaid Card industry's premier forum focused solely on legal, regulatory, and compliance concerns&lt;/I&gt; will take place on &lt;B&gt;October 3-4&lt;/B&gt;, &lt;B&gt;2013&lt;/B&gt; in &lt;B&gt;San Francisco&lt;/B&gt; at the &lt;B&gt;Omni San Francisco Hotel.&lt;/B&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;Planning of the conference is underway and the call for speakers is now open. If you are interested in being considered to speak on a panel at the conference, please let us know of your interest - &lt;STRONG&gt;&lt;I&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'&quot;&gt;&lt;A title=&quot;click here&quot; href=&quot;mailto:K.Horton@AmericanConference.com?subject=Interested%20in%20Speaking%20at%20ACI%27s%20Controlling%20Litigation%20Costs&quot;&gt;click here&lt;/A&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;/STRONG&gt; &lt;B&gt;&lt;I&gt;to submit a speaker nomination and/or a topic or case study&lt;/I&gt;&lt;/B&gt;. &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN-BOTTOM: 0pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;Be sure to mark your calendars now for &lt;U&gt;San Francisco on 10/3 and 10/4.&lt;/U&gt; &amp;nbsp;&amp;nbsp; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN-BOTTOM: 0pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;We look forward to seeing you this Fall in the City by the Bay!&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN-BOTTOM: 0pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;Kind regards,&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;COLOR: black&quot;&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;Kenneth S. Horton, Esq.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Brett Brumberger, Esq.&lt;BR&gt;Division Manager&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: #1f497d; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;Industry Manager&lt;BR&gt;American Conference Institute&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: #1f497d; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;American Conference Institute&lt;BR&gt;45 West 25th Street, 11th Floor&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: #1f497d; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;45 West 25th Street, 11th Floor&lt;BR&gt;New York, NY 10010&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; New York, NY 10010&lt;BR&gt;(212) 352-3220&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (212) 352-3220&lt;BR&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: #0000cc; FONT-SIZE: 10pt&quot;&gt;&lt;A href=&quot;mailto:k.horton@americanconference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: #0000cc; TEXT-DECORATION: none; text-underline: none&quot;&gt;k.horton@americanconference.com&lt;/SPAN&gt;&lt;/A&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;A href=&quot;mailto:b.brumberger@americanconference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: #0000cc; TEXT-DECORATION: none; text-underline: none&quot;&gt;b.brumberger@americanconference.com&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;&lt;I&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;/B&gt;&lt;/P&gt;&lt;B&gt;&lt;I&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA&quot;&gt;P.S. As always, our Washington DC PREPAID CARD COMPLIANCE conference will be held at the very end of January 2014.&lt;/SPAN&gt;&lt;/I&gt;&lt;/B&gt;&lt;BR&gt;</description>
<category>Financial Services</category>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/873/prepaid-card-compliance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Sunshine Act Compliance &amp; Aggregate Spend Reporting</title>
<link>http://www.americanconference.com/2014/878/sunshine-act-compliance--aggregate-spend-reporting/</link>
<pubDate>Mon 7 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;STRONG&gt;Companies are under urgent pressure to swiftly implement and manage a complete and integrated aggregate spend system before tracking commences in August 2013 and the first reports are due in March 2014.&amp;nbsp; Gain advanced strategies to incorporate immediately to meet the massive challenge of satisfying both federal and state disclosure requirements in an expedited timeframe.&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;Time is a luxury life sciences companies cannot afford to waste as the March 2014 deadline for initial reporting and submission quickly approaches.&amp;nbsp; Complying with complicated and evolving federal, state, and global spend disclosure laws demands a massive amount of effort and resources, and companies must be compliant when doing business throughout the U.S. and abroad or else face severe monetary penalties and loss of crucial market share. &lt;STRONG&gt;ACI's 5th Annual Forum on Sunshine Act Compliance &amp;amp; Aggregate Spend Reporting&lt;/STRONG&gt; will save you time and money as a frontline faculty of drug and device manufacturers, government enforcers, and policy advisors help you formulate real-world, cost-effective strategies to streamline your systems and capture and report accurate and compliant spend data. &lt;BR&gt;&lt;BR&gt;With a focus on improving existing compliance protocols post guidance and preparing for the fallout once the reports are public, this is a solutions driven event. Attendees at all phases of aggregate spend implementation will leave this conference with practical tips and tried and true solutions to combat increasingly complex reporting requirements:&lt;BR&gt;&lt;BR&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;&amp;nbsp;BENCHMARK&lt;/STRONG&gt; best practices against in-house leaders from who are developing solutions to the intense challenge of satisfying complex federal and state disclosure requirements while ensuring that corporate objectives are met.&lt;BR&gt;&lt;/LI&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;PREPARE&lt;/STRONG&gt; for increasingly aggressive enforcement activity and public scrutiny as government enforcers reveal how enforcers may view disclosed data.&amp;nbsp;&lt;BR&gt;&lt;/LI&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;GAIN&lt;/STRONG&gt; the most up to date and thorough analysis of current, pending and proposed state disclosure laws to take back to your entire aggregate spend team in the&lt;STRONG&gt; Pre-Conference State Law Boot Camp: Comprehensive State-by-State Breakdown of Disclosure and Reporting Requirements Post Sunshine Act &lt;BR&gt;&lt;/LI&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/STRONG&gt;&lt;STRONG&gt;&amp;nbsp;PROTECT&lt;/STRONG&gt; relationships with healthcare professionals and consumers while creating a compliant system for capturing payments under disclosure laws.&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;STRONG&gt;In addition, this event features special benchmarking sessions on the gray areas post-guidance:&lt;/STRONG&gt; research reporting, third party payment reporting, valuing marketing materials, auditing, certifying with confidence, readying assumptions documents and much more.&lt;BR&gt;&lt;BR&gt;Hear what prior delegates have said about this annual event:&lt;BR&gt;&lt;BR&gt;&lt;EM&gt;&quot;Very good conference with a great array of topics around Sunshine&quot; ? Bill Friedrich, Director-State Reporting, &lt;STRONG&gt;Pfizer Inc,&lt;/STRONG&gt; Prior Delegate 2011&lt;BR&gt;&lt;/EM&gt;&lt;BR&gt;&lt;EM&gt;&quot;Loved having state regulators present ? gives great insight into the somewhat confusing world of state transparency and disclosure.&quot; -&amp;nbsp; Erin Curley, Compliance Manager, &lt;STRONG&gt;Warner Chilcott, &lt;/STRONG&gt;Prior &lt;BR&gt;&lt;/EM&gt;&lt;BR&gt;Join your colleagues who are going through this process alongside you and walk away with real life examples and the most current advice on structuring and managing a comprehensive and viable aggregate spend system by calling &lt;STRONG&gt;888-224-2480&lt;/STRONG&gt;, faxing your registration form to &lt;STRONG&gt;877-927-1563&lt;/STRONG&gt; or registering online.&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/LI&gt;
&lt;UL&gt;&lt;/UL&gt;</description>
<category>Healthcare</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/878/sunshine-act-compliance--aggregate-spend-reporting/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">FDA &amp; USDA Compliance Boot Camp</title>
<link>http://www.americanconference.com/2014/868/fda--usda-compliance-boot-camp/</link>
<pubDate>Tue 8 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;p&gt;Designed specifically to provide an A to Z overview of key regulations applicable to food products at both the federal and state level, &lt;strong&gt;ACI's FDA &amp;amp; USDA Compliance Boot Camp&lt;/strong&gt; will provide attendees with an in-depth overview of key regulations and enforcement initiatives by the FDA and USDA, as well as an update on current regulatory initiatives at the&lt;strong&gt; state level&lt;/strong&gt; in &lt;em&gt;key jurisdictions&lt;/em&gt; including &lt;strong&gt;California&lt;/strong&gt;. Attendees will hear directly from the regulators on their top priorities over the next 18 months and beyond.&lt;/p&gt;
&lt;p&gt;Back by popular demand, ACI's FDA &amp;amp; USDA Compliance Boot Camp will focus on providing &lt;strong&gt;legal and regulatory counsel and government affairs executives&lt;/strong&gt; practical advice on how to navigate the maze of regulations that apply to food products. Whether new to the food industry or a seasoned veteran seeking a comprehensive refresher, this boot camp is invaluable for getting up to speed while also benchmarking and networking with experts in the field.&lt;/p&gt;
&lt;p&gt;This &lt;u&gt;intense, two-day boot camp&lt;/u&gt; will engage attendees in a comprehensive, deep-dive into &lt;strong&gt;food law fundamentals&lt;/strong&gt;, including a hands-on examination of the regulations governing:&lt;br&gt;&lt;br&gt;?&amp;nbsp;Food Ingredients and Additives &lt;br&gt;?&amp;nbsp;Product Labeling &lt;br&gt;?&amp;nbsp;Food Inspections and Recalls&lt;/p&gt;
&lt;p&gt;For more information on sponsorship opportunities, please contact Dan Schmidt, Business Development Executive at &lt;a href=&quot;mailto:D.Schmidt@americanconference.com&quot;&gt;D.Schmidt@americanconference.com&lt;/a&gt;. &lt;/p&gt;
&lt;p&gt;&amp;nbsp;For more information on media and association partnerships please contact Evan Ring, Partnership Maketing Executive at &lt;a href=&quot;mailto:e.ring@americanconference.com&quot;&gt;e.ring@americanconference.com&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Please continue to check this website for conference announcements, speaker additions and the release of the agenda. Reserve your space now by calling 888-224-2480; faxing your registration form to 877-926-1563; or you can register online.&lt;/p&gt;
&lt;p&gt;I look forward to seeing you in October in Chicago!&lt;/p&gt;
&lt;p&gt;Kind Regards,&lt;br&gt;&amp;nbsp;&lt;br&gt;Lori K. Littlejohn, Esq. &lt;br&gt;Program Director &amp;amp; Legal Analyst&lt;br&gt;&lt;br&gt;&lt;/p&gt;</description>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<category>Food and Beverage</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/868/fda--usda-compliance-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">EAR Boot Camp</title>
<link>http://www.americanconference.com/2014/880/ear-boot-camp/</link>
<pubDate>Wed 16 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;American Conference Institute's 3rd  National&lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;EAR Boot Camp&lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;October 16-17, 2013&lt;/strong&gt;&lt;br&gt;
    &lt;strong&gt;Venue TBA, Chicago, IL&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Widely regarded as the  most comprehensive, practical EAR compliance course, &lt;strong&gt;American Conference Institute's&lt;/strong&gt; &lt;strong&gt;3rd National EAR Boot Camp &lt;/strong&gt;is an in-depth, practical nuts and bolts event on how to meet  strict compliance expectations and minimize new penalty risks. &amp;nbsp;&lt;strong&gt;&lt;em&gt;Unlike other courses&lt;/em&gt;&lt;/strong&gt;, this event  will feature a robust faculty of government, industry and private practice  experts, who will deconstruct new and mainstay EAR requirements affecting your  business.&amp;nbsp; &lt;/p&gt;
&lt;p&gt;Amid &lt;strong&gt;heightened enforcement activity&lt;/strong&gt; and ongoing &lt;strong&gt;export  control reform &lt;/strong&gt;initiatives, it is critical for exporters to know how to properly &lt;strong&gt;update their classification and  re-classification strategies&lt;/strong&gt;, meet rigorous&lt;strong&gt; EAR licensing&lt;/strong&gt; requirements, apply new and existing &lt;strong&gt;EAR license exceptions&lt;/strong&gt;, conduct &lt;strong&gt;end-user, end-use and third party due  diligence&lt;/strong&gt;, and make sense of &lt;strong&gt;nationality  and deemed export rules&lt;/strong&gt;. &amp;nbsp;Navigating  highly complex &lt;strong&gt;encryption&lt;/strong&gt; controls  also continues to be a struggle for even the most veteran export professional.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Whether you are new to the EAR or a seasoned professional&lt;/strong&gt;, you  will benefit from an in-depth discussion of the latest reforms, how the EAR has  and will evolve over the next year, &lt;strong&gt;and  how to ensure that your organization is properly implementing new rules&lt;/strong&gt;.&amp;nbsp; &lt;/p&gt;
&lt;p&gt;The 2013 agenda will be  fully updated to include a step-by-step analysis of export control reform and  their practical impact, &lt;strong&gt;how large and  smaller exporters are updating their export compliance management systems&lt;/strong&gt;,  along with comprehensive sessions on core concepts and requirements that  continue to pose significant daily compliance challenges.&lt;/p&gt;
&lt;p&gt;The conference program is  currently under development. For speaking opportunities, please contact Adina  Schwartz, Industry Manager at a.schwartz@americanconference.com.&lt;/p&gt;
&lt;p&gt;If you are interested in  learning more about sponsorship opportunities available for this event, please  contact Wendy Tyler, &lt;a href=&quot;mailto:w.tyler@americanconference.com&quot;&gt;w.tyler@americanconference.com&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;For information on media  and association partnerships, please contact Adina Schwartz, Industry Manager  at &lt;a href=&quot;mailto:a.schwartz@americanconference.com&quot;&gt;a.schwartz@americanconference.com&lt;/a&gt;.&lt;/p&gt;

</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Telecoms &amp; Technology</category>
<category>Aerospace and Defense</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/880/ear-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">ERISA LITIGATION</title>
<link>http://www.americanconference.com/2014/876/erisa-litigation/</link>
<pubDate>Thu 24 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;P&gt;&lt;STRONG&gt;ACI's 6th Annual ERISA Litigation Conference&amp;nbsp; -- Call for Speakers Now Open&lt;/STRONG&gt; &lt;BR&gt;&lt;BR&gt;The next installment of the conference will take place on &lt;STRONG&gt;&lt;U&gt;October 24-25, 2013 &lt;/U&gt;&lt;/STRONG&gt;in &lt;STRONG&gt;New York &lt;/STRONG&gt;at the &lt;STRONG&gt;New York Marriott East Side.&lt;BR&gt;&lt;/STRONG&gt;&lt;BR&gt;Planning of the conference is underway and the call for speakers is now open. If you are interested in being considered to speak at the conference, please let us know of your interest - &lt;EM&gt;&lt;B&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-STYLE: normal; FONT-FAMILY: 'Tahoma','sans-serif'; COLOR: black; FONT-SIZE: 9pt; mso-bidi-font-style: italic&quot;&gt;&lt;A title=&quot;click here&quot; href=&quot;mailto:K.Horton@AmericanConference.com?subject=Interested%20in%20Speaking%20at%20ACI's%20ERISA%20Litigation%20Conference&quot;&gt;&lt;I style=&quot;mso-bidi-font-style: normal&quot;&gt;&lt;FONT color=#0000ff&gt;click here&lt;/FONT&gt;&lt;/I&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/EM&gt;&lt;STRONG&gt;&lt;EM&gt;&amp;nbsp;to submit a speaker nomination and/or a topic or case study&lt;/EM&gt;&lt;/STRONG&gt;. &lt;BR&gt;&lt;BR&gt;We know there are other ERISA litigation conferences on the market.&amp;nbsp;This is the event that the industry has known and trusted for years - &lt;STRONG&gt;&lt;U&gt;accept no imitation conferences&lt;/U&gt;&lt;/STRONG&gt;.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Be sure to mark your calendars now for the annual late October conference (the one now in its 6th installment).&amp;nbsp;&amp;nbsp; &lt;BR&gt;We look forward to seeing you in NYC this Fall!&lt;BR&gt;Kind regards,&lt;BR&gt;&lt;BR&gt;Kenneth S. Horton, Esq.&lt;BR&gt;Division Manager&lt;BR&gt;American Conference Institute&lt;BR&gt;45 West 25th Street, 11th Floor&lt;BR&gt;New York, NY 10010&lt;BR&gt;(212) 352-3220&lt;BR&gt;&lt;A href=&quot;mailto:k.horton@americanconference.com&quot;&gt;k.horton@americanconference.com&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Brett Brumberger, Esq.&lt;BR&gt;Industry Manager&lt;BR&gt;American Conference Institute&lt;BR&gt;45 West 25th Street, 11th Floor&lt;BR&gt;New York, NY 10010&lt;BR&gt;(212) 352-3220&lt;BR&gt;&lt;A href=&quot;mailto:b.brumberger@americanconference.com&quot;&gt;b.brumberger@americanconference.com&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;</description>
<category>Employment &amp; Benefits</category>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/876/erisa-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Managing Complex ITC Litigation</title>
<link>http://www.americanconference.com/2013/869/managing-complex-itc-litigation/</link>
<pubDate>Tue 29 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;Boasting record attendance at the most
recent instalment held in Washington, DC this past February, the &lt;i style=&quot;mso-bidi-font-style:normal&quot;&gt;5&lt;sup&gt;th&lt;/sup&gt; Expert Forum on&lt;/i&gt; &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;ITC Litigation &amp;amp; Enforcement &lt;/b&gt;featured
participation by several members of the senior staff at the &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;U.S. International Trade Commission, &lt;/b&gt;including
ITC Chairman Williamson, Commissioner Aranoff, Commissioner Pearson,
Commissioner Pinkert, Chief Administrative Law Judge Bullock, Administrative
Law Judge Rogers, Administrative Law Judge Essex, as well as Chief Judge Rader
of the U.S. Court of Appeals for the Federal Circuit.&lt;/span&gt;&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot; style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;Building off of the momentum of this
great annual industry event and the positive response we received from
participants at our Forum on&lt;i style=&quot;mso-bidi-font-style:normal&quot;&gt;&lt;span style=&quot;mso-bidi-font-weight:bold&quot;&gt; &lt;/span&gt;&lt;/i&gt;&lt;b&gt;Managing Complex ITC
Litigation &lt;/b&gt;&lt;span style=&quot;mso-bidi-font-weight:bold&quot;&gt;last fall in San
Francisco, ACI is pleased to be offering you the West-Coast based &lt;b&gt;Complex
ITC Litigation&lt;/b&gt; event again this October.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot; style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;Geared specifically towards the needs
of in-house counsel and private practice attorneys engaged in ITC litigation
and featuring a completely updated agenda, &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;Managing
Complex ITC Litigation &lt;/b&gt;will provide an opportunity for in-house counsel and
private practice attorneys to benchmark, share and discuss the most effective
ITC litigation strategies.&lt;/span&gt;&lt;/p&gt;



&lt;p class=&quot;MsoNormal&quot; style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;Don't miss this opportunity to learn
how to best navigate the complexities of litigation at the U.S. International Trade
Commission from a faculty of experienced, senior-level in-house counsel, ITC
practitioners and staff at the Commission.&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp;
&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;u&gt;No other event&lt;/u&gt;&lt;/b&gt; on the
west coast offers you the same calibre of content and expert speakers. &lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;
The conference program for the 2013 &lt;i style=&quot;mso-bidi-font-style:normal&quot;&gt;West
Coast&lt;/i&gt; &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;Complex ITC Litigation&lt;/b&gt; is
currently under development but to inquire regarding speaking opportunities and
submit speaking proposals, please contact Adina Schwartz, Industry Manager at &lt;/span&gt;&lt;span lang=&quot;EN-GB&quot;&gt;&lt;a href=&quot;mailto:a.schwartz@americanconference.com&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot;&gt;a.schwartz@americanconference.com&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;
If you are interested in learning more about sponsorship opportunities
available for this event, please contact Esther Fleischhacker, Senior Business
Development Executive, Special Projects at
&lt;a href=&quot;e.fleischhacker@AmericanConference.com&quot;&gt;e.fleischhacker@AmericanConference.com&lt;/a&gt; or at 212-352-3220 ext. 5232.&lt;br&gt;
&lt;br&gt;
For information on media and association partnerships, please contact Adina
Schwartz, Industry Manager at &lt;/span&gt;&lt;span lang=&quot;EN-GB&quot;&gt;&lt;a href=&quot;mailto:a.schwartz@americanconference.com&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot;&gt;a.schwartz@americanconference.com&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-family:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;&quot; lang=&quot;EN-GB&quot;&gt;.&lt;/span&gt;&lt;/p&gt;



&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;}
&lt;/style&gt;
&lt;![endif]--&gt;</description>
<category>International Trade</category>
<category>Intellectual Property</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/869/managing-complex-itc-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Over the Counter Drugs</title>
<link>http://www.americanconference.com/2014/863/over-the-counter-drugs/</link>
<pubDate>Tue 29 Oct 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;Prepare to meet the challenges of the rapidly evolving legal and regulatory landscape of the non-prescription drug industry.&lt;br&gt;&lt;br&gt;&lt;/b&gt;&lt;div align=&quot;left&quot;&gt;FDA's proposed introduction of a new paradigm for&lt;b&gt; 'OTC drugs with conditions of safe use' &lt;/b&gt;(which some industry observers have referred to as a third class of drug product or &lt;b&gt;'behind the counter'/ 'BTC' products&lt;/b&gt; ) has put a new twist on existing legal and regulatory protocols and product commercialization in the OTC space.&amp;nbsp; Self-diagnosis and self-care, two basic tenants of the current OTC paradigm may be supplemented with the assistance of a pharmacist and rapid diagnosis testing, thus leading to a multitude of questions ranging from scope of FDA authority to potential liabilities. &lt;b&gt;&lt;br&gt;&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;/div&gt;A distinguished faculty will address the intricacies of this new proposal as well as existing challenges affecting such core OTC functions as &lt;b&gt;advertising and promotion; labeling; trademarks, trade names and line extensions; and the modernization of the monograph system&lt;/b&gt;. They will provide you with the critical information that you need to:&lt;br&gt;&lt;ul&gt;&lt;li&gt;Understand the interplay between OTC drugs introduced under this proposed new paradigm and other Rx to OTC switches&lt;/li&gt;&lt;li&gt;Identify prescription products that are appropriate candidates for an Rx to OTC switch and proposed OTC drugs with conditions of safe use&lt;/li&gt;&lt;li&gt;Examine the label as a means of advertising and promotion&lt;/li&gt;&lt;li&gt;Analyze the use of social media in OTC advertising&lt;/li&gt;&lt;li&gt;Overcome challenges with line extensions for monograph and NDA OTCs&lt;/li&gt;&lt;/ul&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Learn to Prevent and Defend Enforcement Actions in the OTC Space by Mastering Critical AER, GMP and Recall Competencies.&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;This is the only legal and regulatory gathering specifically designed for the OTC drug industry which will specifically address enforcement activity and preventative measures based on real world examples impacting non-prescription pharmaceutical products.&amp;nbsp; Present and former FDA enforcers and industry experts will help you:&lt;br&gt;&lt;ul&gt;&lt;li&gt;Understand the scope of FDA and DOJ - as well as FTC - enforcement in the OTC space&lt;/li&gt;&lt;li&gt;Overcome challenges in forming effective recall execution strategies&amp;nbsp;&lt;/li&gt;&lt;li&gt;Explore the link between recent&amp;nbsp; GMP&amp;nbsp; violations and enforcement activity in the OTC space&lt;/li&gt;&lt;li&gt;Establish internal AER review protocols and record keeping systems in accordance with inspection requirements &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Sign up by June 14, and receive a special way in advance rate of $1895. &lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;br&gt;Register today for the industry's premier and most comprehensive legal and regulatory forum on OTC pharmaceutical products by calling &lt;b&gt;1-888-224-2480&lt;/b&gt;, faxing your registration form to&lt;b&gt; 1-877-927-1563&lt;/b&gt;, or logging on to &lt;b&gt;&lt;a href=&quot;http://www.AmericanConference.com/OTCDrugs&quot;&gt;AmericanConference.com/OTCDrugs&lt;/a&gt;&lt;/b&gt;.&lt;br&gt;&lt;b&gt;&lt;br&gt;&lt;i&gt;Hear what delegates had to say about last year's event:&lt;/i&gt;&lt;/b&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;&quot;Great speakers and good presentations.&amp;nbsp; Very helpful.&quot;&lt;/li&gt;&lt;li&gt;&quot;A lot of really good information was presented.&amp;nbsp; I really like the case studies.&quot;&lt;/li&gt;&lt;li&gt;&quot;Great conference!&amp;nbsp; Excellent speakers ? some brilliant!&amp;nbsp; Superb conference co-chairs!&quot;&lt;/li&gt;&lt;li&gt;&quot;Very informative.&amp;nbsp; The material is detailed enough to provide information and guidance while still being presented so that a wide audience can understand.&quot;&lt;/li&gt;&lt;li&gt;&quot;Lots of new learning.&amp;nbsp; Overall good and informative.&quot;&lt;/li&gt;&lt;li&gt;&quot;Good conference.&amp;nbsp; It was useful to hear the FDA perspective, and esp. the speakers from industry.&quot;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Full conference details are on the way shortly.&amp;nbsp; If you are interested in speaking at this event, contact &lt;b&gt;l.piccolo@americanconference.com&lt;/b&gt;.&amp;nbsp; For information on sponsoring or exhibiting at this event, contact Wendy Tyler at &lt;b&gt;w.tyler@americanconference.com&lt;/b&gt;.&lt;br&gt;&lt;br&gt;&lt;/p&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Advertising &amp; Marketing</category>
<category>Litigation</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/863/over-the-counter-drugs/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">FDA Boot Camp Devices Edition</title>
<link>http://www.americanconference.com/2014/882/fda-boot-camp-devices-edition/</link>
<pubDate>Tue 5 Nov 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | The clearance and approval process?pre-approval concerns?product labeling? clinical trials and IDEs?MDRs? QSRs? post-market controls?recalls and withdrawals?enforcement ? all are critical aspects in the commercialization process for medical devices, which are governed by FDA law and regulation. Recent court cases, and high-profile trials concerning FDA-regulated products have made it clear that it is essential for attorneys who do not have regulatory practices ? but who do deal with FDA-regulated medical devices ? to have a familiarity with these concepts.&amp;nbsp;&amp;nbsp; The changing business dynamics of the life sciences industry have also made it critical for business executives, policy analysts and securities experts who work in this field to have a clear understanding of the dynamics of the FDA.&lt;br&gt;&lt;br&gt;&lt;b&gt;Litigation as well as numerous other legal, business, and policy decisions concerning FDA-regulated medical devices often hinge on what happened during the pre-approval, approval, or post-approval periods.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Many products liability lawyers, patent counsel, business and investment experts, medical and regulatory affairs professionals, and those involved in pricing and reimbursement ? despite their tenure in working with FDA-regulated devices ? are not well-versed in the essentials of the approval process and the regulatory hurdles of the post-approval period. Whether you are a products liability or patent litigator, in-house counsel, in-house business development or federal affairs professional, or new to regulatory practice, FDA Boot Camp ? Devices Edition will provide you the insights you need.&lt;br&gt;&lt;br&gt;&lt;b&gt;Boost your medical device FDA regulatory IQ. Learn about the FDA approval process and the ins and outs of post-approval challenges&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;ACI's Third Annual FDA Boot Camp ? Devices Edition&lt;/b&gt; has been designed to give you a strong working knowledge of core FDA competencies.&amp;nbsp; A distinguished faculty of top FDA regulatory device experts ? a &quot;Who's Who of the FDA Bar&quot; ? will share their knowledge and give you critical insights on:&lt;br&gt;&lt;ul&gt;&lt;li&gt;The organization, jurisdiction, functions, and operations of the FDA&lt;/li&gt;&lt;li&gt;An overview of medical device regulations&lt;/li&gt;&lt;li&gt;The classification of devices and the concept of &quot;risk-based&quot; classification&lt;/li&gt;&lt;li&gt;Clinical trials and IDEs&lt;/li&gt;&lt;li&gt;The 510(k) clearance process ? what you need to know now and what to expect in the future&lt;/li&gt;&lt;li&gt;The premarket approval process (PMAs) and drug labeling and promotion&lt;/li&gt;&lt;li&gt;General post-market controls and MDRs&lt;/li&gt;&lt;li&gt;QSRs vs. cGMPs and ISO&lt;/li&gt;&lt;li&gt;Mitigating the impact of enforcement actions&lt;/li&gt;&lt;li&gt;Recalls, product withdrawals, and FDA oversight authority&lt;/li&gt;&lt;/ul&gt;Attend this conference and learn to navigate your way through the regulatory maze that plays such a crucial role to your cases and practice areas. Seating is limited; don't delay ? register now by calling &lt;b&gt;1-888-224-2480&lt;/b&gt;, faxing your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt;, or registering online at &lt;b&gt;&lt;a href=&quot;http://www.AmericanConference.com/FDABootCamp-Devices&quot;&gt;www.AmericanConference.com/FDABootCamp-Devices&lt;/a&gt;.&amp;nbsp; &lt;/b&gt;&lt;br&gt;&lt;br&gt;Full conference details are on the way shortly.&amp;nbsp; If you are interested in speaking at this event, contact Leigh Leventhal at l.leventhal@americanconference.com.&amp;nbsp; For information on sponsoring or exhibiting at this event, contact Wendy Tyler at w.tyler@americanconference.com.&lt;br&gt;</description>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/882/fda-boot-camp-devices-edition/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">DCAA Audits</title>
<link>http://www.americanconference.com/2014/870/dcaa-audits/</link>
<pubDate>Tue 12 Nov 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;The &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;5&lt;SUP&gt;th&lt;/SUP&gt; Annual Advanced Forum on DCAA Audits &lt;/B&gt;is the premier gathering for industry professionals involved in DCAA audits. This two day program is designed to discuss the latest trends at the DCAA and DCMA, the recent developments on incurred cost audits and business system audits and offer guidance on how to prepare for your current and future audits. The 2013 program will feature best practices, fresh perspectives and war stories from senior executives from government contractors and subcontractors discussing what to expect during your audit and how to work effectively with the DCAA/DCMA on ongoing examinations. Some of the topics to be discussed include:&lt;?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-layout-grid-align: none; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraph align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;·&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Learn the best method to push back and refute claims when necessary. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-layout-grid-align: none; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpFirst align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;·&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Hear about the implications of statute of limitations rules and increasing referrals to Department of Justice on aggressive fraud indictors.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoListParagraphCxSpMiddle align=left&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-layout-grid-align: none; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpMiddle align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;·&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Find out the latest developments on adequate and reasonable documentation, access to internal audit work papers, CAS non- compliance issues, and executive compensation.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoListParagraphCxSpMiddle align=left&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-layout-grid-align: none; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpMiddle align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;·&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Best practices to establish and maintain an effective working relationship with the DCAA&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoListParagraphCxSpMiddle align=left&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-layout-grid-align: none; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpMiddle align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;·&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Discover the common findings from incurred cost audits and business system reviews and get tips on how to make your examination more efficient. &lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoListParagraphCxSpMiddle align=left&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-layout-grid-align: none; mso-add-space: auto; mso-list: l0 level1 lfo1&quot; class=MsoListParagraphCxSpLast align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Symbol; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;&lt;SPAN style=&quot;mso-list: Ignore&quot;&gt;·&lt;SPAN style=&quot;FONT: 7pt 'Times New Roman'&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Participate in panel discussion with your peers about the changing regulatory environment and the changing scope of the audits. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;The program is currently in development.&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp; &lt;/SPAN&gt;The 2013 agenda will feature new speakers, new topics and dedicated networking session. Our expert speaker faculty will include senior government officials, corporate executives and leading industry experts.&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp; &lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; mso-layout-grid-align: none&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Mark this date on your calendar and plan to attend this cutting edge event. Sign up today to receive our best pricing. &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/B&gt;Based on the past success of this event, &lt;B&gt;seats are expected to sell out&lt;/B&gt;. Register now by calling &lt;B&gt;1-888-224-2480 &lt;/B&gt;or online.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal align=left&gt;&lt;I&gt;&lt;SPAN style=&quot;FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin&quot;&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;For questions regarding the program and speaking opportunities, please contact Rachel Lewyn, Senior Program Director at &lt;A href=&quot;mailto:r.lewyn@americanconference.com&quot;&gt;r.lewyn@americanconference.com&lt;/A&gt;.&lt;BR&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;For sponsorship opportunities, please contact Wendy Tyler at &lt;A href=&quot;mailto:w.tyler@americanconference.com&quot;&gt;w.tyler@americanconference.com&lt;/A&gt; &lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&lt;BR&gt;For association and media partnerships, please contact Evan Ring at &lt;A href=&quot;mailto:e.ring@americanconference.com&quot;&gt;e.ring@americanconference.com&lt;/A&gt; &lt;BR&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;BR&gt;&lt;BR&gt;</description>
<category>Financial Services</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Ethics Credits</category>
<category>Aerospace and Defense</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/870/dcaa-audits/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Rx Drug Pricing Boot Camp</title>
<link>http://www.americanconference.com/2014/872/rx-drug-pricing-boot-camp/</link>
<pubDate>Tue 12 Nov 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | Now in its twelfth iteration, ACI's Rx Drug Pricing Boot Camp has been designed to provide drug manufacturers, PBMs, plans, and pharmacies with the critical information they need to effectively and efficiently manage government pricing.&amp;nbsp; This conference is a marriage of a primer on the basics of pricing for government payor programs and a comprehensive, in-depth, training program that will ensure that your pricing group and other related departments are well-versed in critical pricing concepts and methodologies, and are apprised of trends, best practices, and imminent changes. This course will enhance your understanding of complicated pricing calculations and will bring you up to speed on the latest in government pharmaceutical pricing.&amp;nbsp; &lt;br&gt;&lt;br&gt;&lt;b&gt;Understand how the implementation of health care reform is impacting government pricing practices.&amp;nbsp; Gain best practices to comply with new regulations.&lt;/b&gt;&lt;br&gt;&lt;br&gt;This conference will bring you up-to-the minute information on recently enacted rules, regulations, and CMS guidance and how your company can incorporate changes resulting from the implementation of health care reform into your pricing and compliance practices.&amp;nbsp; Our faculty of pricing experts will help maximize your company's participation in government payor programs by eliminating the confusion and uncertainty created by health care reform.&amp;nbsp; &lt;br&gt;&lt;br&gt;&lt;b&gt;Learn from and network with your fellow pricing and reimbursement professionals.&lt;/b&gt;&lt;br&gt;&lt;br&gt;In addition to intensive training in core pricing methodologies and concepts, ACI's Rx Drug Pricing Boot Camp, also provides the opportunity to network with fellow pricing colleagues.&amp;nbsp; With 80% of attendees coming from drug manufacturers, PBMs, plans and pharmacies, this is the perfect opportunity to find out what other companies are struggling with and how they are overcoming their pricing related challenges.&amp;nbsp; &lt;br&gt;&lt;br&gt;Attend the pre- and post-conference workshops to get the background and/or the in-depth information you need to maximize your learning and networking experience at this event.&lt;br&gt;&lt;ul&gt;&lt;li&gt;&lt;b&gt;The Pre-Conference Workshop: &lt;/b&gt;Government Payor Pricing 101: Primer for Professionals New to Pharmaceutical Pricing has been specifically designed for those attendees who need a basic introduction to the complex subject of government drug pricing.&amp;nbsp; This workshop will set the stage for the main conference and help attendees flow seamlessly into the conversations over the following days. &lt;br&gt;&lt;br&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Post-Conference Workshop B: &lt;/b&gt;Federal; Government Contracts and Pricing: FSS, VA, DoD, and More will build on the pricing fundamentals covered during the main conference and delve into the core pricing competencies for the &quot;Big Four&quot; government agencies. &lt;/li&gt;&lt;/ul&gt;Past iterations of the Boot Camp sold out; register now to ensure your place at this unique and important event.&amp;nbsp; Call &lt;b&gt;1-888-224-2480&lt;/b&gt;, fax your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt; or log onto &lt;b&gt;&lt;a href=&quot;http://www.AmericanConference.com/RxPricingBC&quot;&gt;www.AmericanConference.com/RxPricingBC&lt;/a&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;Full conference details are on the way shortly.&amp;nbsp; If you are interested in speaking at this event, contact Leigh Leventhal at l.leventhal@americanconference.com.&amp;nbsp; For information on sponsoring or exhibiting at this event, contact Wendy Tyler at w.tyler@americanconference.com.&lt;br&gt;&lt;br&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/872/rx-drug-pricing-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Fraud, Asset Tracing &amp; Recovery</title>
<link>http://www.americanconference.com/2014/596/fraud-asset-tracing--recovery/</link>
<pubDate>Mon 18 Nov 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Miami | The multi-jurisdictional nature of fraud and asset tracing cases requires practitioners to have a detailed working knowledge of the tools and remedies at their disposal to freeze and recover assets in an increasing range of jurisdictions.&amp;nbsp; With more and more fraud cases arising out of Latin America and requiring asset tracing in offshore Caribbean jurisdictions, Miami is a key hub for Fraud and Asset tracing professionals.&lt;br&gt;&lt;br&gt;Building on last year's successful inaugural event which attracted over 100 attendees, &lt;b&gt;C5's Fraud, Asset Tracing and Recovery &lt;/b&gt;in Miami will bring together the leading lawyers, forensic accountants and regulatory experts from the US, Latin America, the UK, Continental Europe as well as key offshore jurisdictions.&lt;br&gt;&lt;br&gt;In addition to extensive coverage of how the key legal challenges can be addressed, our expert faculty will provide you with examples of solutions and strategies that will help you build your plan for fraud litigation, monitor increased fraud activity and maximise the array of potential opportunities available in the America/Caribbean region.&lt;br&gt;&lt;b&gt;&lt;br&gt;Expert led sessions will include:&lt;/b&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Emergency Injunctive Relief and the Changing Attitudes of the Caribbean Courts&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Examining the Role of the State in Asset Recovery Actions:&amp;nbsp; Is Forfeiture the Right Approach?&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;A Comparative View of Conducting Internal Investigations for Fraud in the US, Switzerland and Brazil&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Psychology and Fraud:&amp;nbsp; How to Utilise Profiling Techniques in Fraud Litigation&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;How to Overcome the Challenges Posed by Data Privacy and Data Protection Laws when Conducting Fraud Investigations&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;How Latin American Countries are Tackling Fraud and Corruption&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Cutting Edge Internet Search Techniques to Glean Information in Fraud Cases&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;Given the international nature of fraud cases, cooperation between 
lawyers and other professionals from a multitude of jurisdictions is 
essential for a successful action.This event enables attendees to establish new contacts and exchange current tactics, strategies and best practices which will facilitate successful recovery actions.&lt;br&gt;&lt;b&gt;&lt;br&gt;&lt;/b&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Join your industry in Miami in November 2013!&lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;br&gt;Register Now by calling +44 (0) 207 878 6888 or register online by clicking Register Now above&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;The brochure for this event is currently in production, To ensure you receive a copy please email J.Horner@C5-Online.com&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;span class=&quot;bold&quot;&gt;&lt;/span&gt;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Anti-Corruption &amp; Fraud</category>
<category>Legal</category>
<category>Financial Services</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/596/fraud-asset-tracing--recovery/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Foreign Corrupt Practices Act</title>
<link>http://www.americanconference.com/2014/844/foreign-corrupt-practices-act/</link>
<pubDate>Tue 19 Nov 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | </description>
<guid isPermaLink="true">http://www.americanconference.com/2014/844/foreign-corrupt-practices-act/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Drug and Medical Device Litigation</title>
<link>http://www.americanconference.com/2013/845/drug-and-medical-device-litigation/</link>
<pubDate>Mon 9 Dec 2013</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | </description>
<category>Litigation</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2013/845/drug-and-medical-device-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">DAS &amp; Small Cells Congress</title>
<link>http://www.americanconference.com/2014/883/das--small-cells-congress/</link>
<pubDate>Thu 1 May 2014</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Las Vegas | </description>
<category>Telecoms &amp; Technology</category>
<category>Healthcare</category>
<category>Transportation</category>
<category>CPE Credits</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2014/883/das--small-cells-congress/</guid>
</item>


</channel>

</rss>